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Abstract 
The folding and targeting of membrane proteins poses a major challenge to the cell, as they 
must remain insertion competent while their highly hydrophobic transmembrane (TM) 
domains are transferred from the ribosome, through the aqueous cytosol and into the lipid 
bilayer. The biogenesis of a mature membrane protein takes place through the insertion and 
integration into the lipid bilayer. A number of TM proteins have been shown to gain some 
degree of secondary structure within the ribosome tunnel and to retain this conformation 
throughout maturation. Although studies into the folding and targeting of a number of 
membrane proteins have been carried out to date, there is little information on one of the 
largest class of  eukaryotic membrane proteins; the G-protein-coupled receptors (GPCRs).  
This project studies the early folding events of the human ortholog of GPR35. To analyse 
the structure of the 1
st
 TM domain, intermediates were generated and assessed by the 
biochemical method of pegylation (PEG-MAL). A structurally-similar microbial opsin 
(Bacterioopsin) was also used to investigate the differences in the early protein folding 
within eukaryotic and prokaryotic translation systems. Results showed that neither the 1
st
 
TM domain of GPR35 nor Bacterioopsin were capable of compacting in the ribosome 
tunnel before their N-terminus reached the ribosome exit point. The results for this assay 
remained consistent whether the proteins were translated in a eukaryotic or prokaryotic 
translation system. 
To examine the communication mechanism between the ribosome, the nascent chain and 
the protein targeting pathway, crosslinking experiments were carried out using the 
homobifunctional lysine cross-linker BS
3
. Specifically, the data generated here show that 
the nascent chain of GPR35 reaches the ribosomal protein uL23 in an extended 
conformation and interacts with the SRP protein as it exits the ribosome tunnel. This 
confirms the role of SRP in the co-translational targeting of GPR35. Using these methods 
insights into the early folding of GPCRs has been obtained. Further experiments using site-
directed mutagenesis to reduce hydrophobicity in the 1
st
 TM domain of GPR35, 
highlighted the mechanisms by which GPCRs are targeted to the endoplasmic reticulum. 
Confirming that hydrophobicity within the signal anchor sequence is essential of SRP-
dependent targeting.  
Following the successful interaction of the nascent GPR35 and SRP, GPR35 is 
successfully targeted to ER membranes, shown here as dog pancreas microsomes (DPMs). 
Glycosylation of the GPR35 N-terminus was used to determine nascent chain structure as 
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it is inserted into the ER membrane. These glycosylation experiments confirm that TM1 
has obtained its compacted state whilst residing in the translocon. Finally, a site-specific 
cross-linking approach using the homobifunctional cysteine cross-linker, BMH, was used 
to study the lateral integration of GPR35 into the ER. Cross-linking of GPR35 TM1 and 
TM2 could be detected adjacent to a protein of ~45kDa, believed to be Sec61α. The loss of 
this adduct, as the nascent chain extends, showed the lateral movement of GPR35 TM1 
from the translocon was dependent on the subsequent synthesis of TM2.  
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1. Introduction 
1.1. The Ribosome 
1.1.1 Ribosome Overview 
The ribosome is a multifunctional complex made up of ribosomal proteins (r-proteins) and 
ribosomal RNAs (r-RNAs) that combine to become the „intracellular protein nanofactory‟ 
of the cell. Genomic DNA is transcribed into messenger RNA (mRNA) by the actions of 
RNA polymerase and in turn is translated by the ribosome, producing nascent polypeptides 
by the addition of amino acids (Green & Noller 1997). The rRNA moieties of the ribosome 
provide the catalytic activity to generate peptide bonds at the peptidyl transferase centre 
(PTC), which form at a 2 x10
7 
fold rate of enhancement (Sievers et al. 2004). The ribosome 
was often thought to be non-discriminating against the peptides it generated, but 
accumulating evidence suggests that is not the case, as more and more proteins have been 
identified to interact with the ribosome during translation. R-proteins and r-RNAs are 
believed to play vital roles in processes such as tRNA selection and binding, formation of 
secondary structure, translocation and interactions with targeting factors/chaperones. 
 
1.1.2. Ribosome structure 
All ribosomes consist of two subunits, made up of RNA and proteins. The 70S bacterial 
ribosomes contain a small subunit (30S), made up of one 16S r-RNAs and 21 r-proteins. 
The large subunit (50S) is made up of 5S and 23S rRNAs and 33 r-proteins. X-ray 
crystallographic structures of the individual subunits and complete 70S ribosome of T. 
thermophilus revealed the complex make-up and interactions that occur between r-proteins 
and r-RNA (Ban 2000). The small subunit 16S rRNA can be split into four domains and is 
the centre point to which r-proteins interact. The rRNA of the 50S subunit can be split into 
7 domains and in contrast to the 30S is made up of interwoven RNA and r-proteins (Ban et 
al. 2000; Yusupova et al. 2001). Eukaryotic ribosomes, unlike their prokaryotic 
counterparts, are much larger and have a higher degree of complexity to their structure. 
The 80S ribosome made up of a small 40S subunit and large 60S subunit, containing 4 r-
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RNAs (18S in the small subunit and 5S, 5.8S and 28S in the large subunit) and ~80 r-
proteins, depending on the species.  
Although the mass and structural complexities of the eukaryotic and prokaryotic ribosomes 
differ considerably, much of the core structure is highly conserved. In fact, early cryo-EM 
maps of the eukaryotic ribosome were built around the crystal structure of the prokaryotic 
30S and 50S subunits (Wimberly et al. 2000; Ban et al. 2000) and enabled the 
identification of 46 eukaryotic r-proteins with bacterial and/or achaeal homologs (Spahn et 
al. 2001). One specific region that is conserved in all species of ribosome is the main 
catalytic and active site, which can be found at the interface between the large and small 
subunits; this region is known as the PTC (Figure 1.1). Through X-ray crystallographic 
experiments this region was shown to be made up solely of rRNA (Nissen et al 2000), with 
both ribosomal subunits contributing to the 3 tRNA binding sites, named the A 
(aminoacyl) site, which is required to accept incoming aminoacylated tRNA for synthesis; 
the P (peptidyl) site, which holds the tRNA molecule in place as the nascent chain is 
extended; and the E (exit) site, which holds the deacylated tRNA after dissociation with the 
nascent chain and prior to exit from the ribosome (Schmeing & Ramakrishnan 2009) 
(Figure 1.1 B). In each ribosome, the small subunit specifically binds mRNA and the anti-
codon stem loops of the tRNA, ensuring the translation reaction is carried out effectively 
by monitoring the base pairing between the codon and anti-codons. The large subunit, 
catalyzes the peptide bond formation between the incoming amino acids on the A site 
tRNA and the nascent chain at the P site.  
Although prokaryotic and eukaryotic ribosomes share a relatively conserved core, there are 
a number of variations within their composition. The differences between the two subsets 
of ribosomes mainly occur due to changes in sequence and lengths of r-proteins and 
rRNAs, known as expansion segments. Adaptations in cellular growth and stress 
conditions can be enough to vary rRNA elements, known as expansion bodies, proteins 
and add insertions to existing proteins (Jenner et al. 2012). Specifically, there were 32 
extra r-proteins found within the ribosome crystal structure of yeast that showed no 
prokaryotic homology, with the majority of these found to be located on the solvent 
exposed surface of the ribosome. Such differences as these are believed to enable the 
eukaryotic ribosomes to interact with eukaryotic specific translation factors and chaperones 
(Ben-Shem et al. 2010) 
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The difference in complexity of the prokaryotic and eukaryotic ribosomes is believed to be 
due to the differences seen throughout the prokaryotic and eukaryotic cell as a whole. The 
initial assembly in eukaryotes commences in the nucleolus and progresses to the 
nucleoplasm where it requires >350 specialized factors to preform specific assembly steps 
on pre-ribosomal particles. Following this, the pre-ribosomes are exported to the cytoplasm 
and undergo final maturation before they can begin translation (Gerhardy et al. 2014). 
Subsequently, prokaryotic ribosomes do not undergo the same level of assembly due to 
their lack of nucleus; hence there is no compartmentalisation in bacterial cells. The number 
of maturation factors required is also much lower than in eukaryotes.  
Eukaryotes themselves also contain a number of structurally distinct ribosome species. 
Alongside the ribosomes existing in the cytoplasm, the mitochondrion and chloroplasts of 
eukaryotes contain structurally different ribosomes. Mitochondrial ribosomes differ from 
Figure 1.1 Structure of the 70S prokaryotic ribosome. A. An x-ray crystallographic structure of 
the 70S ribosome containing mRNA and displaying A-, P- and E-tRNA sites. B. Separated 30S (B1) 
and 50S subunits (B2). The 30S subunit is displayed in orange and the 50S subunit in blue, with the 
A-, P- and E-sites coloured magenta, green and yellow respectively. Figure reproduced from 
Schmeing and Ramakrishnan (2009). 
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cytoplasmic and bacterial ribosomes, firstly in size and secondly in the number of proteins 
they synthesize. The ribosomes in the mitochondrion are made up from the large 39S 
subunit and the small 28S subunit (Greber et al. 2015). As the mitochondria only generate 
a small number of proteins themselves, the mito-ribosomes are only required to produce 13 
peptides used for ATP synthesis or oxidative phosphorylation (Breiman et al. 2015). The 
chloroplastic ribosomes are very similar in composition and overall structure to eubacterial 
ribosomes. They too consist of a 30S and 50S subunit, generating a 70S ribosome. The 
ribosomes in a chloroplast differ slightly from bacterial ribosomes in that they contain 
some plastid-specific ribosomal proteins (PSRBs). These proteins are believed to have 
some structural relevance, yet this cannot be confirmed due to the lack of a high resolution 
crystal structure (Breiman et al. 2015). 
  
1.1.3 Ribosome function 
1.1.3.1 Translation overview 
The ribosome is a large ribonucleoprotein with a primary function to synthesize proteins 
within the cell, using mRNA as a template and aminoacyl tRNAs as its substrates 
(Schmeing & Ramakrishnan 2009). Protein synthesis occurs at the catalytic PTC of the 
ribosome, which efficiently carries out its role in the transfer of amino acids to the growing 
nascent chain. The structure of the PTC is well adapted to deal with the wide range of 
amino acids that pass through the ribosome and is key to achieving a rate of synthesis 2 x 
10
7
-fold quicker than that of an uncatalyzed bond. By lowering the entropy of activation, 
excluding water and optimally positioning substrates, the PTC is capable of enhancing the 
rate of peptide bond formation (Sievers et al. 2004). The translation process can be roughly 
split into 3 stages, initiation, elongation and termination, a continuous cycle that occurs due 
to the recycling of many components. Both eukaryotic and prokaryotic ribosomes carry out 
these 3 stages, with elongation and termination following a similar pattern. The process of 
initiation however differs between the two cell types and is partly due to the increasing 
complexity found within eukaryotes. The following sub-sections will describe in greater 
depth the role of each stage in the translation process, focusing on the simplified 
prokaryotic translation and describing any differences that exist in eukaryotic translation. 
25 
 
1.1.3.2. Translation initiation  
Prokaryotic initiation 
The initiation of translation in prokaryotes begins during transcription, as the two are a 
tightly coupled process within the cell. The formation of the initiation complex on the 
small ribosome subunit requires 3 intermediary initiation complexes involving formylated 
aminoacyl initiator tRNA (fMet-tRNA
fmet
), the translated mRNA and 3 initiation factors 
(IF1, IF2 and IF3) (Laursen & Sørensen 2005).  Firstly IF3 binds to the 30S subunit and 
promotes dissociation of the two ribosomal subunits, enabling IF1 to bind specifically to 
the A-site in the 30S subunit and directing the initiator tRNA to the ribosomal P-site 
(Petrelli et al. 2001). X-ray crystallography shows IF1 actively blocks the A site and allows 
the fMet-tRNA
fmet
 to associate with the P-site (Clemons  Jr. et al. 2001). The actions of IF1 
enables IF2, a small GTPase, to bind to the initiator tRNA and aid its binding at the P-site 
(Lockwood et al. 1971). Finally, IF3 binds to the E site of the small subunit to prevent its 
association with the 50S subunit (Dallas & Noller 2001). It is also believed to help 
selection of the initiator tRNA by destabilizing the binding of other tRNAs in the P site of 
the ribosome (Hartz et al. 1990).  
At the point in which the 30S subunit binds to IF3, the ribosome is once again prepared to 
begin the initiation process (Figure 1.2A). At this point the subunit can then bind directly 
to a purine rich sequence within the mRNA known as the Shine Dalgarno sequence (5‟-
ACCUCCUUA-3‟), found  between 5-8 bases upstream of the AUG start codon (Shine & 
Dalgarno 1974)(Figure1.2B). The Shine Dalgarno sequence base pairs to a complementary 
sequence within the 16S rRNA of the 30S subunit. Formation of the 30S initiation complex 
(30S-IC) is completed when IF1, IF2 and the fMet-tRNA
fmet
 join the 30S subunit (Figure 
1.2C).Through GTP hydrolysis, IF2 binding promotes the release IF3  and the immediate 
joining of the 50S subunit(Figure 1.2D). As the 50S joins the 30S-IC to generate the 70S 
initiation complex (70S-IC) IF1, IF2 are released and the initiator tRNA moves into the 
PTC, readying the prokaryotic ribosome for elongation (Figure 1E). 
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Figure 1.2 Prokaryotic translation initiation. (A) Initiation Factor (IF) 3 binds to the 30S 
ribosomal subunit. (B) The mRNA Shine-Dalgarno (SD) sequence interacts with and binds 
to the 30S subunit. (C) This is followed by the binding of initiator fMet-tRNAfMet , IF1 
and IF2, completing the 30S Initiation Complex. Hydrolysis of GTP by IF2 results in 
release of IF3 from the recruitment of the 50S subunit. (D) Subsequent release of the 
remaining Initiation Factors IF1 and IF2 enables the binding of the 50S subunit. (E) The 
70S-IC is complete and the process of protein synthesis can continue into the elongation, 
termination and recycling stages.  
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Eukaryotic initiation 
Eukaryotic initiation differs substantially to prokaryotic initiation, mainly due to actions of 
a multitude of initiation factors (Pestova & Hellen 2001). As in prokaryotes, the small 40S 
subunit acts as the centre point for the assembly of the pre-initiation complex (PIC) 
(Jackson et al. 2010; Jenner et al. 2012). The eukaryotic initiation process can be 
subdivided into the formation of 3 intermediary complexes: the first step is the formation 
of the 43S-PIC, which occurs when the 40S subunit, eIF3, eIF1 and eIF1A enter the 
initiation process following ribosome recycling. The multisubunit eIF3 prevents the 
association of the 40S and 60S subunits and aids the binding of eIF1/1A. Cryo-EM and 
kinetic studies have shown that together, eIF1A and eIF1, stabilize a conformational 
change on the 40S subunit, opening the mRNA channel and aiding the formation of a 43S-
PIC (Pestova et al. 1998; Passmore et al. 2007). Formation of the 43S-PIC is completed 
when eIF2 and initiator tRNA (Met-tRNAi; post-transcriptionally modified to distinguish it 
from elongation Met-tRNA (Sonenberg & Hinnebusch 2009)) bind to the 40S subunit 
(Figure 1.3A), generating a complex that is capable of scanning the incoming mRNA 
template.  
Following the formation of the 43S-PIC, attachment to the 5‟ untranslated region (UTR) of 
the mRNA begins. To prepare for ribosomal attachment, the mRNA template is activated 
firstly by the attachment of a eukaryotic specific initiation factor complex, eIF4F.The 
eIF4F complex is made up of eIFs 4E, 4A and 4G and recruits the 43S-PIC to the mRNA 
template and to begin scanning (Pestova et al. 2001; Kolupaeva et al. 2007) (Figure 1.3B) 
Specifically, eIF4A and eIF4G have been shown structurally to undergo conformational 
changes to enable co-folding, which enhances binding to the m
7
G-cap (Gross et al. 2003). 
The crystal structure of yeast eIF4A provides a model for its role as an ATP-dependant 
helicase, interacting specifically with eIFG to unwrap the mRNA and preparing it for an 
association with eIF4E (Schütz et al. 2008). At the 3‟ end of the mRNA template, 150 or 
more adenine nucleotides are found making up a region known as the poly A-tail (Sheets 
& Wickens 1989). At the poly-A tail, an interaction takes place between the poly(A)-
binding protein (PABP) and the 5‟m7G cap of  the mRNA template, which results in a 
„closed loop‟ mRNA conformation due a secondary interaction with eIF4G. 
To prepare for ribosomal attachment to the mRNA template, eIF4F, eIF4B and eIF4A 
unwind the secondary structure of m
7
G cap in an ATPase dependant manner, enabling the  
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Figure 1.3 Schematic overview of eukaryotic translation initiation. (A) Initiation Factor 
(eIF) 1/1A and 3 binds to the 40S ribosomal subunit. This is followed by the binding of initiator 
Met-tRNAi and eIF2 and eIF5, completing the 40S Initiation Complex. (B) The mRNA is 
primed with a 5‟ m‟G cap and interacts with and binds to initiation factor complex eIF4F. (C) 
ATP hydrolysis enables the poly (A) binding protein and m‟5 cap to interact, activating the 
mRNA and completing the 43S complex. (D) Hydrolysis of GTP by eIF2 results in release of 
initiation factors and enables the binding of the 60S subunit. (E) The 70S-IC is complete and 
the process of protein synthesis can continue into the elongation, termination and recycling 
stages. 
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eukaryotic 43S-PIC to begin scanning from the 5‟ untranslated region (5‟UTR) of the 
mRNA. Initiation factors eIF1/1A begin the search for a suitable AUG start codon (located 
within a Kozak Sequence GCC(A/G)CCAUGG (Kozak 1986)) upon which codon-
anticodon interaction can take place (Figure 1.3C).  Eukaryotic PIC, in contrast to 
prokaryotic PIC, does not bind the incoming mRNA template directly at the AUG start 
codon; instead it is recruited to m
7
G-cap (post-transciptionally modified GTP (Shatkin 
1976)) found at the 5‟-end of the mRNA Interaction between the 40S, eIFs, initiator tRNA 
and mRNA template completes the formation of the 48S pre-initiation complex (Figure 
1.3C).  
Finally, following codon recognition, a step that commits the ribosome to the initiation 
process is required. Initiation factors, eIF1 and eIF1A (functionally similar to the IF3 and 
IF1 respectively in prokaryotes), promote irreversible GTP hydrolysis and aid the 
dissociation of incorrectly formed complexes from the mRNA template (Mitchell & 
Lorsch 2008). Upon forming the 48S complex correctly, subunit joining begins via the 
actions of eIF5 and eIF5b. The actions of eIF5 encourage the disassociation of initiation 
factors eIF1, eIF3 and residual eIF2-GDP (Figure 1.3E). The eIF5B has been shown to 
display GTPase activity and in doing so promoting the joining of the two subunits, whilst 
releasing itself from the 80S complex (Pestova et al. 2000). 
 
1.1.3.2. Translation elongation 
The elongation cycle consists of several steps by which amino acids are sequentially added 
to the polypeptide chain (Figure 1.4). In preparation for peptide synthesis, each individual 
amino acid is activated by ATP and paired to the correct tRNA in the cytoplasm, by the 
actions of a specific aminoacyl-tRNA synthase (Ibba et al. 1997).  By the generation of 
aminoacyl-tRNAs, the initial decoding step of the elongation cycle can begin. Decoding 
ensures that the ribosome selects the correct aminoacyl-tRNA, as dictated by the mRNA 
codon, to take up its place in the vacant A-site (Schmeing & Ramakrishnan 2009). The 
delivery of the correct amino acid to the A-site occurs in a ternary complex made up of 
aminoacyl-tRNA, elongation factor Tu (EF-Tu) and GTP (Figure 1.4A). Complementary 
pairing of the codon-anticodon in the A-site is believed to occur at random, with the 
ribosome sampling multiple codons until there is a match (Figure 1.4B). However, the 
accuracy in codon selection at the A-site is high and is believed to be due to three 
universally conserved bases (A1492, A1493, and G530) situated in 16S RNA of the 30S  
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subunit (Ogle et al. 2001). Once a codon-anticodon match occurs, a conformational change 
in the 30S subunit takes place, which stabilizes the ternary complex at the A-site. 
Stabilization of the ternary complex on the 30S subunit causes a distortion in the tRNA, 
which simultaneously leads to interactions occurring between the aminoacyl-tRNA, EF-Tu 
and the decoding site (Schmeing 2010). At this point EF-Tu can take up a GTPase 
activated state in which GTP hydrolysis occurs (Figure 1.4C), resulting in the movement of 
the aminoacyl-tRNA towards the PTC and the disassociation of EF-Tu-GDP (Figure 1.4D) 
(Rodnina et al. 1996; Blanchard et al. 2004).   
The movement of the aminoacyl end of the tRNA into the PTC signals the start of the 
central catalytic event of protein synthesis, peptide bond formation. This reaction occurs 
when the α-amino group of the aminoacyl-tRNA nucleophilically attacks between the 
carboxylate group of the growing peptide chain and the 3‟OH group of peptidyl-tRNA 
bound at the P-site (Beringer et al. 2005). At this point, the elongation cycle enters 
translocation, where the nascent peptide chain is moved to the A-site, leaving a deacylated 
Figure 1.4 Schematic overview of translation elongation. (A). Elongating peptide makes its 
way through the ribosome exit tunnel bound to tRNA situated in the ribosome P-site. (B) A 
complex of aminoacyl tRNA, elongation factor Tu (EF) and GTP enter the ribosome A site. (C) 
Base pairing of the A-site tRNA with the mRNA results in hydrolysis of GTP by EF-Tu. (D) 
Dissociation of EF-Tu-GDP and accommodation of the aminoacyl-tRNA in the A-site in 
preparation for peptide bond synthesis. 
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tRNA at the P-site. During translocation, the ribosome subunits move in a ratchet-like 
manner, during which time the mRNA is moved exactly 3 bases, whilst the tRNAs at the A 
and P-sites translocate to the P and E-sites respectively (Frank & Agrawal 2000; Blanchard 
et al. 2004; Cornish et al. 2008). To accommodate the movement of the nascent chain, the 
ribosome changes from a classical binding state (A/A and P/P) to a hybrid binding state 
(A/P and P/E) (Figure 1.5) (Frank and Agrawal 2000). Crystallographic structures of the 
ribosome trapped in these two states, verified previous research and discovered ~9° of 
relative rotation between the 30S and 50S subunits (Dunkle et al. 2011). Single molecule 
FRET assays demonstrated in real-time,  how the spontaneous ratchet-like movement is 
capable of switching the ribosome between a „non-rotated‟ and „rotated‟ state after peptidyl 
transfer, until the point at which elongation factor G (EF-G) binds and stabilizes the 
„rotated‟ conformation(Figure 1.5) (Cornish et al. 2008). The binding of EF-G catalyses 
the entire translocation reaction by the hydrolysis of GTP (Rodnina et al. 1997). Structural 
studies show that EF-G contains a GTPase domain which becomes activated upon binding 
the ribosome at the sarcin-loop (Connell et al. 2007). GTP hydrolysis generates the 
necessary conformational changes in the ribosome to translocate the mRNA and tRNA, 
with translocation being complete when the EF-G·GDP and Pi are released from the 
ribosome (Savelsbergh et al. 2003).  Following translocation, the newly extended peptide 
is located in the P-site of the ribosome where another elongation cycle can proceed until 
synthesis is complete. 
  
Figure 1.5 Schematic overview of deacylated tRNA and peptidyl tRNA during elongation. 
Deacylated tRNA is initially in the P-site and peptidyl tRNA is initially in the A-site in the classical 
binding state pre-translocation. Rotational movement of the 30S and 50S during translocation 
generates hybrid state and the actions of EF-G.GTP stabilises the ribosome, moving the deacylated 
tRNA into the E site.   
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1.1.3.4 Translation termination and recycling of ribosomes 
Termination occurs when the synthesis of the nascent peptide is complete and a mRNA 
stop codon (UAA, UAG or UGA) moves into the A-site, signalling the end of translation. 
The stop codon is recognised by a class I release factor that is capable of cleaving the 
polypeptide chain from the P-site by hydrolysing the tRNA bond and releasing the protein 
from the ribosome. In prokaryotes, two class I release factors exist, RF1 and RF2. High 
resolution structures of RF1 and RF2  binding to the ribosome shows a conformational 
change in conserved bases (G530, A1492 and A1493) of 16S RNA at the decoding centre, 
generating stabilizing interactions between release factors, the stop codon and PTC, which 
allows the cleavage of the amide bond to take place (Figure 1.6A)(Laurberg et al. 2008; 
Weixlbaumer et al. 2008). Both factors are capable of recognising the UAA stop codon 
when bound to the ribosome by the conserved tripeptide motif GQQ. However, the UAG 
and UGA stop codons can only be recognised by RF1 motif PXT and RF2 motif SPF 
respectively (Ito et al. 2000). Following peptide release, the class II release factor RF3 
binds to RF1/2 and disassociates them from the ribosome (Figure 1.6B) (Freistroffer et al. 
1997). Through hydrolysis of GTP, a conformational change within RF3 enables an 
interaction with the ribosome  at the P-site, destabilizing RF1/2 binding, accelerating their 
disassociation (Figure 1.6C)(Zavialov et al. 2001). Hydrolysis of GTP causes the release 
factor itself to dissociate from the ribosome, leaving the mRNA and deacylated tRNA 
bound to the P-site (Figure 1.6D)(Schmeing & Ramakrishnan 2009). At this point the 
recycling of the ribosomal subuints begins, enabling further rounds of protein synthesis. 
The process is carried out by the ribosome recycling factor (RRF) and EF-G (Hirashima & 
Kaji 1973), separating the 30S and 50S subunit through a mechanism that has yet to be 
fully understood. IF3 is then believed to engage the 30S subunit, releasing the associated 
tRNA and mRNA and preventing early reassembly (Zavialov et al. 2005). 
In eukaryotes, termination is carried out in a similar fashion to prokaryotes, by release 
factors eRF1 (class I) and eRF3 (class II), neither of which are related to either RF1 or RF2 
(Song et al 2000).  eRF1 and eRF3 are believed to form a complex with GTP, in which 
eRF1 is responsible for recognising all 3 variations of the stop codon and eRF3 is required 
for GTP hydrolysis (Alkalaeva et al. 2006). Recycling of the ribosomal subunits, as in 
prokaryotes, follows the actions of the release factors. In mitochondria and chloroplasts, 
the mechanism follows closely that which was described in prokaryotes, with both 
containing homologs of the prokaryotic recycling factor (Rorbach et al. 2008). However, 
the method for  recycling in cytoplasmic ribosomes differs, relying on the actions of 
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ABCE1, an ATPase which dissociates the large and small subunit (Pisarev et al. 2010).  
The release of mRNA and tRNA from the 30S subunit is believed to be carried out by a 
number of initiation factors, in preparation for a new round of protein synthesis. 
 
  
Figure 1.6 Schematic overview of translation termination. (A)Termination begins as stop 
codon enters the A-site (B) Release Factor binding (RF1 and RF2) and GTP hydrolysis triggers 
the release of the nascent chain. (C) GTP bound release factor RF3 binds to RF1/2.  (D) GTP 
hydrolysis of RF3 drives the dissociation of release factors and deacyl-tRNA . 
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1.1.4 The ribosome exit tunnel 
1.1.4.1 The structure of the ribosome exit tunnel 
As elongation continues and the nascent peptide increases in length, the ever expanding 
polypeptide follows a route from the PTC, through the large subunit and out into the 
cytoplasm. The existence of a tunnel within the large subunit of the ribosome was 
suggested many decades ago through biochemical and imaging studies. Protease digestion 
assays carried out by Malikin and Rich (1967), showed the first signs of the ribosome 
offering protection to the translating nascent chain, suggesting an exit tunnel was present. 
Following this, the first image reconstruction of the large ribosomal subunit was produced, 
providing a reliable model of an exit tunnel, ~100-120Å length, making its way from the 
PTC through the large subunit (Yonath et al. 1987). The first studies using cryo-Electron 
Microscopy (cryo-EM) confirmed the existence of the tunnel (Frank et al. 1995), with 
more recent high resolution structures containing a nascent peptide removing any doubt 
(Figure 1.7B) (Bhushan et al. 2010; Seidelt et al. 2009) 
Numerous 3D-structures of different ribosomes have provided us with a detailed view of 
the ribosome exit tunnel (Ban 2000; Ben-Shem et al. 2010; Jenner et al. 2012).  The 
structure and environment of the tunnel in cytoplasmic ribosomes is phylogenetically well 
conserved. The size of the tunnel from PTC to the point of exit is ~100Å in length and its 
diameter ranges from 10Å at its narrowest point to 20Å at the vestibule near its exit (Figure 
1.7)(Ban et al. 2000; Voss et al. 2006; Bhushan et al. 2010). The tunnel itself is shaped by 
the conserved r-RNA 23S and multiple r-proteins. In all ribosome structures, r-proteins 
uL4 and uL22 create a constriction point ~25-30Å from the PTC, the point at which the 
tunnel is narrowest. At the bottom of the tunnel is the uL23 protein, which lines the exit 
interface and is believed to play a key role in signalling to cytoplasmic ribosome associated 
factors (Figure 1.7A)(Woolhead et al. 2004; Robinson et al. 2012). Specific to bacteria is a 
finger-loop of uL23 which protrudes from the tunnel wall. In eukaryotes this is replaced by 
the r-protein eL39 (Ben-Shem et al. 2010; Anger et al. 2013). Originally the ribosome 
tunnel was believed to possess „teflon-like‟ qualities allowing the nascent chain to move 
through relatively unhindered (Ban et al. 2000). However, increasing evidence is now 
suggesting that the tunnel plays a key role in interacting with the elongating nascent chain 
as it makes its way out of the ribosome. Although the tunnel is predominantly hydrophilic, 
patches of hydrophobicity do exist and together with the r-proteins may generate sites 
where the translating peptide and tunnel can interact. The solvent face of the ribosome exit 
tunnel also shows a considerable degree of conservation and plays a key role in harbouring 
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co-translational factors that are required for the capture of an exiting nascent chain. 
Prokaryotic ribosomes have a total of 6 r-proteins located around the rim of the tunnel, 
were as eukaryotes, with their greater complexity, have 10.   
 
 
 
 
 
 
 
  Figure 1.7 The ribosome exit tunnel makes it way through the large ribosome subunit  
A. Eukaryotic large ribosomal subunit, indicating the path of the nascent chain (grey line) 
through the exit tunnel. The ribosomal proteins uL4 and uL22 form the narrowest part of the exit 
tunnel known as the constriction site. eL39 and uL23 form contacts within the tunnel at the distal 
of the tunnel close to the exit site. Nomenclature of r-proteins is not up to date with renaming 
that occurred in 2014 (Ban et al., 2014).  Structures reproduced from (Nissen 2000) B. 
Schematic cross-section of the 80S ribosome tunnel highlighting regions in which secondary and 
tertiary structure may form. Diagram reproduced from (Bhushan et al., 2010) 
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1.1.4.2 Folding in the ribosome tunnel 
Over the last two decades it has become clear that the ribosome exit tunnel is much more 
than a passive channel, with many studies highlighting its ability to promote a certain 
degree of folding within the nascent chain. The dimensions of the tunnel make it difficult 
to imagine the folding of a complex structure, but increasing evidence has built up to 
suggest that secondary structures can be formed within the ribosome (Lu & Deutsch 
2005a; Bhushan et al. 2010; Woolhead et al. 2004). Indeed a number of biochemical 
studies, using pegylation and cross-linking assays, and structural studies have shown that 
the ribosome is capable of housing nascent chains up to 40aa in length, which is more than 
expected to be required to traverse ~100Å in an extended form (Lu & Deutsch 2005b; 
Houben et al. 2005; Bhushan et al. 2010).   
The ribosome tunnel, as described in Section 1.1.4.1, does not offer structural uniformity 
throughout, with certain regions believed to accommodate secondary structure more than 
others. Indeed a number of studies have shown that the ribosome contains distinct „folding 
zones‟ within the tunnel (Figure 1.7B).  The first study to directly show compaction taking 
place within a nascent peptide used the biophysical technique fluorescence resonance 
energy transfer (FRET) (Woolhead et al. 2004). These experiments carried out on an α-
helical transmembrane (TM) domain, highlighted an area just after the PTC in the upper 
tunnel as a possible „folding zone‟. Following this, a biochemical assay using an 
engineered peptide with a high α-helical propensity, indicated that folding could also take 
place in the lower regions of the ribosome tunnel (Lu & Deutsch 2005b). These 
experiments were later followed by cryo-EM data to confirm two distinct regions where 
folding may be possible; one close to the PTC, before the constriction point and a second 
after the constriction point as you near the exit site (Figure 1.7B)(Bhushan et al. 2010).  
In recent years, further interest has explored the possibility of tertiary structure forming 
within the ribosome. Due to size restrictions within the tunnel, the only viable region that 
could possibly house such structures would be the vestibule, which is ~20Å in diameter. 
Computational studies agreed that this was the most likely region of the tunnel to see 
tertiary interactions and suggested that transient tertiary structures could form in the final 
20Å of the tunnel (O‟Brien et al. 2010). Subsequent biochemical studies have since shown 
the presence of a helical hairpin structure forming between two TM domains, in the 
vestibule of the tunnel, whilst the nascent peptide is stably bound to the ribosome (Tu et al 
2014). Recently, the complete folding of small protein domains (Nilsson et al. 2015; 
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Marino et al. 2016), such as the ADR1a zinc finger, within the lower ribosome tunnel has 
been observed, suggesting the folding capacity of the ribosome could be even greater than 
imagined. 
 
1.1.4.3 Ribosome tunnel-nascent chain interactions 
The concept of the ribosome tunnel having a passive role on the nascent chain during 
elongation is has been dispelled. Mounting evidence has built up over the last decade and a 
half, suggesting that interactions between the ribosome and the nascent chain are essential 
during protein biogenesis. Interactions between the ribosome and nascent chain have been 
postulated to occur for a number of reasons: firstly, the ribosome acts as a sensory 
organelle, preparing for when the nascent chain is about to leave the tunnel. The ribosomal 
proteins uL23 and uL22 proteins are both suggested to have finger-loop domains that 
protrude into the ribosome tunnel. These loops are believed to sense the elongating nascent 
chain and prepare the ribosome for the recruitment of targeting factors, chaperones and 
possible interaction with the membrane translocon (Woolhead et al. 2004; Bornemann et 
al. 2008; Liao et al. 1997). Another possible reason, as discussed above, is to aid the 
formation of secondary structure. Some suggest that the formation of secondary structure 
may be required for an interaction between the nascent chain and targeting factors such as 
the signal recognition particle (SRP) (Robinson et al. 2012). The presence of secondary 
structure within the ribosome may also increase the efficiency of insertion into the ER 
membrane (Tu et al. 2014). Finally, a major tunnel-nascent chain interaction that has been 
identified in certain nascent peptides, is to induce co-translational stalling from within the 
tunnel. Proteins such as SecM for example, contain specific arrest motifs that selectively 
position amino acids in regions of the tunnel where interactions between the nascent chain 
and uL4 can cause translational arrest (Nakatogawa & Ito 2002). These „translation arrest 
peptides‟ have been identified in both eukaryotic and prokaryotic genomes and act to 
regulate gene expression by sensing cellular conditions (Cruz-Vera et al. 2011). 
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1.1.4.4 Nascent peptides at the ribosome exit site 
As newly-synthesised proteins approach the exit of the ribosome, a number of mechanisms 
are in place to ensure proper protein homeostasis occurs. At the exit site, a number of 
protein biogenesis machineries meet and compete to gain access to the translating nascent 
peptide (Zhang & Shan 2012). As the nascent chain begins to leave the tunnel, there is a 
high chance that it will come into contact with chaperones associated with the ribosome. 
Interactions with these chaperones prevent misfolding and aggregation of the nascent 
chain. In prokaryotes, a high number of polypeptides come in to contact with the ribosome-
associated chaperone trigger factor (TF), which has been shown to provide stability, 
prevent aggregation and even unfold misfolded nascent chains (Kaiser et al. 2006; 
Hoffmann et al. 2012). In eukaryotes, most nascent chains again encounter chaperones, 
such as heat shock proteins and the nascent polypeptide-associated complex (NAC), which 
offer protection from aggregation similar to prokaryotic chaperones (Wang et al. 1995; 
Yam et al. 2008).    
After initially binding ribosome associated chaperones, there are a number of routes that a 
nascent chain can potentially take. The first major route is for proteins that are cytosolic or 
destined for cellular organelles. They can be passed onto post-translational chaperones or 
post-translational targeting factors enabling them to be managed after they have become 
detached from the ribosome. Post-translational chaperones, such as DnaK/DnaJ in 
prokaryotes and the TRiC/CCT complex in eukaryotes provide favourable conditions for 
the peptide to begin folding into their tertiary structure (Calloni et al. 2012). Post-
translational targeting factors prepare the nascent chain for translocation, in doing so 
maintaining their loosely folded state and directing them to the appropriate translocon 
(Cross & High 2009).  
Peptides that are destined for cellular membranes or the secretory pathway require a 
second route, carried out by co-translational machineries. The most well studied example 
of the co-translational targeting pathways is through SRP (discussed at length in section 
1.2). SRP is found in both eukaryotic and prokaryotic cells and is essential for the targeting 
of many nascent peptides to their target membranes. The SRP machinery enables an 
interaction with the appropriate translocon (Sec61 and SecYEG in eukaryotes and 
prokaryotes respectively) and aids the unloading of the nascent peptide (Akopian et al. 
2013).  
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1.2 Co-translationally-mediated targeting 
1.2.1 Overview of SRP-dependant co-translational targeting 
The correct localization of a nascent peptide to its cellular destination is an essential step in 
protein biogenesis. As approximately 30% of the proteome is initially destined for the ER 
or plasma membrane in prokaryotes, it is widely recognised that many are targeted by the 
signal recognition particle (SRP) (Figure 1.8). SRP interacts with the nascent chain co-
translationally as the peptide begins to emerge from the ribosome exit tunnel. Through a 
methionine rich M-domain, SRP can recognise a specialised N-terminal sequence within 
the nascent chain. This sequence provides a signal for the SRP to bind to the ribosome and 
generate a complex that can be targeted to the membrane. Upon binding to the ribosome-
nascent chain complex (RNC), SRP interacts with the SRP receptor (SR) and delivery to 
the translocon occurs. At the translocon the RNC is transferred from the SRP and insertion 
of the nascent chain into the membrane can begin.  
  
Figure 1.8 Schematic overview of the signal recognition particle (SRP) targeting pathway. 
1. SRP binds to the signal sequence (Black square) within the nascent chain as it emerges from the 
ribosome. 2. SRP and SRP receptor (SR) bind and dock to the translocon when bound to GTP. 3. Docking 
enables co-translational insertion into the membrane. GTP hydrolysis allows the disassociation of SRP and 
the SR from the RNC-translocon complex. 5. Insertion of polypeptide triggers release and recycling of 
ribosome for further rounds of translation.  
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1.2.2 Components of the SRP system: A structural overview 
The SRP system plays a vital role in the proper localization of secretory and membrane 
proteins to the endoplasmic reticulum (ER) membrane. Throughout all kingdoms SRP has 
a highly conserved function, yet a number of organisms have evolved producing variability 
in the SRP structure (Figure 1.9)(Pool 2005). The eukaryotic SRP system (Figure 1.9A), 
even though it is the most complex, is possibly the best characterised and is centred around 
two conserved proteins, SRP54 (SRP protein, homologous to the prokaryotic Ffh) and the 
SRP receptor (SRα subunit, homologous to the prokaryotic FtsY). 
 
 
 
 
 
 
 
 
 
 
Eukaryotic SRP is known to be made up of 6 protein components and a 7S RNA. In higher 
eukaryotes the six protein domains are named according to their molecular weights; SRP9, 
14, 19, 54, 68 and 72 (LUIRINK 2004). Assembly of SRP takes place in two 
compartments of the cell; the SRP RNA is transcribed at the nucleus and the proteins are 
synthesised in the cytoplasm before being imported into the nucleus. A pre-SRP complex 
is assembled by the formation of the SRP proteins (except SRP54) around the RNA 
component. Export of the pre-SRP complex and binding with SRP54 in the cytoplasm 
completes the assembly of mature SRP (Politz et al. 2000; Grosshans et al. 2001). Limited 
nuclease assays were carried out and show that mature SRP can be split in two major 
Figure 1.9 Schematic representations of signal recognition particles from human and 
E.coli. Both human and E.coli contain M and N/G domains (red and blue circles 
respectively) which are required for SR binding and signal peptide recognition. The 
eukaryotic SRP contains higher levels of complexity, with human SRP containing the 
protein domains SRP19 (purple), SRP72/68 (green) and SRP9/14 (yellow).  
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domains; the Alu-domain and the S-domain (Figure 1.9) (Gundelfinger et al. 1983). The 
Alu-domain has been proven to be an essential requirement for translational arrest 
(discussed further in section 1.2.4) in co-translationally targeted RNCs (Thomas et al. 
1997). Crystal structures of the Alu-domain show it is comprised of a SRP9 and SRP14 
heterodimer, as well as the 3‟ and 5‟ end of the 7S RNA (Figure 1.9) (Weichenrieder et al. 
2001).The S-domain is composed of the remaining for protein components and the central 
core of the RNA domain. The S-domain is believed to contain the site for SRP receptor 
(SR) binding and the site required to interact with the signal peptide. The 54 kD subunit 
found within the S domain is recognised as one of the most conserved domains throughout 
all kingdoms and it is this that has been shown to play a key role in recognition of signal 
peptides (Keenan & Freymann 2001). 
The core, and only components present in all SRPs are the SRP54 (Ffh in bacteria) and 
helix 8 of SRP RNA. Helix 8 is essential for facilitating the binding of SRP54, in doing so 
providing a base for SRP54 assembly (Oubridge et al. 2002). The SRP54 protein is made 
of a number of components and can be split into: N, G and M domains (Figure 
1.9B)(LUIRINK 2004). The N-domain and G-domain are found in the centre and at the N-
terminus respectively and together make up the SRP GTPase. Structural studies show that 
the N-domain is formed of a 4-helix bundle, which serves as a platform for the GTPase of 
the G-domain. The two domains specifically communicate through 3 motifs to carry out 
the GTPase activity: the ALLEADV motif in the N-domain, and the GQ and DARGG 
motifs in the G domain (Grudnik et al. 2009). A strikingly similar NG-domain also exists 
in the SR, which associates with the NG-domain in SRP54. 
The final protein component that makes up SRP54 is a methionine rich M-domain found at 
the C-terminus (Figure 1.9 and 1.10A). Through structural studies in both prokaryotic and 
eukaryotic SRP, it has been shown that the methionine rich M-domain, due to the presence 
a hydrophobic groove, can interact with the SRP RNA and the signal peptide of emerging 
nascent chains from the ribosome (Figure 1.10B) (Keenan et al. 1998; Halic et al. 2006b). 
Crystal structures have also revealed the presence of a helix-turn-helix motif in this region, 
which plays a key role in the interaction with helix 8 in the SRP RNA (Keenan et al. 1998; 
Batey et al. 2000). The M-domain itself is connected to the NG-domain via a flexible 
linker, allowing the SRP54 (Ffh) protein to make structural rearrangements that are key in 
the selection of appropriate nascent chains (Keenan et al. 1998; Rosendal et al. 2004).  
5S RNA 7S RNA 
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The final core SRP structure is the 7S RNA domain, a 114-nucleotide-long molecule that is 
made up of the most evolutionary conserved part of the SRP RNA, helix 8. High resolution 
structures of the 7S RNA (and also the 4.5S RNA in bacterial) have proved very 
informative, with the RNA believed to have the ability to stabilize the M-domain and 
promote GTPase activity between the SRP and SR complex (Batey et al. 2000).  
The SRP receptor is final component that make up the SRP system. As described 
previously, these proteins belong to a specific family of SRP-type GTPases and confer a 
similar activity as that described in the NG-domain of SRP54. In eukaryotes, SR is made 
up of 2 subunits: SRα and SRβ.  The SRα subunit is essential for the interaction with 
SRP54 and also carries out a GTP dependant interaction with the SRβ subunit. SRβ is 
bound to the cytosolic face of the membrane and is believed to add another level of 
specificity to eukaryotic targeting (Bacher et al. 1996). 
Figure 1.10 Crystal structure of core SRP domain and SRP bound to a nascent chain. (A) The 
SRP core consisting of SRP54 and helix 8 of the SRP RNA is shown from the crenarchaeon S. 
solfataricus. The SRP54 domains are coloured in blue, the rigid part of the M domain is in red 
(MC domain), the flexible part (MN domain) is in orange and in yellow is the finger loop. The 
RNA helix is brown. (B) Model for SRP-nascent chain binding based on the closed structure of S. 
solfataricus. The nascent peptide (grey and blue) is bound between the rigid and flexible regions of 
the M domain. Figure adapted from (LUIRINK 2004) 
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1.2.3 The interaction between SRP and the RNC 
The structure of the main SRP system components, as described above, highlights the 
importance of their interactions in targeting the nascent chain to the membrane co-
translationally. However, co-translational targeting does not occur through the actions of 
the SRP components alone, in fact a multitude of extra SRP interactions are known to be 
essential such as those with the ribosome, the emerging nascent chain and membrane 
proteins (Bibi 2011).  The ribosome itself has been proven to be a critical part of the co-
translational targeting machinery and can often be seen as the initiator of the process.  
The ribosome has been shown to weakly bind SRP whilst in a non-translating state 
(Flanagan et al. 2003), but as translation occurs and a nascent peptide makes its way 
through the ribosome tunnel, decisions are made as to whether the SRP targeting system is 
required. Biochemical and cryo-EM data from prokaryotic ribosomes has shown that the 
uL23 protein, located near the exit site of the large subunit, acts as a docking site for the N-
domain in bacterial Ffh (Ullers et al. 2003; Halic et al. 2006a). Cross-linking experiments 
also showed that uL23 could specifically interact with the emerging nascent chain through 
a finger-loop domain which protruded into the ribosome tunnel. This interaction with the 
nascent chain plays a sensory role in detecting the proximity of potential SRP cargo to the 
exit site of the ribosome. If the nascent chain contains structural or chemical properties that 
require co-translational targeting, the ribosome responds by altering the conformation of 
the globular domain on uL23 and in doing so increasing its affinity for SRP (Bornemann et 
al. 2008). The ribosome has also, through biochemical and structural studies, been shown 
to interact with SRP through a number of other r-proteins and rRNAs. uL29, also found 
close to the exit site is believed to make contact with N-domain of Ffh, whereas the SRP 
M-domain is believed to interact with the rRNAs, uL22 and uL24 (Halic et al. 2006a; 
Schaffitzel et al. 2006; Yosef et al. 2010). In some cases, these interactions have been 
postulated to play a role in altering the conformational shape of the ribosome upon SRP 
binding, possibly impacting the interactions between the tunnel and the nascent chain or 
effecting future targeting events such as translocon docking (Halic et al. 2006b; Yosef et 
al. 2010). After an interaction with the ribosome at the exit site, SRP binds the nascent 
chain through certain signals located within its N-terminus. Generally, peptides that are 
required to be co-translationally targeted by SRP contain an N-terminal signal sequence 
that directs the RNC-SRP complex to the appropriate destination. SRP is highly 
promiscuous in its choice of signal sequence, with a  
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peptide containing a hydrophobic core of 8-18aa usually being adequate (von Heijne 1985; 
Akopian et al. 2013). High levels of diversity have been shown to exist between signal 
sequences, with length, shape and sequence content all varying. This enables SRP to 
interact with a variety of domains that can act as a signal sequence, such as short signal 
peptides or larger, integral TM domains (signal anchors). Cross-linking experiments have 
shown that the hydrophobic groove in the M-domain of SRP is responsible for the 
recognition and binding of the signal sequence (Zopf et al. 1990), with structural data 
suggesting that changes in conformational shape whilst bound to the RNC allows efficient 
capture of the nascent chain (Wild et al. 2004; Halic et al. 2006b). However, evidence also 
suggests that both the NG-domain and SRP RNA may also play some part (Bradshaw et al. 
2009; Clérico et al. 2009). 
 
 
Figure 1.11 Structure of the prokaryotic and eukaryotic ribosome at the ribosome tunnel 
exit site. The ribosome exit site is marked (black circle), with the position of surrounding r-
proteins highlighted by different colours. Conservation of the protein is denoted by the use of the 
same colour. (A) Cryo-EM structure of the bacterial ribosome. (B) Cryo-EM structure of the 
plant cytoplasmic ribosome. Adapted from (Breiman et al. 2015b) 
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1.2.4 RNC delivery to the membrane by SRP 
Following the recognition of the signal sequence by SRP, the RNC-SRP complex is 
targeted to the Sec translocase machinery. In prokaryotes, SRP targets membrane proteins 
to the plasma membrane but in eukaryotes, it targets both luminal and membrane proteins 
to the ER. Upon recognising the presence of a signal sequence, SRP is capable of slowing 
down elongation of the nascent chain to ensure correct protein biogenesis; a process known 
as translation arrest. Cryo-EM and crystal structures have confirmed the exact interactions 
taking place between the ribosome and SRP to enable this process to occur (Weichenrieder 
et al. 2001; Blau et al. 2006; Bousset et al. 2014). Elongation arrest primarily requires the 
actions of the Alu domain, more specifically the first 48 residues and the SRP9/14 
heterodimer (Halic et al. 2004; Lakkaraju et al. 2008). The binding of these domains to the 
ribosome, at sites known to be required for elongation factor binding, determines 
elongation arrest is carried out through direct competition between SRP and EFs. In vivo 
experiments using human cells containing SRP14 lacking arrest activity, showed an 
inefficient delivery of the nascent chain to the ER and cellular defects, thus confirming its 
role in proper protein biogenesis (Lakkaraju et al. 2008).  
Following translation arrest, the RNC-SRP complex is recruited to the membrane via an 
interaction that takes place between SRP and SR (FtsY in prokaryotes). Upon binding the 
signal sequence at the ribosome exit site, ribosomal components prime SRP54 for an 
interaction with GTP (Bacher et al. 1996; Buskiewicz et al. 2009). At this point GTP is not 
stably bound to either SRP54, nor SRα, therefore this interaction is not enough to drive the 
GTPase activity and they remain in their free state (or open conformation). The GTP-
bound state however, is essential in initiating the interaction between SRP and its receptor, 
in which both GTPases are said to form an almost identical dimer, capable of activating 
each other (Powers & Walter 1995).  
GTPase activation occurs over a number of steps, details of which have only been provided 
through studies in prokaryotic systems. However, the conserved nature of the interaction 
between SRP and its receptor suggest the eukaryotic system may function in a similar 
manner (Nyathi et al. 2013). Initially an intermediate complex is formed between Ffh and 
FstY, due to the binding of GTP to Ffh. Both Ffh and FtsY at this point remain in their 
open conformations, forming an intermediate that is highly unstable as it interacts 
primarily through electrostatic attractions between the N-domains (Zhang et al. 2008). 
Once the early intermediate complex has formed, extensive rearrangements in both 
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molecules drive the more significant interactions between the NG-domains, generating a 
stabilized closed conformation (Shan et al. 2004; Zhang et al. 2008). At this point the RNC 
plays an important role in „pausing‟ GTP hydrolysis, ensuring it does not occur before the 
nascent chain is ready to be translocated through the Sec translocon (Shen et al. 2012). 
Finally, GTPase activity occurs upon the rearrangement of helix-turn-helix motifs within 
the RNA component of SRP, which must be brought in close proximity to the molecules of 
GTP to enable complex activation (Akopian et al. 2013). Mutagenesis experiments have 
highlighted that each individual rearrangement step acts as essential checkpoint in the 
targeting of membrane proteins. Compromised GTPase activation in either SRP or the 
receptor prevents the structural rearrangements required in the complex to allow protein 
translocation (Shan et al. 2007; Grudnik et al. 2009). These structural rearrangements are 
critical to promote the release of the signal sequence by SRP and in doing so enabling the 
binding of the RNC to the Sec translocon (Sec61 in eukaryotes and SecYEG in 
prokaryotes).   
The delivery of the RNC-SRP-SR complex to the membrane is required before signal 
peptide release from the complex can begin. Upon arriving at the membrane, the RNC-
SRP-SR forms a quaternary complex by interacting with the SecYEG translocon. The 
rearrangement of the cytosolic loops of the translocon, C4 and C5, have been shown to be 
essential in triggering GTPase activation between SRP and SR (Shen et al. 2012; Akopian 
et al. 2013). Finally, the activation of the GTPase in SRP and SR enables the hydrolysis of 
GTP, hence releasing the signal peptide and allowing the RNC to bind to the translocon, 
and SRP-SR dissociation to occur.  
 
1.2.5 Interaction between the ribosome and Sec translocon 
The release of the RNC by the SRP-SR complex enables the ribosome to bind to the 
translocon in preparation for protein insertion. As discussed above, the interaction between 
the RNC-SRP-SR complex and the translocon is co-ordinated, ensuring the constant 
shielding of the translating signal peptide or TM domain. Ribosome-translocon binding 
sites are evolutionarily conserved regions, with the proteins close to the exit site of the 
ribosome (uL23, uL24 and uL29 (Figure 1.11)), as well as the rRNA region, providing the 
greatest number of contacts with the translocon (Becker et al. 2009; Frauenfeld et al. 
2011). Cryo-EM data available shows the binding sites that are presented by the ribosome 
remain accessible to the translocon regardless as to whether it is in a translating or non-
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translating state (Gogala et al. 2014). During translation the ribosome undergoes major 
structural changes, which play a role in the binding of the translocon. Contacts occur 
between the ribosome and the cytosolic loops of Sec61α, C4 and C5 (Frauenfeld et al. 
2011). Upon binding, the translocon is also believed to undergo conformational changes, 
most likely causing the opening of the channel by the displacement of the plug (Berg et al. 
2004). Many models suggest that the Sec61 translocon is capable of switching between an 
„open‟ and „closed‟ conformation during the insertion of the nascent peptide into the ER 
membrane. However, based on the comparison with a non-translocating, Sec61 channel, 
recent cryo-EM models suggest that upon docking of the ribosome the translocon channel 
remains constitutively opened (Pfeffer et al. 2015). A constitutively opened channel would 
therefore, as suggested in a number of studies, require a number of accessory factors to 
maintain membrane permeability especially during the lateral integration of membrane 
proteins.  
A multitude of components have been suggested to interact with the RNC-translocon 
complex as it forms. On the cytosolic side of the ER, a gap of ~15Å between the ribosome 
and the Sec translocon is believed to exist (Berg et al. 2004). The role of the gap is poorly 
understood, with some suggesting that it may allow the nascent chain to form secondary 
structures that were not possible in the ribosome (Conti et al. 2015).  The size of the gap is 
small enough to prevent the movement of large molecules through the pore, but in the 
absence of a gating system would require assistance maintain membrane permeability. 
Proteins such as the translocating-chain associated membrane protein (TRAM) or 
translocating-associated protein (TRAP) have been shown in structural studies to form at 
the interface between the ribosome and Sec61 translocon, suggesting a functional role in 
maintaining an ion-tight channel (Pfeffer et al. 2014).    
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1.3 Membrane protein insertion into the endoplasmic 
reticulum 
1.3.1 Overview of the endoplasmic reticulum  
The endoplasmic reticulum is the largest site for the synthesis of proteins within eukaryotic 
cells and processes the majority of secreted and integral membrane proteins made by the 
cell. Targeting signals within nascent chains of newly-synthesised proteins direct them to 
the ER, via the co-translational targeting pathway, where they interact with specialised 
translocon machinery and make their way into the ER lumen. Due to the large amount of 
protein traffic entering the ER, it follows that it is an important site for post-translational 
modifications and protein folding.  
Although the targeting of membrane and secretory proteins to the ER follows the same 
route, the maturation of membrane proteins at the ER membrane differs substantially. 
Insertion of the nascent chain into the ER and its exposure to the ER lumen enables the 
interaction of the peptide with a variety of enzymes that catalyse post-translational 
modifications of the amino acid sequence. An integral membrane protein will only 
partially translocate through the ER membrane, with integral TM segments becoming 
integrated laterally, hence anchoring the protein in the ER membrane. Upon integration of 
the proteins into the membrane, the ER assists with the formation of the protein‟s native 
structure and this in turn may be influenced by post-translational modifications, or vice-
versa (Braakman & Bulleid 2011).  
Multiple post-translational modifications can occur in the ER lumen such as N-linked 
glycosylation, disulphide bond formation and the cleavage of signal sequences. In the case 
of N-linked glycosylation, nascent chains are post-translationally modified by the addition 
of a carbohydrate group to the amide (NH) group on asparagine residues. The addition of 
carbohydrate groups is catalysed by a specific complex found in close proximity to the 
translocon, on the lumenal side of the ER. This complex, the oligosaccharyltransferase 
(OST) complex, seeks out the consensus sequence Asn-X-Ser/Thr within the nascent 
chain, as the site of N-linked glycosylation (Figure 1.12). N-linked glycosylation aids the 
proper folding, enhances stability and ensures correct topology in membrane proteins 
(Burda & Aebi 1999).  
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A second form of post-translational modification that is facilitated by the ER is disulphide 
bond formation. By providing a slightly oxidising environment, the ER enables a family of 
protein disulphide isomerises (PDIs) to assist folding by the formation, rearrangement and 
removal of disulphide bonds. Folding within the ER is also aided by a number of 
chaperones such a BiP, a lumenal Hsp70, which interacts with membrane proteins to 
ensure the production of a correctly folded structure (discussed further in section 1.3.3).   
 
1.3.2 The Sec61 translocon: structure and function 
The protein-conducting channel that enables the translocation of both membrane and 
secretory proteins is well conserved throughout the kingdoms. The Sec61/SecYEG 
complexes allow proteins to be translocated across or inserted into the ER of eukaryotes 
and the plasma membrane of prokaryotes. Early screens in E. coli and Saccharomyces 
cerevisiae identified a number of proteins are now known to make up the Sec translocon 
and to be involved in translocation of proteins at the plasma membrane (Emr et al. 1981; 
Rothblatt et al. 1989). The heterotrimeric Sec61 complex that makes up the translocon in 
the eukaryotic ER, is believed to have evolved from the SecYEG complex, associated with 
Figure 1.12 Schematic diagram of Asparagine–linked (N-linked) glycosylation. (A) Synthesis 
of N-linked oiligiosaccharide occurs in 2 phases; firstly in the cytosol, 2 N-acetylglucosamines 
are added to a dolicol molecule, before the addition of 5 manose residues. Secondly, after being 
flipped into the ER lumen by a flippase, 3 addition mannose residues and 3 glucose residues are 
added. (B) The oligosaccharyltransferase (OST) complex then attaches glycans to a protein at the 
NXT/S consensus motif.  
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the plasma-membrane in prokaryotes (Rapoport 2007).  The Sec61heterotrimer is made up 
of two-well conserved subunits, the α and γ subunits, with a third and less well conserved 
subunit, the β subunit, completing the complex (Nyathi et al. 2013).   
The major component of the Sec61 complex is the Sec61α subunit, which forms the 
central, aqueous pore of the translocon (Görlich & Rapoport 1993; Crowley et al. 1994) 
The structure of the Sec61α subunit was initially modelled on the crystal structure of the 
Methanococcus jannaschii SecY translocon, (Berg et al. 2004). The SecY structure 
provided evidence that the α-subunit could be split into two domains, joined by a linker, 
with one half containing TM helices 1-5 and the other 6-10. The linker between the two 
domains of α-subunit is believed to act as a hinge which is capable of opening the 
translocon to the lipid bilayer, between TM2 and 7, allowing from membrane protein 
integration (Berg et al. 2004). The two domains of the α-subunit form an hourglass shaped 
pore with two funnels, one opening onto the cytosolic face and the other onto the ER 
lumen. At the centre of the pore is a ring of hydrophobic residues (such as 6 isoleucines in 
the SecY translocon (Berg et al. 2004)) that form a constriction site. The pore is ~6Å in 
diameter when in its „closed‟ conformation, but would be required to increase to ~20Å in 
the presence of an unfolded or α-helical protein. Fluorescent quenching assays used probes 
inserted into translocating nascent chain to map the diameter of the translocon. These 
experiments suggested that the  diameter of the channel could increase to between 40 and 
60Å (Hamman et al. 1998).  
The γ-subunit, a small 8 kDa tail-anchored membrane protein, is the second 
phylogenetically conserved protein that makes up the Sec61 complex. It contains a 
diagonal TM domain that traverses the ER bilayer and is in contact with both halves of the 
α-subunit. The γ-subunit specifically contacts the α-subunit at the back of the channel, near 
the opening of the two TM domains. Mutagenesis experiments in yeast were carried out to 
remove the Sec61γ/Sec61p subunits, with results suggesting a possible role in the lateral 
movement of the nascent chain into the ER membrane (Wilkinson et al. 2010). In SecY, 
proteolysis experiments cleaving the hinge region showed the channel remained in 
working order in the presence of Sec61γ/SecE, again suggesting a role in opening the 
channel laterally (Lycklama A Nijeholt et al. 2013). 
Finally the third subunit which makes up the Sec61 complex is the 12 kDa β-subunit. Like 
Sec61γ, it is a tail anchored membrane protein however its role in translocation remains 
relatively unclear. The β-subunit has been shown to interact with SR and signal peptidase 
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in yeast, suggesting Sec61β may span the membrane (Helmers et al. 2003; Kalies et al. 
1998). In vivo studies have also shown yeast homologues, Sbh1p and Sbh2p, to be non-
essential, but in the absence of the β-subunit translocation rates are dramatically reduced 
(Finke et al. 1996). 
On the lumenal side of the Sec61α pore a small helix, referred to as the plug, occupies the 
centre of the channel when the translocon is in a resting state. The plug is postulated to 
influence the opening and closing of the translocon by sealing the pore, generating a 
selective gate system allowing substrate translocation (Egea et al. 2005). However, 
experiments have suggested that the existence of a plug is non-essential and residues from 
neighbouring subunits can replace its function, without the same substrate selectivity (Li et 
al 2007). Recent cryo-EM models have also suggested that a translocating channel does not 
alter between the „open‟ and „closed‟ conformation, instead is constitutively „open‟ which 
suggest the need for accessory factors (Pfeffer et al. 2015). Early studies of the Sec 
translocon suggested the chaperone BiP, played a role in closing the Sec61 translocon and 
maintaining membrane permeability. BiP bound to ADP was associated with the „closed‟ 
conformation of the translocon and upon binding ATP; opening of the channel could occur 
(Alder & Johnson 2004). Whether the translocon gating mechanism is carried out 
intrinsically by the plug domain or aided by BiP, maintaining permeability of the ER 
membrane during translocation is essential.  
 
1.3.3 Sec61 accessory factors 
The Sec61 complex is the core machinery involved in the insertion of membrane proteins 
into the ER membrane. Although this is the case, a number of accessory components are 
required to assist with the translocation and integration of integral membrane proteins. 
Accessory factors could aid membrane protein biogenesis in various ways; firstly, they 
could directly impact on translocation, interacting with the translocon to assist with 
insertion or lateral movement into the ER membrane. Secondly, accessory factors may aid 
the folding and assist with the orientation of a nascent chain. Finally, others may have an 
effect on the lipid bilayer surrounding the translocon, into which some proteins will be 
integrated.  
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Sec62/63 complex 
The Sec62/63 complex aids Sec61-dependant translocation in a 1:1 ratio with the Sec61 
translocon. The complex is made up from two conserved membrane proteins Sec62 and 
Sec63, yet in yeast it also known to contain two extra subunits Sec71 and Sec72 (Deshaies 
et al. 1991). Mutagenesis experiments in yeast show that Sec71 and 72 are non-essential, 
although do increase the rate of protein translocation (Fang & Green 1994). 
Sec62 is a 32 kDa protein with two-membrane spanning domains and a positively charged 
N-terminus, whilst the Sec63 protein has a molecular weight of 73kDa and has 3 
membrane spanning domains (Deshaies et al. 1991). Both protein components are said to 
interact directly with the Sec61 complex, as well as interacting with each other, through the 
N-terminus of the Sec62 and the C-terminus of Sec63. The roles of the two components 
differ dramatically, with Sec62 believed to be largely involved in post-translational 
translocation, whereas Sec63 is involved in both co-translational and post-translational 
translocation (Lang et al. 2012). The Sec62 pathway, through cross-linking studies, has 
been shown to interact specifically with β-subunit of Sec61 (Jadhav et al. 2015). This 
interaction is absent in the presence of RNC-SRP complexes, further confirming what was 
previously believed to be an SRP independent pathway (Jadhav et al. 2015). Recent studies 
in mammalian systems have also shown Sec63 to play a non-essential role in co-
translational translocation, with its function being recovered by the Hsp40 protein, Erj1 
(Kroczynska et al. 2004). Experiments in mammalian cells have also discovered the 
existence of a ribosome-binding site on the cytosolic face of the TM subunit, suggesting an 
evolutionary change providing a role in co-translational translocation (Muller et al. 2010). 
TRAM (translocating chain associated membrane protein) 
TRAM is a 37 kDa integral membrane protein, with 8 TM domains that span the ER 
membrane. The interactions between TRAM and the components of the Sec61 translocon 
has been well studied, identifying it as a key partner of many secretory proteins (Görlich et 
al. 1992) and a required component for the insertion of TM proteins in proteoliposomes 
(Görlich & Rapoport 1993). Cross-linking studies show TRAM interacts with both signal 
sqeuences and TM domains within the nascent chain (Görlich et al. 1992; McCormick et 
al. 2003), directly aiding their insertion and also enhancing the integration of domains with 
low levels of hydrophobicity into the bilayer (Voigt et al. 1996; Heinrich et al. 2000). 
Cross-linking data also provides evidence that TM domains can interact with both Sec61α 
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and TRAM simultaneously, hence TRAM may function to assemble multiple TMs at the 
lateral gate before allowing their integration into the bilayer (Sadlish et al. 2005). 
TRAP (translocon associated protein complex) 
The TRAP complex is made up of 4 membrane spanning subunits (α, β, γ, δ) that are 
capable of interacting with the Sec61 complex (Hartmann et al. 1993). Initially assays 
using the detergent Nonidet P-40, suggested the complex only consisted of the α and β-
subunits of TRAP (then known as the signal sequence receptor (SSR)). This was later 
discovered not to be the case when assays carried out with milder detergents discovered γ 
and δ-subunits also comprised part of the complex (Gorlich et al 1990; Hartmann et al 
1993).  
The precise function of TRAP is yet to be determined, but studies have suggested that it 
may interact with weakly hydrophobic signal sequences and aid their insertion into the ER 
membrane (Fons et al. 2003). More recent in vivo studies using mutagenesis and silencing 
RNAs have also suggested that it may aid membrane protein topogenesis, with the 
topologies of proteins found to be mixed in the absence of TRAP (Sommer et al. 2013). 
BiP (Binding immunoglobulin protein) 
A member of the heat shock protein (Hsp) 70-family of chaperones, the 74 kDa protein 
BiP, is found in the lumen of the ER. BiP is found to interact with the Sec61 translocon 
indirectly via the chaperones Sec63 and Erj1 (Blau et al. 2005; Lang et al. 2012). BiP has 
been described to have a wide variety of functions during ER transport; it has been shown 
to act as a seal for the Sec61 channel, helping with the gating mechanism and preventing 
the permeability of the membrane being disrupted (Alder et al. 2005; Schäuble et al. 2012). 
BiP has also been suggested to be essential for the efficient translocation of proteins into 
the ER, acting with a racheting mechanism on the translocating peptide to aid its 
movement into or across the ER membrane (Tyedmers et al. 2003a). Experiments using 
microsomes washed out and lacking lumenal chaperones failed to translocate with optimal 
efficiency, something that could be restored upon the reconstitution of lumenal proteins 
(Nicchitta & Blobel 1993; Tyedmers et al. 2003b) 
OST (oligosaccharyl transferase) 
Asparagine-linked (N-linked) glycosylation is one of the most common post-translational 
modifications in eukaryotic cells and is highly conserved in bacteria also.  Approximately 
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70% of proteins that pass through the ER of eukaryotes have the potential for glycoylation, 
with errors leading to increased risk of congenital disease (Denks et al. 2014). N-linked 
glycosylation occurs at the OST (as described in section 1.3.1), a heteromeric complex that 
is embedded into the ER membrane. The catalytic subunit of the OST, first discovered in 
yeast, is the STT3 subunit and is highly conserved throughout all kingdoms (Burda & Aebi 
1999). The OST complex has been shown to interact with a number of components 
regarded as essential for translocation. Co-translational N-linked glycosylation sees an 
interaction between the ribosome, Sec61 translocon and the OST complex, with TRAM 
also having been shown to interact directly with the OST (Shibatani et al. 2005; Harada et 
al. 2009; Pfeffer et al. 2014) 
 
1.3.4 Determinants of membrane proteins topology 
The insertion of membrane proteins into the lipid bilayer of the ER is mediated by the 
Sec61 translocon. During the initial stages of insertion the topology of many polypeptides 
is decided; with the composition of their amino acid structure being the major influence. 
Membrane protein topology is usually dictated by the first „stop-transfer‟ or „signal anchor‟ 
sequence that enters the translocon. These sequences can take up one of two orientations; a 
type I orientation, with the N-terminus of the peptide existing in the ER lumen or a type II 
orientation, with the N-terminus facing out into the cytosol (Figure 1.13). These topologies 
are generally determined by the positive-inside rule; which relies on existence of positively 
charged amino acids (lysines or arginines) flanking the TM domain. The positively 
charged flank of the TM domain is thereby positioned at the cytosolic membrane, whilst 
the more negatively charged region of the TM domain exists nearer the lumenal side 
(Hartmann et al. 1989; von Heijne 1990). This rule was originally observed for bacterial 
proteins however, a similar charge bias exists for targets of the ER, with the more 
positively charged flank remaining cytoplasmic (von Heijne 1992). Further studies, using 
site-directed mutagenesis, have shown that the topology of a protein can be reversed by 
simply altering the position of the positively charged residues in relation to the TM domain 
(Harley et al. 1998). An interaction between the positively charged flanking residues of the 
nascent chain and the positively charged plug region of the Sec61 translocon may generate 
repellent electrostatic forces between the two. Therefore, if the positively charged residues 
within the nascent chain were N-terminal, it is likely that a reorientation from a type I to 
type II topology would occur.  
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Single-spanning membrane proteins 
Single-spanning membrane proteins are seen as the least complex of the membrane 
proteins, with the positive-inside rule impacting highly on their topology (Figure 1.13). 
Although this is the case, studies have highlighted additional factors which may impact on 
the topology of a membrane protein during insertion (Goder & Spiess 2001). One such 
factor is the length and structure of the N-terminal sequence that becomes exposed to the 
cytosol following elongation. If folding takes place in this region, it becomes less 
favourable for the Sec61 translocon to feed the N-terminus through the channel, therefore a 
type II orientation with a cytosolic N-terminus is generated (Beltzer et al. 1991). 
Experiments removing the long and structured N-terminus of a single-spanning membrane 
receptor (truncations reducing the length or mutations to remove the structure within the 
N-terminus) were able to reverse the topology and produce a type I orientation. 
To avoid a type II topology, yet maintain a long and structured N-terminus, some 
membrane proteins required the services of a cleavable signal sequence. Cleavable signal 
sequences are found downstream of the first TM anchor and are orientated so their N-
terminus faces the cytosol. The topology of the signal sequence commits the first TM 
domain to a type I topology by forcing its N-terminus through the Sec61 translocon. The 
constraints placed on the TM domain whilst in the translocon channel prevent it from 
reverting back to a type II orientation (Shao & Hegde 2011). 
The hydrophobicity of a nascent chain also contributes to the topology of a membrane 
domain. In vivo experiments, in which polypeptide chains contained a stretch of between 
7-25 leucine residues, proved higher hydrophobicity or a longer TM domain containing 
more hydrophobic residues could orientate themselves differently than a short, less 
hydrophobic domain (Wahlberg and Spiess 1998). The possibility that large hydrophobic 
TM domains could rapidly integrate into the lipid bilayer as they are inserted into the 
Sec61 channel may also occur. Integration during translocation would fix membrane 
domains in a type I topology as the N-terminus is fed through into the lumen whilst the TM 
segment enters the translocon channel (Hessa et al 2005).  
Polytopic membrane proteins 
Complex multi-spanning membrane proteins (type III membrane proteins) were originally 
believed to insert into the lipid bilayer in a linear fashion. This „linear insertion model‟ 
proposed that the topology of TM domains within a polytopic membrane protein were 
defined by the topology of the most N-terminal signal anchor (Blobel 1980). This would 
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therefore require the remaining TM segments to alternate between signal and stop transfer 
signal sequences (Wessels & Spiess, 1988). Although this model of insertion is feasible, it 
would require a highly unusual degree of regularity throughout the individual domains of 
the membrane protein. Certainly in eukaryotic proteins, which have been shown to be 
highly diverse, this is not expected to be the case. Indeed experiments carried out in a 12 
TM domain glucose transporter (Glut1), in which mutations were carried out to alter the 
charge difference across TM1, showed inverting the topology of TM1 had no effect on the 
overall topology of the downstream TM domains. The mutations did generate aberrant TM 
segments in domains 1 and 2 that failed to insert, however, the remaining TM domains 
inserted in the correct orientation suggesting downstream domains were not affected by 
TM1 topology (Sato et al. 1998). 
Although polytopic membrane proteins follow the positive-inside rule to some extent, less 
stringently in eukaryotes than in bacteria, there are other factors which may help guide TM 
domain topology that cannot be seen in single-spanning membrane proteins. One example 
is Aquaporin-1, which undergoes a reorientation of 3 TM domains and two connecting 
peptide loops after translocon and integration (Foster et al. 2000). Post-translational 
reorientation of TM3 through 180° from a type I topology to a type II topology, leads to a 
repositioning of TM2 and TM4 from the ER lumen into the lipid bilayer, thus generating a 
mature form of the protein (Lu et al. 2000). This suggests that the translocation of 
subsequent domains can alter the topology of domains previously translocated through or 
inserted into the ER membrane. A second example using the Glutamate transporter from 
Pyrococcus horikoshii, shows that a TM domains can be repositioned during post-
translational folding and oligiomerization in the ER membrane. This suggests that 
polytopic membrane domains can alter their topology prior to integration into the lipid 
bilayer (Kauko et al. 2010). Finally, glycosylation of a membrane protein can be a 
determining factor in topogenesis. Watson et al (2013) generated truncated peptides of the 
potassium channel, TASK-1, and displayed evidence that a number of nascent chains could 
vary their topology. The peptides were capable of reorientation and a mixed population of 
topologies could be detected. N-linked glycosylation was believed to sterically hinder 
reorientation and trap the protein in the topology where the glycosylation site was in the 
lumen of the ER (Watson et al. 2013). 
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1.3.5 Lateral movement of a TM domain from the Sec61 
translocon 
The Sec61 translocon not only plays a key role in the movement of proteins through the 
ER membrane, but also allows the integration of TM domains into the lipid phase of the 
bilayer. Recently both the cryo-EM and crystal structures of the Sec translocon have 
emerged whilst engaged with a nascent chain (Gogala et al. 2014; Li et al. 2016). This 
provided clear evidence of the opening of the lateral gate in which the hydrophobic nascent 
chain requires to be partitioned into the membrane bilayer. Cross-linking experiments had 
previously shown large stretches of the nascent chain can interact with the Sec61 channel 
and the lipid bilayer simultaneously (McCormick et al. 2003), which both these models 
confirmed by repositioning the nascent chain in a groove outside the lateral gate and in 
contact with the ER membrane (Gogala et al. 2014; Li et al. 2016). This lateral movement 
of the nascent chain from the Sec61 channel into the bilayer is highly dependent on the 
intrinsic hydrophobicity of the sequence (Hessa et al. 2005; Hessa et al. 2007). The Sec 
translocon is believed to have a hydrophobicity threshold, therefore recognising domains 
destined to be integrated in to the ER bilayer. Studies have shown that the constriction 
Figure 1.13 Schematic diagram of co-translationally targeted membrane protein topology. 
Single-spanning and polytopic membrane proteins are capable of taking up different topologies 
within the ER membrane.  
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point in the Sec61 channel may be the key site for recognising a translocating TM segment 
(Hessa et al. 2005). 
The lateral movement of membrane proteins into the ER is unlikely to be a solo act carried 
out by the Sec61 complex. In fact a number of photo cross-linking experiments have 
shown that a variety of other components may be involved. One model suggests that events 
taking place as early as the ribosome tunnel, at the uL22 protein and may be responsible 
for co-ordinating the gating mechanism involved in releasing the nascent chain from the 
translocon channel. The opening and closing of the translocon in this model is driven by 
BiP, suggesting the chaperone plays a key role in the integration of membrane proteins 
(Tyedmers et al. 2003b; Alder et al. 2005). Previous experiments have also shown TM 
domains within the nascent chain to interact with the TRAM/ Sec61complexes 
simultaneously during integration. TRAM has been shown to restrict the movement of both 
single-spanning and polytopic membrane proteins into the phospholipid bilayer (Hung et 
al. 1996; McCormick et al. 2003). Specifically in polytopic membrane proteins, 
experiments using single-site cross-linking to Sec61α and TRAM prove that TM domains 
can move to different locations within the translocon (Meacock et al. 2002; McCormick et 
al. 2003). This, coupled with studies suggesting different TM domains can be 
simultaneously cross-linked to Sec61, supports the theory that the Sec61 channel is 
dynamic enough to hold more than one TM domain at a time (Sadlish et al. 2005; 
McCormick et al. 2003).   
The ability for Sec61 to house multiple TM domains simultaneously suggests the 
possibility that more than one model of integration exists in polytopic membrane proteins. 
The simplest model for the integration of multiple TM segments is the sequential model. 
This mode of integration was suggested to occur due to the inability to isolate TM 
segments from the membrane, via alkali and urea extraction, before translation had been 
terminated (Mothes et al. 1997). Whilst the sequential integration of polytopic membrane 
proteins is highly possible, subsequent experiments have shown that it is not the only mode 
of integration. A second method relies on the movement of multiple TM domains from the 
Sec61 channel. Ismail et al (2007 and 2008) show that TM segments from the G protein-
coupled receptor, Opsin, can move out of the translocon in both a singular and multimeric 
form. TM1 shows a delayed release from the translocon, coinciding with the translocation 
and exit of TM2 (Ismail 2006), whereas TM5-7 move into the bilayer in a trimer of TM 
domains (Ismail 2006). Finally, TM domains with unusually low hydrophobicity may 
require the help of the next domain to become integrated into the membrane. If the 
59 
 
hydrophobicity is low and the TM domain is not recognised as such by the translocon, it 
may transiently enter the ER lumen and await the following TM domain to integrate it into 
the bilayer (Öjemalm et al. 2012).   
 
1.4. G protein-coupled receptors (GPCRs) 
1.4.1 GPCR biogenesis: What is known? 
The GPCR family is one of the largest and most versatile groups of transmembrane 
proteins, consisting of 4 major classes, with over 800 different genes encoding for GPCRs 
in humans. GPCRs are comprised of seven transmembrane helical domains, essential for 
their function of signal transduction from extra- to intracellular. They play a crucial role in 
regulating numerous physiological functions, as well as being the target for ~40% of all 
drugs, making them an area of ever increasing interest in research. 
Although the structure of a GPCR directly impacts its function, relatively little research has 
been carried out on the events leading up to and resulting in their biogenesis at the ER 
membrane. Early studies using opsin as a GPCR model protein were capable of 
determining, like many integral membrane proteins, GPCRs could be targeted to the ER in 
a SRP-dependant manner (Audigier et al. 1987). These experiments used SRP-depleted 
microsomes to confirm that only in the presence of SRP could Opsin be effectively 
targeted to the ER. This was later confirmed by Laird and High (1997), who went on to use 
Opsin as a model to study integration into the ER membrane (Laird & High 1997). This 
indicated that Opsin integrated into the ER membrane through the Sec61 translocon, as 
cross-linking to components such as Sec61α, β and associating factor TRAM confirmed. 
More recent experiments by the same group, provided information on the mode of 
integration of individual TM domains within Opsin (Meacock et al. 2002; Ismail 2006; 
Ismail et al. 2008). In particular Ismail et al (2006 and 2008), brought together two pieces 
of work which produced a complete model for the integration of Opsin. This provided 
evidence of variability in the behaviour of individual TM domains whilst integrating into 
the lipid bilayer. Site-specific cross-linking assays produced results indicative of TM 
domains exiting the Sec61 translocon individually, as pairs and as larger complexes (Ismail 
et al. 2008). As this is the only GPCR model of integration available it is impossible to say 
whether it could be applied to the entire family of proteins.   
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The correct biogenesis at the ER membrane is essential for all IMPs, and it is during the 
processes of insertion and integration that their mature structure begins to form. Incorrect 
folding at this point could lead to serious aberrations in the mature structure of a membrane 
protein. In GPCRs, one such event occurs frequently due to the loss of a specific 
disulphide bond forming between the extracelluar loops 1 and 2, located in the ER lumen 
during biogenesis. This has been shown to occur in a number of family members of 
GPCRs, leading to impaired trafficking from the ER and poor receptor function (Peeters et 
al. 2012) 
1.4.2 G protein-coupled receptor 35: A model GPCR 
G protein-coupled receptor 35 (GPR35) is an orphan, 7-transmembrane domain G protein-
coupled receptor (GPCR) first identified more than 15 years ago and is yet to be well 
characterized (Figure 1.14)(O‟Dowd et al. 1998). The human orthologue of GPR35 was 
found to be located on chromosome 2, region q37.3 and corresponded to a protein of 309 
amino acids in length (O‟Dowd et al. 1998; Milligan 2011). The same sequence was also 
identified to contain an N-terminal extension of 31 amino acids, producing a differentially 
spliced isoform known as the long GPR35 isoform (GPR35b) (Figure 1.14) (Okumura et 
al. 2004). GPR35 shares a sequence similarity with a number of different GPCRs and has 
been found to be related to the purinergic receptor LPA4 (32%), the hydroxycarboxylic 
acid binding receptors HCA2 and HCA3 (30%), and the cannabinoid and 
lysophosphatidylinositol-binding GPR55 receptor (30%) (Mackenzie & Milligan 2015).  
The short (GPR35a) and long (GPR35b) isoforms of GPR35 have been shown to play a 
role in a number of different disease physiologies. Originally, GPR35a was discovered to 
exist in a wide variety of tissue types (e.g. small intestine, colon and stomach), with 
GPR35b originally discovered in human gastric cancer cells (Milligan 2011). Although the 
two different isoforms exist, very little is known about how they are differentially 
regulated or how they differ functionally. One experiment in human gastric cells found that 
GPR35a was located in the tumorous regions of the cancer at low levels, whereas GPR35b 
could be found at higher levels, in both the tumorous and non-tumorous regions (Okumura 
et al. 2004). Both isoforms also show little variation in how they respond to GPR35 
agonists. However, it has been suggested that the 31aa extension in GPR35b, although not 
causing any pharmacological differences, may provide different protein-protein 
interactions as it extends the N-terminus (MacKenzie et al. 2014). In humans, both forms 
of the GPR35 gene show polymorphic variations in the amino acid sequence that may 
61 
 
result in disease phenotypes (Figure 1.14). Single nucleotide polymorphisms have been 
shown to enhance the risk of early onset inflammatory bowel disease and colitis. However, 
due to the poor characterisation of the receptors and the lack of information regarding their 
expression, the role of GPR35 is often overlooked in many associated disease phenotypes 
(Mackenzie & Milligan 2015). Rat and mouse models have provided some evidence that 
GPR35 overexpression in the dorsal route ganglion may result in elevated pain and 
inflammatory response. 
 
 
 
GPR35 is a plasma membrane receptor, found in a wide variety of tissue and cell types. 
Much of the interest around GPR35 has focused on functional and pharmacological 
research into the receptor. No work to date has been carried out to investigate the early 
folding events and the biogenesis of the GPR35 at the ER membrane. Therefore, the work 
presented in this thesis will attempt to determine the folding profile of TM1 during protein 
synthesis, the role the first TM domain plays in co-translational targeting and investigate 
the biogenesis of GPR35 at the ER membrane.  
  
Figure 1.14 Schematic representation of GPR35. GPR35 exists in two isoforms 
differing by a 31 amino acids (purple sequence bar).  Non-synonymous mutations (red 
circles) and Arg/Tyr residues that play a role in ligand interactions (yellow circles) 
identified. Diagram adapted from Milligan et al., 2000. 
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1.5 Project Aims 
The aims of this project were to investigate the folding profile of the N-terminus of GPR35 
as it is synthesised, co-translationally targeted and integrated into the ER membrane. 
Chapter 3 of this thesis investigates the folding profile of the 1
st
 TM domain of GPR35 as 
it is elongated through the ribosome exit tunnel. Using an in vitro translation and an assay 
known as pegylation, this enables me to directly measure the compaction within the 
nascent chain of GPR35 intermediates containing the first 1
st
 TM domain. These 
pegylation assays will be carried out in both prokaryotic and eukaryotic translation systems 
to investigate any environmental differences that may occur between the ribosomes of the 
two systems.  
Chapter 4 of this study investigates the mechanism of co-translational targeting, identifying 
the driving force behind the interaction between the principle targeting component SRP 
and GPR35 nascent chain. Initially, we set out to confirm an interaction with components 
of the prokaryotic SRP targeting pathway uL23 and Ffh. Using the chemical cross-linker 
BS
3
 we were capable of confirming the previously acquired folding profile of GPR35 TM1 
as it made its way through the tunnel. Following this, mutations to reduce the 
hydrophobicity of TM1 were engineered to enable investigations into the importance of 
hydrophobicity within the nascent chain for driving an SRP-dependant mode of targeting. 
This was also carried out in the eukaryotic in vitro translation system to investigate any 
differences existing between the prokaryotic Ffh and eukaryotic SRP54. 
Finally, Chapter 5 of this project focused on the insertion and integration of GPR35 into 
the ER membrane. Using N-linked glycosylation as a marker for insertion, I investigated 
the effect of a lack of hydrophobicity in the 1
st
 TM domain of GPR35 on the translocation 
of the N-terminus across the ER bilayer. Glycosylation assays were also used as a marker 
for investigating the folding profile of TM1 as it was inserted into the membrane, 
following the model described by Whitley et al (1996). Finally the mode of integration of 
the 1
st
 and 2
nd
 domains of GPR35 was investigated using a site-specific cross-linking assay 
and the homobifunctional cysteine cross-linker BMH.
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2. Materials and Methods: 
2.1 General Reagents: 
 
Agilent Technologies UK Ltd., Wokingham, Berkshire, UK  
PfuTurbo DNA Polymerase; QuikChange Multi Site-Directed Mutagenesis Kit; 
QuikChange Site-Directed Mutagenesis Kit  
 
BioRad Laboratories Ltd., Hemel Hempstead, Hampshire, UK  
Agarose  
 
Fisher Scientific UK Ltd., Loughborough, Leicestershire, UK  
Ammonium persulphate (APS); Ethylenediaminetetraacetic acid (EDTA); Glucose; 
Glycerol; Glycine; Methanol; Potassium hydroxide (KOH); Sucrose; Tris base  
 
Formedium Ltd., Hunstanton, Norfolk, UK  
Bacterial Agar; Tryptone; Yeast Extract Powder  
 
Integrated DNA Technologies, Leuven, Belgium  
Oligonucleotide primers  
 
Invitrogen Ltd., Paisley, UK 
PureLink PCR Purification Kit; SeeBlue Pre-stained Standard 
  
Kodak, Hemel Hempstead, Hertfordshire, UK  
X-ray film  
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Melford Laboratories Ltd., Chelsworth, Ipswich, UK  
Dithiothreitol (DTT); Isopropyl-β-D-thiogalactopyranoside (IPTG)63  
 
Merck Millipore, Billerica, MA, USA  
Amicon Ultra 0.5 ml Centrifugal Filters (10K); Cetyltrimethylammonium bromide; di-
Potassium hydrogen phosphate (K2HPO4)  
 
New England Bioscience (UK) Ltd., Hitchin, Hertfordshire, UK  
100 mM dNTPs (dATP, dCTP, dGTP, dTTP); 10x T4 DNA Ligase Buffer; T4 DNA 
Ligase; Prestained Protein Marker, Broad Range (7-175 kDa)  
 
PerkinElmer, Cambridge, UK  
EXPRESS Protein Labelling Mix (35S Met)  
 
Polysciences Incorporated, Eppelheim, Germany 
polyethyleneimine (PEI) (linear, mw 2500) 
 
Promega, Southampton, UK  
1 kb DNA Ladder; 100 bp DNA Ladder; 100 mM rNTPs (rATP, rCTP, rGTP, rUTP); 
Bovine Serum Albumin (BSA); Dithiothreitol (DTT); E. coli S30 Extract System for 
Linear Templates; HindIII; KpnI; Mfe1; Recombinant RNasin Ribonuclease Inhibitor; 
RNA Polymerase Transcription Buffer; SP6 RNA Polymerase; T7 RNA Polymerase; 
Wheat Germ Extract; XbaI  
 
Qiagen Ltd., Crawley, West Sussex, UK  
Nuclease-free Water; QIAquick Gel Extraction Kit; QIAprep Spin Miniprep Kit  
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Roche Diagnostic Ltd., Burgess Hill, UK  
Creatine kinase; Dpn1; tRNA from E. coli MRE 600  
 
Severn Biotech Ltd., Kidderminster, Worcestershire, UK  
30 % Acrylamide [Acrylamide: Bis-acrylamide ratio 37.5:1]  
 
Sigma-Aldrich Ltd., Gillingham, Dorset, UK  
Adenosine 3′,5′-cyclic monophosphate (cAMP); Adenosine 5′-triphosphate (ATP); 
Ammonium persulphate; Ampicillin; β-mercaptoethanol; Brilliant blue; Bromophenol 
blue; Calcium chloride (CaCl2); Creatine phosphate; Dulbecco‟s modification of Eagle‟s 
medium (DMEM); EDTA; Ethidium bromide; Folinic acid; Hydrochloric acid; 
Isopropanol; L-Amino acids; L-Glutathione oxidised; Lysozyme; Magnesium acetate 
(MgOAc); Methoxypolyethylene glycol maleimide (PEG-MAL); N,N,N‟,N‟-
Tetramethylethylenediamine (TEMED); 1X penicillin/streptomycin mixture ; PIPES; 
Phosphoenol pyruvate; Poly(ethylene glycol) MW 8000; poly-D-lysine hydrobromide; 
Potassium Glutamate (KGlu); Puromycin; Pyruvate kinase from Bacillus 
stearothermophilus; Phenylmethylsulphonyl fluoride (PMSF); Ribonuclease A from 
bovine pancreas; Tricine  
 
Takara Bio Europe, Saint-Germain-en-Laye, France  
Ex Taq DNA Polymerase; Ex Taq DNA Polymerase Buffer  
 
Thermo Fisher Scientific Inc., Waltham, Massachusetts, USA 
Slide-A-Lyzer Dialysis Cassette 3,500 MWCO  
 
tRNA probes, College Station, Texas, USA 
Non radioactive εANB-Lys-tRNAamb 
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VWR International Ltd., Lutterworth, Leicestershire, UK  
Acetone; Ammonium acetate (NH4OAc); Disodium hydrogen orthophosphate 
(Na2HPO4); Ethanol; Glacial acetic acid; 2-(4-(2-Hydroxyethyl) -1-piperazinyl)-
ethanesulphonic acid (HEPES); Magnesium chloride (MgCl2); Potassium acetate (KOAc); 
Potassium dihydrogen orthophosphate (KH2PO4); Potassium chloride (KCl); Sodium 
acetate (NaOAc); Sodium chloride (NaCl); Sodium dodecyl sulphate (SDS); 
Trichloroacetic acid (TCA); 30 mm glass cover slips  
 
2.2 General Buffers 
 
Competent cell buffer  
60 mM CaCl2, 15% (v/v) glycerol, 10 mM PIPES (pH 7).  
Gel fixing solution  
40% (v/v) methanol, 7% (v/v) Glacial acetic acid.  
6x DNA loading buffer  
30% (v/v) glycerol, 0.25% (w/v) bromophenol blue.  
LB media  
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl. LB agar 1% (w/v) tryptone, 
0.5% (w/v) yeast extract, 1% (w/v) NaCl, 1.5% (w/v) agar.  
PEG buffer  
20 mM HEPES (pH 7.2), 100 mM NaCl, 5 mM MgCl2.  
RNC (Ribosome Nascent Chain buffer)  
20 mM HEPES (pH 7.5), 14 mM MgOAc, 100 mM KOAc.  
Run-out premix  
0.75 mM HEPES (pH 7.5), 7.5 mM DTT, 21.3 mM MgOAc, 75 µM each amino acid, 6 
mM ATP, 20 mg/mL phosphoenol pyruvate, 0.14 mg/mL pyruvate kinase.  
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2x SDS PAGE Sample  
125 mM Tris-HCl (pH 6.8), 20% (v/v) glycerol, 4% (w/v) Buffer SDS, 5% 2-
mercaptoehtanol, 0.04 % (w/v) bromophenol blue.  
SDS-PAGE resolving gel  
375 mM Tris-HCl (pH 8.8), 12.5% Acrylamide, 0.1% (w/v) SDS, solution 0.05% (v/v) 
ammonium persulphate, 0.005% (v/v) TEMED  
10x SDS-PAGE running buffer 
 0.25 M Tris, 1.92 M glycine, 1% (w/v) SDS. buffer SDS-PAGE stacking gel 125 mM 
Tris-HCl (pH 6.8), 6% Acrylamide, 0.1% (w/v) SDS, solution 0.05% (v/v) ammonium 
persulphate, 0.005% (v/v) TEMED.  
S-30 extract Buffer 1  
20 mM HEPES (pH 7.5), 14 mM MgOAc, 100 mM KCl, 6 mM β-mercaptoethanol, 0.5 
mM PMSF.  
S-30 extract Buffer 2  
20 mM HEPES (pH 7.5), 14 mM MgOAc, 100 mM KCl, 1 mM DTT, 0.5 mM PMSF.  
S-30 extract Buffer 3  
20 mM HEPES (pH 7.5), 14 mM MgOAc, 100 mM KOAc, 1 mM DTT, 0.5 mM PMSF.  
SOC media  
2 % (w/v) Tryptone, 0.5 % (w/v) Yeast Extract, 0.05 % (w/v) NaCl, 10 mM MgCl2, 10 
mM MgSO4, 20 mM Glucose.  
50x TAE buffer  
2 M Tris, 5.71 % (v/v) glacial acetic acid, 0.05 M EDTA (pH 8.0). 
2.5x Translation premix  
137.5 mM HEPES (pH 7.5), 520 mM KGlu, 68.75 mM NH4OAc, 48.25 mM MgOAc, 
4.25 mM DTT, 3 mM ATP, 2 mM each rNTPs, 625 µg/mL creatine kinase, 200 mM 
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creatine phosphate, 444 µg/mL E. coli tRNA, 2 mM IPTG, 60 mg/mL PEG 8000, 170 µM 
folinic acid, 1.6 mM cAMP.  
10x Tricine gel Anode running buffer 
1 M Tris, 1 M tricine, 1% (w/v) SDS.  
10x Tricine gel Cathode  
2 M Tris-HCl (pH 8.9). running buffer  
Tricine separating gel solution 
496 mM Tris-HCl (pH 8.45), 8.4% Acrylamide, 6.5% (v/v) solution glycerol, 0.07% (v/v) 
ammonium persulphate, 0.004% (v/v) TEMED.  
Tricine spacer gel  
1 M Tris-HCLl (pH 8.45), 10% Acrylamide, 0.07% (v/v) ammonium persulphate, 0.004% 
(v/v) TEMED.  
Tricine stacking gel solution  
750 mM Tris-HCl (pH 8.45), 4% Acrylamide, 0.07% (v/v) ammonium persulphate, 
0.004% (v/v) TEMED. 
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2.3 Escherichia coli strains and plasmid vectors 
2.3.1 Escherichia coli strains 
 
The following strains of E coli were used at various points throughout this project: 
C41 competent cells: F – ompT hsdSB (rB- mB-) gal dcm (DE3) 
DH5α competent cells:  F- Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17(rk
-
, mk
+
) phoA supE44thi-1 gyrA96 relA1 λ- 
XL1 Blue competent cells: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIq Z∆M15 Tn10 (Tetr )]. 
XL10 Gold competent cells: TetrD(mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 gyrA96 relA1 lac Hte [F´ proAB lacIqZDM15 Tn10 (Tetr) Amy Camr] 
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2.3.2 Plasmid Vectors 
The following plasmid vectors were used throughout this project: 
pTrc99A- a bacterial expression vector with a lacI promoter chemically induced by 
isopropyl-β-D-thiogalactopyranoside (IPTG).  It contains an ampicillin resistance gene 
which acts as a selectable marker and its multiple cloning site is useful for restriction 
enzyme cloning. The restriction enzymes shown are those used during cloning experiments 
in this plasmid vector. 
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pcDNA 3.1- a high level expression vector for mammalian cell lines. Genes of interest are 
placed under the control of the T7 promoter. It contains an ampicillin resistance which acts 
as a selectable marker and its multiple cloning site is useful for restriction enzyme cloning. 
The restriction enzymes shown are those used during cloning experiments in this plasmid 
vector. 
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2.4 General Methods 
 
2.4.1 Preparation of LB plates: 
LB-Agar was autoclaved to 126°C for 30 minutes and allowed to cool before ampillicin 
was added at a final concentration of 100 µg/mL. The LB-Agar was mixed well and 
poured into plates under sterile conditions. 
 
2.4.2 Preparation of bacterial competent cell stocks:  
Glycerol stocks of competent bacterial cells, XL-1 Blue or DH5α, were streaked out onto 
LB-Agar plates and incubated overnight (~16 hours) at 37°C. A single colony was picked 
and used to inoculate 5 mL of LB media and incubated overnight at 37°C in a shaking 
incubator. 500µL of the overnight culture was then used to inoculate 50mL of sterile LB 
broth which was then incubated with moderate agitation (~220 rpm) until an Optical 
Density (OD) of 0.375 at 595 nm had been reached. Upon reaching the required OD, cells 
were chilled for 10 minutes before being transferred to sterile 50 mL falcon tubes and 
centrifuged at 2,500 rpm for 10 minutes at 4°C to pellet the bacteria. The supernatant was 
removed and the pellet re-suspended in 10 mL competent cell buffer (see section 2.2 for 
details) before being centrifuged again at 2,500 rpm for 5 minutes at 4°C. The supernatant 
is again removed and the pellet re-suspended in 10 mL of competent cell buffer, incubated 
on ice for 30 minutes and then centrifuged at 2,500 rpm for 5 minutes at 4°C. Finally, the 
pellet is re-suspended in 2 mL of competent cell buffer and the bacterial cells are aliquoted 
into sterile eppendorf tubes, frozen with liquid nitrogen and stored at -80°C. 
 
2.4.3 Transformation of competent bacteria: 
Transformations of well-established plasmids were carried out in DH5α cells, whilst XL1-
Blue and XL10-Gold cells were used for the transformation of site-directed mutagenesis 
plasmids. A 50 µL aliquot of competent cells were thawed on ice and 1 µL of the relevant 
DNA plasmid was added. The cells were then incubated on ice for a further 30 minutes 
before a heat shock at 42°C was carried out for 1 minute and returned to ice for 5 minutes. 
500 µL of LB broth was then added and samples were incubated at 37°C for 1 hour in the 
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shaking incubator. Following this, the entire transformation sample was split and spread 
over two LB-ampicillin plates and incubated overnight (~16 hours) at 37°C. 
 
2.4.4 Small-scale preparation of plasmid DNA (MINI-PREP): 
A single colony is selected from a bacterial transformation and used for the inoculation of 
5 mL LB media containing 100 µg/mL of ampicillin which was then incubated overnight 
at 37°C in the shaking incubator. The overnight culture was centrifuged at 6000 x g for 10 
minutes at 4°C to pellet the cells. The plasmid DNA was then purified from the bacterial 
cells using the Qiagen QIAprep Spin Miniprep Kit. Firstly, the pellet was re-suspended in 
250 µL of Buffer P1 and transferred to a sterile eppendorf tube.  Cell lysis was then carried 
on the addition of 250 µL of Buffer P2. The cell lysis was then neutralised after 5 minutes 
by the addition of 350 µL of Buffer N3. The sample was centrifuged at 15871 x g for 10 
minutes and the supernatant transferred to a QIAprep spin column. The column was 
centrifuged at 15871 x g for 1 minute and the flow-through was discarded. The column 
was then washed with 750 µL of Buffer PE and centrifuged at 15871 x g for 1 minute with 
the flow-through again discarded. To remove any residual PE buffer the column was spun 
again for 2 minutes. The plasmid DNA was then eluted into a sterile eppendorf by adding 
50 µL of nuclease-free water to the column and centrifuging for 2 minutes at 15871 x g. 
Plasmid DNA is then stored at -20°C 
 
2.4.5 Large-scale preparation of plasmid DNA (MAXI-PREP) 
After successful small-scale preparation of plasmid DNA, larger quantities required for 
transfection of cells was required. This was prepared using the Qiagen Maxi Plasmid Kit, 
using the materials and reagents supplied and following the manufacturer‟s instructions.  
300 µL bacterial cultures in LB broth containing 0.01 mg/mL ampicillin, were grown 
overnight at 37°C in the shaking incubator. The overnight cultures were centrifuged at 
6000 x g for 10 minutes at 4°C to pellet the cells. The pellet was then re-suspended in 10 
mL of P1 solution, followed by the addition of P2 solution to lyse the cells and incubated 
at room temperature for 5 minutes. 7.5 mL of Buffer P3 was then added to neutralise the 
lysate, before 20 minute incubation on ice, followed by two centrifugation steps at 20000 x 
g for 30 minutes at 4°C. The supernatant was then loaded onto a Qiagen Maxi column and 
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under gravity was allowed to flow through with the DNA remaining bound to the column. 
Three wash steps in QC buffer followed and plasmid DNA elution was carried out using 
buffer QF. The eluted DNA was then precipitated by adding 10 mL of isopropanol, 
centrifuged at 15000 x g for 30 minutes at 4°C and washed twice with 70% (v/v) ethanol. 
The pellet was subsequently air-dried and the DNA was re-suspended in 300 µL of ddH2O. 
The DNA concentration was determined by spectrometry and stored at -20°C. 
 
2.4.6 Polymerase Chain Reaction (PCR). 
2.4.6.1 DNA amplification by PCR 
DNA sequences of interest were amplified by specifically designed forward and reverse 
oligonucleotide primers (refer to Appendix 2). Forward and reverse primers also included 
any appropriate restriction sites required for restriction digests. All primers used in this 
study were synthesised by Integrated DNA technologies. PCR samples were set up on ice 
in thin-walled PCR tubes, using plasmid DNA as the template. PCR reactions were set up 
to follow the general protocol below: 
 
 10x DNA polymerase buffer      10 µL  
 dNTP mix (2.5 mM each: dATP ,dCTP ,dGTP, dTTP)   8 µL  
 Forward primer (100 pmol)       1 µL 
 Reverse primer (100 pmol)       1 µL 
 Template DNA (~100 ng/µL)      1 µL 
 Ex Taq DNA polymerase (5 units/µL)     0.5 µL 
 ddH2O        Final volume  100 µL 
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PCR was carried out in the Applied Biosciences 2720 thermal cycler using the following 
standard conditions: 
 
  Temp  Step   Time   # Cycles 
  94°C  Initial Denaturing 1 minute  1 cycle  
  94°C  Denaturing  30 seconds  
  56°C  Annealing  30-60 seconds  30 cycles 
  72°C  Elongation  1 minute/kb 
  72°C  Final Elongation 8 minutes  1 cycle 
  4°C     Hold 
 
The standard protocol for PCR can be altered to account for the different melting 
temperatures of individual primers. Optimal annealing temperature is ~5°C lower than the 
lowest melting temperature of the set of primers. 
Upon completion of PCR, the products were purified by PCR clean-up (see Section 2.4.6) 
and run on an agarose gel (see Section 2.4.8) to confirm the obtained product was of the 
correct base pair size. 
 
2.4.6.1 Site-directed mutagenesis by PCR 
Single site directed mutagenesis 
Single point mutations were generated in constructs using the Quick Change Site Directed 
Mutagenesis kit (Agilent). Forward and reverse primers were designed to incorporate a 
desired mutation (refer to Appendix 1). PCR samples were set up on ice, in thin-walled 
PCR tubes and the following protocol was followed: 
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 10x DNA polymerase buffer      5 µL  
 dNTP mix (10 mM each: dATP ,dCTP ,dGTP, dTTP)   1 µL  
 Forward primer (100 pmol)       1 µL 
 Reverse primer (100 pmol)       1 µL 
 Template DNA (~100 ng/µL)      1 µL 
 Pfu Turbo DNA polymerase (2.5 units/µL)    1 µL 
 ddH2O        Final volume  50 µL 
 
PCR was carried out in the Applied Biosciences 2720 thermal cycler using the following 
standard conditions: 
 
  Temp  Step   Time   # Cycles 
  94°C  Initial Denaturing 30 seconds  1 cycle  
  94°C  Denaturing  30 seconds  
  58°C  Annealing  1 minute  18 cycles 
  72°C  Elongation  1 minute/kb 
  72°C  Final Elongation 10 minutes  1 cycle 
  4°C     Hold 
 
Upon completion of single site directed mutagenesis, products were treated with 1 µL of 
the restriction enzyme Dpn1 for 1 hour at 37°C. The Dpn1 enzyme recognizes methyl 
groups on the backbone of the parental DNA molecules and removes them via digestion. 1 
µL of the final reaction is used to transform 50 µL of competent XL-1 blue cells (see 
Section 2.4.2). Plasmid DNA is isolated through small-scale DNA preparation (see Section 
2.4.4) and was subsequently sent for sequencing to confirm whether the mutation had been 
successfully incorporated. 
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Multiple site directed mutagenesis 
Multiple point mutations were incorporated into the same construct simultaneously by 
using the QuickChange Multi Site-Directed Mutagenesis kit. On this occasion, only 
forward primers containing the desired mutations were designed and used, with care taken 
so that primers did not overlap. PCR samples were set up on ice in thin-walled PCR tubes 
and the following protocol was followed: 
 
 10x DNA polymerase buffer      2.5 µL  
 dNTP mix (10 mM each: dATP ,dCTP ,dGTP, dTTP)   1 µL  
 Forward primer (100 ng 1-3 primers or 50 ng 4-5 primers)   1 µL of each 
 QuickChange Quick Solution       0.75 µL 
 Template DNA (~100 ng/µL)      1 µL 
 QuickChange Multi enzyme blend (2.5 units/µL)   1 µL 
 ddH2O        Final volume  25 µL 
 
PCR was carried out in the Applied Biosciences 2720 thermal cycler using the following 
standard conditions: 
 
  Temp  Step   Time   # Cycles 
  94°C  Initial Denaturing 1 minute  1 cycle  
  94°C  Denaturing  1 minute  
  55°C  Annealing  1 minute  30 cycles 
  65°C  Elongation  2 minutes/kb 
  4°C     Hold 
 
Upon completion of single site directed mutagenesis, products were treated with 1 µL of 
the restriction enzyme Dpn1 for 1 hour at 37°C. The Dpn1 enzyme recognizes methyl 
groups on the backbone of the parental DNA molecules and removes them via digestion. 1 
µL of the final reaction is used to transform 50 µL of competent XL-1 blue cells (see 
Section 2.4.2). Plasmid DNA was isolated through small-scale DNA preparation (see 
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Section 2.4.4) and was subsequently sent for sequencing to confirm whether the mutation 
had been successfully incorporated. 
 
2.4.7 PCR purification 
Products produced by PCR were purified using the PureLink PCR Purification Kit 
(Invitrogen). 1 volume of the PCR sample (100 µL) was mixed with 4 volumes of Binding 
Buffer (B2) in an eppendorf and added to a PureLink Spin Column provided. The sample 
was then centrifuged at 15871 x g for 1 minute to bind the DNA to the column.  The flow-
through was discarded and the column was washed with 650 µL of Wash Buffer and 
centrifuged at 15871 x g for 1 minute. The flow-through was once again discarded and the 
column centrifuged at 15871 x g for a further 2 minutes to remove any residual Wash 
Buffer. The column was then transferred to a fresh eppendorf and the PCR product was 
eluted from the column by applying 50 µL of ddH2O and centrifuging at 15871 x g for 1 
minute. The PCR product was analyzed on an agarose gel (see Section 2.4.8) to confirm 
both the PCR and purification were successful. 
 
2.4.8 DNA agarose gel electrophoresis 
Between 1-2% (w/v) agarose powder was dissolved in 1x TAE buffer (see Section 2.2) by 
heating in the microwave. The molten gel was allowed to cool before adding 0.5 µg/mL 
ethidium bromide. The molten gel was then poured into a mould containing a loading 
comb and allowed to set. The gel was then placed in a gel tank, the comb removed and 
immersed in 1x TAE buffer. The DNA samples were prepared by adding 6x Loading dye 
(see section 2.2) before being loaded into individual wells on the gel. Either a 100bp or 1kb 
DNA ladder (Promega) was run alongside the samples as a marker for size. Electrophoresis 
was carried out at 80 volts for ~ 40 minutes and the gel was visualised, with images being 
recorded, using the BioRad Molecular Imager ChemiDoc XRS+ System. 
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2.4.9 DNA purification from agarose gel 
DNA samples were resolved by gel electrophoresis and purified using the QIAquick Gel 
Extraction kit (Qiagen). DNA samples resolved within a gel were visualised on a UV light 
box and bands corresponding the correct size were excised using a scalpel and placed into 
sterile eppendorfs. The gel was weighed and 3 gel volumes (1 g: 300 µL) of Buffer QG 
were added and incubated at 50 °C for 10 minutes until the gel was completely dissolved. 1 
volume of isopropanol was added to the sample, mixed and transferred to a QIAquick spin 
column and centrifuged at 15871 x g for 1 minute. The flow-through was discarded and the 
column was washed with 750 µL of PE Buffer and centrifuged at 15871 x g for 1 minute. 
The flow-through was once again discarded and the column centrifuged at 15871 x g for a 
further 2 minutes to remove any residual Wash Buffer. The column was the transferred to a 
fresh eppendorf and the PCR product was eluted from the column by applying 50 µL of 
ddH2O and centrifuging at 15871 x g for 1 minute. The products were collected and stored 
at -20 °C. 
 
2.4.10 Restriction Endonuclease Digestion 
Plasmid DNA or PCR products containing specific restriction sites were digested by pairs 
of selectively chosen restriction enzymes. Samples for restriction digestions were set up as 
follows: 
  Component        Volume 
  Restriction enzyme buffer      10 µL  
  Plasmid DNA/PCR product (100 ng/µL)   1.5 µL 
  Restriction enzyme 1 (20 units/µL)     0.5 µL 
  Restriction enzyme 2  (20 units/µL)    0.5 µL 
  10x BSA (as recommended by manufacturer)   0.15 µL 
  ddH2O      Final Volume 15 µL 
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Reactions were incubated at a temperature and a time in accordance to the manufacturer‟s 
guidelines. Upon completion, enzymes were heat inactivated at 65 °C for 10 minutes. 
Samples were resolved on an agarose gel and purified by gel extraction (see Section 2.4.9). 
Samples were stored at -20  C. 
 
2.4.11 Ligation of DNA 
PCR products with 5‟ and 3‟ ends cleaved by restriction enzymes underwent a ligation 
reaction to insert the product into a vector prepared by digestion with the same enzymes. 
The ligation protocol is as follows: 
   
  Components       Volume 
  10x T4 DNA ligase buffer     2 µL 
  Insert DNA- PCR product (~ 100 ng/µL)   6 µL 
  Plasmid vector DNA (~ 100 ng/µL)    1 µL 
  T4 DNA Ligase (400 units/µL)    1 µL 
  ddH2O      Final Volume 20 µL 
Reactions were incubated at room temperature for 1 hour or at 16 °C in the cold room 
overnight. 5 µL of the reaction mix was used to transform DH5α competent cells (see 
Section 2.4.2). Plasmid DNA was isolated through small-scale DNA preparation (see 
Section 2.4.4) and was subsequently sent for sequencing to confirm whether the ligation 
was successful. 
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2.4.12 DNA sequencing 
Plasmid DNA required for sequencing was prepared via small-scale DNA preparation and 
diluted to a concentration of 20 ng/µL. Samples were sent to the Sequencing Service at the 
School of Life Sciences, University of Dundee. Results were analysed and compared to 
known nucleotide sequences using BLAST and the Swiss Institute of Bioinformatics (SIB) 
ExPASy translate online software. 
 
 2.4.13 In vitro transcription 
Using Linear DNA from PCR, RNA was transcribed by the following protocol. Reactions 
were set up in thin-walled PCR tubes and incubated in the Applied Biosciences 2720 
thermal cycler for 2 hours at 37°C. 
  Components       Volume 
  5x Transcription buffer     10 µL 
  dNTP mix (25 mM each: dATP ,dCTP ,dGTP, dTTP)  6 µL 
  Linear DNA (~ 100 ng/µL)     10 µL 
  DTT (1M)       2 µL 
  RNasin® Ribonuclease Inhibitor (40 units/µL)  1 µL 
  T7 RNA polymerase       2 µL 
  ddH2O      Final Volume 50 µL 
Synthesised RNA was used directly in the Rabbit Reticulocyte Lysate (RRL) in vitro 
translation system, but required the following clean-up measures when used in the Wheat 
Germ (WG) in vitro translation system. RNA was precipitated by adding 0.1 volumes of 
3M NaOAc (pH 5.2) and 3 volumes of 100% ethanol and incubating on ice for 10 minutes. 
The mix was then centrifuged at 19071 x g at 4°C for 10 minutes. The supernatant was 
discarded and the remaining pellet was washed with 200 µL of 70% (v/v) ethanol and 
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centrifuged at 19071 x g at 4°C for a further 10 minutes. The supernatant was again 
discarded and the pellet was resuspended in 50 µL of ddH2O. At this point, 2 µL of the 
RNA was resolved on an agarose gel (see Section 2.4.7), confirming the RNA was the 
correct size and adequate quality. Aliquoted samples were stored at -80  C. 
2.5 In vitro translation systems 
2.5.1 Preparation of E. coli S-30 extract 
C41 cells from glycerol stocks were streaked onto an LB-agar plate and incubated 
overnight at 37°C. From the plate, two individual colonies were picked and used to 
inoculate separate 5 mL LB-broth cultures overnight. The following day, the two 5 mL 
cultures were used to inoculate 500 mL cultures of SOC media (see Section 2.4.2). The 
cells were incubated at 37°C in a shaking incubator and grown to mid-log phase (A600= 
0.8). At this point, 1 litre of ice was added to the cultures and then centrifuged at 6732 x g 
for 10 minutes at 4°C. The supernatant was discarded and the pellet re-suspended in 100 
mL of Buffer 1 and re-centrifuged at 6732 x g for 10 minutes at 4°C. The supernatant was 
again discarded and the pellet re-suspended in 100 mL of Buffer 1 and then centrifuged 
again at 6732 x g for 10 minutes at 4°C. After removal of the supernatant, the wet cell 
mass of the pellet was weighed and re-suspended in Buffer 2 to a concentration of 0.5 
g/mL. Lysosyme (100 mg/mL) was added to a final concentration of 1 mg/mL before the 
cell suspension was passed twice through a French Press at 8,000 psi. The extract was then 
centrifuged at 29994 x g for 30 minutes at 4°C. The supernatant was retained and 
transferred to a fresh tube and centrifuged again at 29994 x g for 30 minutes at 4°C. The 
supernatant was then incubated with 0.15 volumes of Run-out premix at 26°C for 70 
minutes, before the extract was dialysed 3 times using a Slide-A-Lyzer Dialysis Cassette 
3500 MWCO, in Buffer 3 for a minimum of 1 hour each. Following dialysis, the extract 
was centrifuged at 19071 x g at 4°C for 10 minutes before being aliquoted and then snap 
frozen to be stored at -80°C.  
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2.5.2 In vitro transcription/translation in E. coli S-30 extract 
translation system 
Translation reactions in the E.coli transcription/translation system were set up as follows in 
a standard 25 µL volume (volumes can be adjusted accordingly).  
   
  Components       Volume 
  Translation premix      10 µL 
  1mM each L-amino acid (minus methionine)    2.5 µL 
  Linear DNA (~ 100 ng/µL)     2.5 µL 
  S-30 extract       7.5 µL 
  [
35
S] methionine      10 µCi 
  5 µg/µL of anti-ssrA oligonucleotide    1 µL 
  (5‟-TTAAGCTGCTAAAGCGTAGTTTTCGTCGTTTGCGACTA-3‟) 
        Final Volume 25 µL 
Translation reactions were incubated at 37°C for 30 minutes and were terminated by 
incubating on ice for 5 minutes. SDS-PAGE analysis of results was carried out as 
described in Section 2.6.1 
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2.5.3 In vitro translation in Wheat Germ extract translation system 
Translation reactions in the Wheat Germ Extract translation system were set up as follows 
in a standard 50 µL volume (volumes can be adjusted accordingly).  
   
  Components       Volume 
  Wheat Germ Extract       25 µL 
  1mM each L-amino acid (minus methionine)    4 µL 
  RNA substrate in ddH2O (~500 ng/µL)   5 µL 
  Potassium Acetate (1M)     6.5 µL 
  [
35
S] methionine      2.5 µL 
  RNasin® Ribonuclease Inhibitor (40 u/µL)   1 µL 
  ddH2O       Final Volume 50 µL 
Translation reactions were incubated at 26°C for 30 minutes and were terminated by 
incubating on ice for 5 minutes. SDS-PAGE analysis of results was carried out as 
described in Section 2.6.1 
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2.5.4 In vitro translation in Rabbit Reticulocyte Lysate translation 
system 
Translation reactions in the Flexi® Rabbit Reticulocyte Lysate translation system were set 
up as follows in a standard 25 µL volume (volumes can be adjusted accordingly).  
   
  Components       Volume 
  Rabbit Reticulocyte Lysate      16.5 µL 
  1mM each L-amino acid (minus methionine)    1 µL 
  RNA substrate in ddH2O (~100 ng/µL)   1 µL 
  Potassium Chloride (2.5 M)     0.4 µL 
  DTT (1M)        0.2 µL 
  [
35
S] methionine      1 µL 
  RNasin® Ribonuclease Inhibitor (40 units/µL)  1 µL 
  ddH2O       Final Volume 25 µL 
Translation reactions were incubated at 30°C for 30 minutes and were terminated by 
incubating on ice for 5 minutes. SDS-PAGE analysis of results was carried out as 
described in Section 2.6.1. 
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2.5.5 TCA precipitation of translated peptides 
Translation reactions were carried out as described in Section 2.5.2.4 and following the 5 
minute incubation on ice, 1% (w/v) final volume of TCA was added to the reaction mix. 
The samples were incubated on ice for 15 minutes and then centrifuged at 19071 x g at 4°C 
for 10 minutes. The supernatant was discarded and the pellet was twice washed with 1 mL 
of 100% cold acetone and incubated on ice for 10 minutes, before being centrifuged at 
19071 x g at 4°C for 10 minutes. The supernatant was removed and the precipitated pellets 
were dried in the speedy vacuum for 15 minutes. Pellets were re-suspended in 2x Sample 
Buffer and SDS-PAGE analysis of results was carried out as described in Section 2.6.1. 
 
2.5.6 Pegylation assay to assess compaction of nascent chain in 
the ribosome exit tunnel. 
Translation reactions were carried out as described in Section 2.5.2 and 2.5.3 at a volume 
of 50 µL and following the 5 minutes incubation on ice, the translation product was 
overlaid onto 100 µL sucrose cushion (0.5M sucrose in RNC buffer). Ultracentrifugation 
of the samples in a Beckman TLA-100 rotor took place at 436000 x g for 10 minutes at 
4°C to isolate ribosome bound nascent chains (RNCs). The supernatant was discarded and 
pellets were re-suspended on ice in 60 µL PEG Buffer. The samples were split in half (30 
µL) and added to either 30 µL PEG Buffer containing 2mM PEG-MAL or a control 
containing 30 µL of PEG Buffer only.  The reactions were incubated on ice for 2 hours. To 
terminate the reaction, 100 mM DTT was added and incubated at room temperature for 10 
minutes. The samples were then CTABr precipitated by adding 10 volumes of 0.5M 
NaOAc (pH 4.7) and 2% (w/v) CTABr (600 µL of each) and incubated on ice for 15 
minutes. They were then centrifuged at 15871 x g for 15 minutes at room temperature 
before discarding the supernatant. The remaining pellets were twice washed with 1 mL of 
100% cold acetone and incubated on ice for 10 minutes, before being centrifuged at 19071 
x g at 4°C for 10 minutes. The supernatant was removed and the precipitated pellets were 
dried in the speedy vacuum for 15 minutes. The dried pellets were re-suspended in 15 µL 
1mg/mL RNaseA in ddH2O and incubated at room temperature for 10 minutes, before the 
addition of 2x Sample Buffer and analysis of results by SDS-PAGE as described in Section 
2.6.1. 
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2.5.7 Chemical cross-linking of ribosome-bound nascent chains 
using BS3   
Translation reactions (100 µL) were carried out as previously described in Section 2.5.2 
and 2.5.4 to generate nascent peptides of desired lengths. After the 5 minute incubation on 
ice, a 7 µL portion of the reaction was overlaid onto a 50 µL sucrose cushion (0.5M 
sucrose in RNC buffer) (tube A) while the remainder is overlaid onto a 100 µL sucrose 
cushion (tube B). Ultracentrifugation of the samples in a Beckman TLA-100 rotor took 
place at 436000 x g for 10 minutes at 4°C to isolate ribosome bound nascent chains 
(RNCs). Pellet A was re-suspended in 8 µL of RNC buffer, 100 µg/mL RNase A and 5 
mM EDTA at incubated at 26°C for 10 minutes. The sample was the heated in 2 X Sample 
Buffer at 95°C for 5 minutes before the analysis of results by SDS-PAGE as described in 
Section 2.6.1.  
Pellet B was re-suspended in 88 µL of BS
3
 buffer (RNC buffer and 1 mM BS
3
) and 
incubated on ice for 2 hours. The reactions are quenched by the addition of 5 mL of 1M 
Tris (pH 8.0) and incubated at room temperature for 15 minutes. 7 µL of the sample was 
added to 100 µg/ mL RNase A and 5 mM EDTA at incubated at 26°C for 10 minutes and 
heated in 2 X sample buffer at 95°C for 5 minutes before the analysis of results by SDS-
PAGE as described in Section 2.6.1. The remainder of the samples were incubated with 
1% (w/v) final volume of TCA and placed on ice for 15 minutes before centrifugation at 
19071 x g at 4°C for 10 minutes. The supernatant was discarded and the pellets were used 
for immunoprecipitation experiments.  
 
2.5.8 Chemical cross-linking of ribosome-bound nascent chains 
to Sec61α using BMH    
Translation reactions (100 µL) were carried out as previously described in Section 2.5.2 
and 2.5.4 to generate nascent peptides of desired lengths. For cross-linking assays to 
Sec61α, the translation mix also contained 1 µL (<80 equivalents/µL) of dog pancreas 
microsomes (DPMs) and 1 µL (0.5 pmol/µL) of signal recognition particle (tRNA probes). 
After the translation reaction was terminated, ultracentrifugation in a Beckman TLA-100 
rotor at 436000 x g for 10 minutes at 4°C is required to pellet the DPMs. The DPM pellet 
was then washed with 3M potassium acetate and centrifuged at 19071 x g at 4°C for 10 
minutes. The pellet was resuspended in 50 µL of RNC buffer and split into (A) a 5 µL 
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sample and (B) a 45 µL sample. Sample A was treated with 100 µg/mL RNase A and 5 
mM EDTA at incubated at 26°C for 10 minutes. The sample was then heated in 2 X 
Sample Buffer at 95°C for 5 minutes before the analysis of results by SDS-PAGE as 
described in Section 2.6.1. 
5 µL of BMH buffer (DMSO and 20 mM BMH) was added to sample B and incubated 30 
°C for 30 minutes. To terminate the reaction, 100 mM DTT was added and incubated at 
room temperature for 10 minutes. 6 µL of the sample was added to 100 µg/ mL RNase A 
and 5 mM EDTA and incubated at 26°C for 10 minutes and heated in 2 X sample buffer at 
95°C for 5 minutes before the analysis of results by SDS-PAGE as described in Section 
2.6.1. The remainder of the samples were centrifuged at 19071 x g at 4°C for 10 minutes to 
isolate the DPM pellet. The supernatant was discarded and the pellets were used for 
immunoprecipitation experiments 
 
2.5.9 Immunoprecipitation of cross-linked products 
TCA precipitated pellets from cross-linking experiments were re-suspended in 50 µL 
Solubilisation Buffer (see Section 2.2 for all buffers used in the following protocol) and 
heated to 95°C for 5 minutes. The sample was then incubated in 1 mL of ice cold RIPA 
buffer on ice for 5 minutes, before centrifugation at 19071 x g at 4°C for 10 minutes. The 
supernatant was retained and transferred to a fresh tube to be incubated on ice for 2 hours 
with the desired primary antibody. 30 µL Protein- A sepharose beads (0.2 g in 1 mL of 
RIPA buffer) were added to each sample and incubated for 30 minutes at 4°C. They were 
then centrifuged at 2655 x g for 1 minute at 4°C and the supernatant discarded. The beads 
were then washed in High Strength (HS) RIPA buffer and again centrifuged at 2655 x g for 
1 minute at 4°C and the supernatant discarded. The HS-RIPA buffer wash was repeated 
once before a wash with RIPA buffer and re-centrifuged at 2655 x g for 1 minute at 4°C. 
The supernatant was discarded and 15 µL of 1x Sample Buffer was added to the beads 
before they were heated to 95°C for 5 minutes. SDS-PAGE analysis of results was carried 
out as described in Section 2.6.1. 
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2.5.10 Digestion assay assessing insertion into Dog Pancreas 
Microsomes (DPMs) 
Translation reactions (50 µL) were carried out as previously described in Section 2.5.4 to 
generate peptides of desired length. For insertion assays the translation mix also contained 
1 µL (<80 equivalents/µL) of dog pancreas microsomes (DPMs) and 1 µL (0.5 pmol/µL) 
of signal recognition particle (tRNA probes). After the translation reaction was terminated, 
ultracentrifugation in a Beckman TLA-100 rotor at 436000 x g for 10 minutes at 4°C is 
required to pellet the DPMs. The DPM pellet was then washed with 3M potassium acetate 
and centrifuged at 19071 x g at 4°C for 10 minutes. The pellet was re-suspended in 20 mM 
HEPES buffer (pH 7.4) and Proteinase K is added at a concentration of 0.2 mg/mL (in the 
presence or absence of 1% (v/v) Triton X-100) and incubated at room temperature for 30 
minutes. The DPMs were once again centrifuged at 19071 x g at 4°C for 10 minutes. The 
supernatant was removed and the DPMs were re-suspended in 1x Sample Buffer and 
analysed by SDS-PAGE gel.  
2.6 Imaging 
2.6.1 Gel Electrophoresis and western blotting 
Polyacrylamide separating gels of the appropriate percentage were prepared as described 
by Laemmili (1970) for the separation of large proteins with a MW > 15 kDa. To resolve 
smaller proteins with a MW <15 kDa tricine gels were used (see Section 2.2 for the 
solutions used to make separating, stacker and spacer (tricine gel only) components of each 
gel). Prepared samples were added to the gel, alongside the SeeBlue Pre-stained Marker 
(Invitrogen) and electrophoresed at 120 volts until through the stacking gel. When the 
samples entered the resolving gel, the voltage was increased to 200 volts and the gel was 
run until complete. Following completion, the gel apparatus was removed, the stacking gel 
cut off and the separating retained. If the results of the gel were to be visualised by 
autoradiography (see Section 2.1), the gel was placed in destain solution (see Section 2.2) 
for 1 hour whilst shaking and dried for 2 hours at 60°C on the gel drier. If the gel was to be 
analysed by immunoblotting, it transferred to an Invitrogen Xcell II wet blotting apparatus. 
The proteins were then transferred to a nitrocellulose membrane in transfer buffer (see 
Section 2.2) at 100 mA for 1 hour. 
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2.6.2 Autoradiography  
Following gel electrophoresis, destaining and drying, the protein samples radiolabelled 
with 
35
S-methionine were visualised by autoradiography. Dried gels were placed into an 
autoradiographic cassette and exposed to Kodak X-ray film for a certain period of time 
before being processed by the Kodak X-Omat 100 processor.  
 
2.6.3 Immunoblotting 
Following western blotting, the nitrocellulose membrane was incubated for 1 hour at 4°C 
with 10 (w/v) Marvel skimmed milk powder in order to block non-specific binding of 
antibodies. The membrane was washed in TBS (see Section 2.2 for all solution used in the 
following protocol) and incubated with the appropriate antibody (prepared at 1:1000 in 
TBS) at 4°C overnight.  Three 10 minute wash steps using TBS/0.1% (v/v) Tween 20 
followed by a 1 hour incubation with the secondary antibody (prepared at 1:20000 in 
TBS). Three further wash steps in TBS were carried out, before the membrane was 
developed using Amersham™ ECL western blotting reagent. Equal volumes of the two 
ECL solutions were mixed and poured over the nitrocellulose membrane and left to 
incubate for 2 minutes. The excess ECL was then dabbed off and the membrane was 
placed into an autoradiographic cassette. The membrane was exposed to Kodak X-ray film 
for a certain period of time before being processed by the Kodak X-Omat 100 processor. 
 
2.7 Statistical analysis 
Group data are expressed as mean ± SD. Groups were compared using one-way ANOVA 
with Tukey‟s post hoc analysis. Analysis was carried out using GraphPad Prism version 5.0 
(GraphPad Software, Inc., USA). Significance was accepted at p < 0.05.
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3. Investigating secondary structure formation in 
transmembrane domain 1 of hGPR35 and Bacterioopsin 
3.1. Introduction 
Like all other proteins, a GPCR starts its life as a nascent peptide in the ribosome tunnel. 
GPCRs are comprised of seven transmembrane (TM) helical domains, which are vital in 
how the receptor functions. Although these TM segments are critical to both the structure 
and function of GPCRs, little is known about their biogenesis and the mechanisms that are 
intrinsic to obtaining the secondary, tertiary and quaternary structure of these domains. 
Much research has been carried out investigating the mature structure, indicating the 
helical nature of the individual TM domains, but little is known as to when this helicity 
first arises. Potentially, this could occur during peptide synthesis and may involve the 
ribosome itself. 
Many theories suggest that the tertiary structure of integral membrane proteins (IMPs) is 
established as they are co-translationally inserted into the membrane. This therefore asks 
the question, when does secondary structure form and can it occur before the nascent chain 
has left the ribosome? The large subunit of the ribosome is approximately 100Å in length 
when measured from the PTC to the base of the exit tunnel (Lu & Deutsch 2005b). The 
diameter of the tunnel also ranges from 10-20Å, suggesting the ribosome tunnel could 
tolerate the formation of an α-helix within a nascent chain during translation (Mingarro et 
al. 2000; Ban 2000; Kramer et al. 2001). The ribosome tunnel has been shown to be both 
structurally and biochemically diverse, as well as being favourable towards the formation 
of α-helices (Ziv et al. 2005). For example, structural studies have provided evidence of 
ribosomal proteins not only lining, but protruding into the tunnel, generating zones of helix 
stabilization (Lu & Deutsch 2005b). Biochemical studies have also suggested that these 
zones could be key in promoting peptide folding (Woolhead et al. 2004; Bhushan et al. 
2010; Robinson et al. 2012). 
The size restraints and dimensions of the tunnel lead us to believe only helices can form in 
the upper and middle regions of the tunnel, leaving other secondary structures such as β-
sheets and tertiary structures such as β-hairpins to develop in the distal regions of the 
ribosome exit tunnel (Kosolapov & Deutsch 2009; Conti et al. 2014; Lu & Deutsch 2014; 
Marino et al. 2016). Although the environment of the tunnel is favourable towards the 
formation of secondary structure, examples such as TM1 in leader peptidase (Lep) and 
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TM2 in Kv1.3 choose not to take up their folded conformation in preference of an 
extended conformation whilst fully in the tunnel (Houben et al. 2005; Tu & Deutsch 2010). 
The amino acid sequence of a nascent chain is believed to be equally as important as the 
ribosome environment in relation as to whether secondary structure forms in the tunnel. 
The tunnel acts to decode certain motifs within the amino acid sequence but it is the two in 
tandem which control such events as elongation, folding and termination (Kramer et al. 
1999; Woolhead et al. 2006).  
The formation of secondary structure within TM domains of IMPs has been frequently 
remarked upon, with several studies showing the ability of the ribosome to recognise a TM 
segment as it makes its way through the tunnel. Experiments using a single-spanning 
membrane protein produced results suggesting that upon recognition of the TM segment, 
the ribosome was capable of aiding its folding (Liao et al. 1997; Woolhead et al. 2004). 
Later experiments identified this region of the ribosome to contain the uL22 protein and 
linked the folding of TM domains within the tunnel to a signalling pathway for ER gating 
(Woolhead et al. 2004). This prediction was later verified by cross-linking data suggesting 
the appearance and folding of the TM domains within the tunnel triggered a structural 
rearrangement of the Sec61 translocon, priming it for TM integration (Pool 2009). The 
importance of co-translational targeting of RNCs has lead us to question the importance of 
TM domain secondary structure for SRP. Actively translating ribosomes have been shown 
to increase their affinity for SRP as the nascent chain enters the distal regions of the tunnel 
(Berndt et al. 2009; Flanagan et al. 2003) which in some cases has been enhanced by TM 
domain folding (Tu et al. 2000). 
Not only has secondary structure formation within the tunnel been shown to play a pivotal 
role in the targeting of TM proteins to the membrane, there is some evidence that it also 
aids the assembly of multimeric membrane spanning proteins in the ER. Studies by 
Kosolapov and Deutsch (2003) reveal that the folding of the 1
st
 TM domain of a voltage 
gated potassium (Kv) channel, whilst ribosome bound, is essential for acquiring its tertiary 
and quaternary structure within the ER membrane. Folding within TM 1 and later TM 
segments of the Kv channels was assayed in further experiments using a technique known 
as pegylation. Pegylation will be utilized in this chapter to analyze the co-translational 
folding of the N-terminal TM 1 of GPR35. 
The pegylation assay has been used by several groups to demonstrate nascent peptide 
compaction within the ribosome tunnel (Lu & Deutsch 2005b; Lu & Deutsch 2005a; Conti 
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et al. 2014). The pegylation assay firstly requires an in vitro translation to produce stalled 
RNCs. The assay relies on mass-tagging the nascent peptide with a molecule of methoxy-
polyethylene glycol malemide (PEG-MAL), to cysteine residues, which increases the 
molecular weight of a nascent peptide by 5 kD when separated on an SDS-PAGE gel. Each 
nascent chain will contain a single, specifically-placed cysteine residue (the marker 
cysteine), which when exposed to the PEG-MAL molecule will become mass-tagged and 
detectable by a gel shift assay (Figure 3.1B). Due to the size of the PEG-MAL molecule, 
RNCs containing a cysteine buried within the ribosome tunnel will be protected from 
pegylation (Figure 3.1 C1). As the cysteine emerges from the ribosome it is no longer 
protected and becomes available for pegylation (Figure 3.1 C2). As the ribosome tunnel is 
known to be approximately 100Å, from the PTC to its exit, a fully extended peptide at 3-
3.4Å/ amino acid would require approximately 30 amino acids to traverse the tunnel, 
where as an α-helix at 1.5Å/ amino acid would require approximately 67 amino acids (Lu 
et al. 2007). From these studies, nascent chains within the ribosome exit tunnel have been 
shown to exist in different forms, with different levels of compaction within the tunnel 
(Figure 3.1A). Hence, it is difficult for a pegylation to discriminate between tight 
compaction in one region of the nascent chain and full extension in another. Therefore, 
using pegylation we can measure the point at which the nascent peptide first emerges from 
the ribosome exit tunnel and by calculating the nascent chain length detect whether 
secondary structure has formed within the ribosome.  
The aim of this chapter is therefore, to use a pegylation assay to investigate the folding 
profile of the N-terminal region of the human orthologue of GPR35 (a GPCR), specifically 
assessing if secondary structure is apparent within the first TM domain. The folding profile 
of a structurally similar microbial Opsin (Bacterioopsin) was also assessed and used to 
investigate the differences between prokaryotic and eukaryotic in vitro translation systems. 
Using two different systems offered the opportunity to compare two different subsets of 
ribosomes, in turn providing us with the chance to investigate if the two proteins of interest 
produced the same co-translational folding profile in the eukaryotic and prokaryotic 
systems. This would therefore enable us to establish whether ribosome environment or 
sequence specificity within the nascent peptide had a greater impact on generating 
secondary structure within a nascent chain.  
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Figure 3.1 Pegylation assay to measure the level of secondary structure formed within the ribosome exit 
tunnel. (A) PEG-MAL molecule forms a thoil bond between malemide head group and free cystiene residues, attaching 
polyethylene glycol chains to other molecules. (B) Schematic representing the length of nascent chain required to traverse 
the ribosome exit tunnel, depending on the degree of compaction. (C1) Schematic diagram representing the protection 
offered to the marker cysteine (red circle) from a molecule of PEG-MAL by the ribosome tunnel and (C2) interaction 
between PEG-MAL and the cysteine when exposed from the ribosome exit tunnel. 
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3.2. Results 
3.2.1. Investigating the formation of secondary structure in TM1 
of GPR35 and Bacterioopsin within the prokaryotic ribosome. 
To measure the compaction of the first TM domain of GPR35 and BO within the ribosome 
exit tunnel, we first had to prepare the constructs to be used in the pegylation assay. For 
pegylation assays, we require a single cysteine residue in the N-terminus of our genes of 
interest, upstream of the first TM domain. Figures 3.3A and 3.4A show the sequence of the 
N-terminal regions of both hGPR35 and BO respectively. GPR35 contains a native 
cysteine at residue 8 (C8) which was calculated to be too far upstream from the first TM 
domain to determine if compaction occurred when using pegylation as an assay. Therefore, 
by site-directed mutagenesis (see section 2.4.6.1), C8 was substituted for an alanine and a 
cysteine residue was placed at amino acid position 15 (C15). The C15 residue is located 10 
amino acids upstream of TM1 and will become a marker for pegylation, hence it will be 
known as the marker cysteine (Figure 3.3A).  
To determine if secondary structure was forming within TM1 of GPR35 whilst ribosome 
bound, we generated translation intermediates of various lengths ranging from 25-50aa 
from the peptidyl transferase centre (PTC) to the marker cysteine.  Individual intermediates 
were generated from linear DNA, which lacked a stop codon in the reverse primer and 
hence produced stable RNCs.  The length each intermediate increased by 5aa within the 
range and were chosen to provide a detailed analysis of the movement of the TM domain 
through the ribosome tunnel. RNCs were generated using the coupled 
transcription/translation S-30 expression system. Following pegylation, the RNCs were 
precipitated using cetyltrimethylammonium bromide (CTABr) was carried out to isolate 
the nascent chains that remained bound to the ribosome and to discriminate against those 
that may have become disengaged from the PTC. Pegylation of C15 was detectable by a 
single 5 kDa shift of translation product on a tricine gel. 
The results of the pegylation assay to assess the compaction of TM1 in GPR35 are shown 
in Figure 3.3. The intermediate length of 25aa at which the marker cysteine is 25 amino 
acids from the PTC shows clearly what is expected when pegylation does not occur. At this 
length there is no change in the size of the translation product, with C15 expected to be 
found within the ribosome tunnel and hence, should be unavailable to interact with the 
PEG-MAL molecule. This agrees with previous studies suggesting that PEG-MAL is 
inaccessible to the mid-tunnel of the ribosome 
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Figure 3.2 Diagram to show how ribosome bound nascent chains (RNCs) are generated. Firstly, linear DNA is generated 
from PCR reactions using a plasmid DNA template. The reaction specifically contains a reverse primer without a stop codon to 
prevent the release of the nascent peptide from the ribosome. Transcription of linear DNA to messenger RNA is preformed either 
manually or as part of a coupled transcription/translation reaction. Finally, within in vitro translation systems generate nascent 
peptides attached to the ribosome, which can be used to measure secondary structure within the ribosome tunnel. 
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Figure 3.3.  Analysis of the pegylaltion assay of GPR35 in the prokaryotic S-30 transcription/translation system. (A) Schematic diagram 
of the GPR35 gene highlighting the substitution mutations made by SDM to place a single cysteine (marker cysteine) at position 15 for pegylation and 
remove the native cysteine at position 8. From the marker cysteine, the position of the reverse primers generating various lengths of intermediates can be 
seen. (B) Intermediate lengths of GPR35 were expressed in the S-30 coupled transcription/translation reaction. The reaction was split into two, with one 
half being incubated with 1mM PEG-MAL and the other half incubated in buffer as a control. CTAB precipitation was carried out to ensure selection of 
ribosome-bound nascent chains and exclude those which had dissociated from the PTC.  A representative gel displays how the pegylated (1) and non-
pegylated (0) samples were resolved by SDS-PAGE, measuring if pegylation had taken place by a gel-shift of the translation product by ~ 5kDa. (C) The 
average % pegylation of individual intermediates shows pegylation of cysteine 15 occurs as early as 30 amino acids from the PTC. The % pegylation of 
intermediates shows an increase between 30 and 40 amino acids before it plateaus. All % pegylation values were calculated using [pegylated/(unpegylated 
+ pegylated)] adjusted for background. Average percentage pegylation is calculated from an n of 3. Error bars indicate standard deviation. 
 
98 
 
(Lu & Deutsch 2005b; Lu & Deutsch 2005a). As the nascent chain increases in length to 
30aa, a small fraction of the translation product, approximately 30%, becomes pegylated 
resulting in a gel shift (Figure 3.3 B and C). At this point the marker cysteine is believed to 
be in the vestibule of the exit tunnel where the PEG-MAL molecule can interact with 
cysteine residues in an inefficient manner. As the distance of the marker cysteine increases 
to 35-40aa from the PTC, we see a greater rate of pegylation increasing from 45% to 75%, 
correlating with the ability of the PEG-MAL molecule to efficiently bond to the C15 
residue at the N-terminus of GPR35. Further lengths of 45aa and 50aa show pegylation at 
levels of approximately 80%, little change from that seen at 40aa, suggesting the marker 
cysteine had fully exited the ribosome tunnel and was completely exposed at that point to 
the PEG-MAL molecule (Figure 3.3).  
The findings above suggest that TM1 of GPR35 exists in an extended conformation as it 
makes its way through the prokaryotic ribosome tunnel. With the marker cysteine located  
10 amino acids  downstream from TM1 showing signs of pegylation as early as 30aa from 
the PTC, and pegylation  increasing thereafter, it seems unlikely that compaction of the 
nascent chain is taking place while the N-terminus of TM1 is in the lower regions of the 
tunnel . However, as the prokaryotic ribosome would not be considered a native 
environment for the expression of a eukaryotic GPCR, this may affect how the components 
of ribosome tunnel interact with the GPR35 nascent chain. To investigate a possible 
prokaryotic specific interaction, the folding profile of a structurally similar protein, BO, 
was examined in this translation system. 
To enable the assessment of secondary structure in BO by pegylation, SDM was carried 
out to introduce a marker cysteine at position 15, to make the system comparable to the 
results for GPR35. As BO had no native cystienes upstream of the first TM domain, C15 
(the marker cysteine) would be the sole site for pegylation. The pegylation assay was 
carried out as with GPR35 using identically sized intermediates. In every assay carried out 
with BO, neither the 25 nor 30aa intermediate could be expressed, possibly due to 
prokaryotic ribosome specific instability of these lengths of BO at the PTC. The first 
length to express is the intermediate presenting the marker cysteine 35aa from the PTC. At 
this length PEG-MAL already shows signs of binding with ~60% efficiency, generating a 
shift in a high portion of the translated product. This, as with the 35aa intermediate of 
GPR35, would suggest the marker cysteine now resides outside exit site of the ribosome 
tunnel and is available for efficient pegylation of the nascent chain.  
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Figure 3.4.  Analysis of the pegylaltion assay of Bacterioopsin in the prokaryotic S-30 transcription/translation system. (A) Schematic diagram of the BO 
gene highlighting the substitution mutations made by SDM to place a single cysteine (marker cysteine) at position 15 for pegylation From the marker cysteine, 
the position of the reverse primers generating various lengths of intermediates can be seen. (B) Intermediate lengths of BO were expressed in the in vitro S-30 
couple transcription/translation reaction. The reaction was split into two, with one half being incubated with 1mM PEG-MAL (+PEG-MAL) and the other half 
incubated in buffer as a control (-PEG-MAL). The representative gels displays how the pegylated (1) and non-pegylated (0) samples were resolved by SDS-
PAGE, measuring if pegylation had taken place by a gel-shift of the translation product by ~ 5kDa. (C) The average % pegylation of individual intermediates 
shows pegylation of cysteine 15 occurs from 35 amino acids from the PTC. The % pegylation of intermediates shows an increase between 35 and 40 amino 
acids before it plateaus in the subsequent intermediates. Both the 25 and 30aa BO constructs failed to express in the prokaryotic system. All % pegylation 
values were calculated using [pegylated/(unpegylated + pegylated)] adjusted for background. Average percentage pegylation is calculated from an n of 3. Error 
bars indicate standard deviation. 
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(Figure 3.4 B and C). All subsequent intermediate lengths of BO were pegylated with 
upwards of 70% efficiency, suggesting the nascent chain was fully available to PEG-MAL.  
The above results of the pegylation assay indicate that the first TM domain of BO, like 
GPR35, is absent of secondary structure and remains in an extended conformation whilst 
its N-terminus is in the lower regions of the ribosome tunnel. This suggests that either the 
sequence coding for the nascent peptide in both proteins does not favour the generation of 
secondary structure or that the environment of the E. coli ribosome does not support the 
co-translational folding of these nascent chains. To test this theory, the next set of 
experiments will be assessing the capability of GPR35 and BO to compact within 
eukaryotic ribosome exit tunnel. This will enable us to investigate the impact the ribosome 
tunnel environment has on the translating nascent chain and whether the change in 
environment produces a change in the folding profile of GPR35 and BO. 
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3.2.2. Investigating the formation of secondary structure in TM1 
of GPR35 and Bacterioopsin within the eukaryotic ribosome. 
Following the investigation of the formation of secondary structure within the 1
st
 TM 
domain of GPR35 and BO in the prokaryotic ribosome, the next step was to assay if 
secondary structure was capable of forming within the eukaryotic ribosome exit tunnel. 
The ribosome tunnel environment has been shown to play a vital role in the compaction of 
nascent peptides whilst being co-translationally expressed (Woolhead et al. 2006; 
Kosolapov et al. 2004; Robinson et al. 2012). With this mind, the pegylation assay 
previously carried out in the S-30 coupled transcription/translation system will be 
attempted in the eukaryotic wheat germ (WG) extract translation system. A eukaryotic 
system will enable us to assess how critical the change in ribosome tunnel environment is 
in the formation of secondary structure within TM1 of GPR35 and BO.  
Again the pegylation assay assessed RNC lengths ranging from 25-50aa from the PTC to 
the marker cysteine at residue 15, in both model proteins. Levels of pegylation of the 
RNCs in the eukaryotic system follow closely the results previously seen the prokaryotic 
system. In GPR35, we again witness no pegylation at the 25aa intermediate as expected 
with the marker cysteine buried deep within the ribosome exit tunnel and inaccessible to 
PEG-MAL. As the cysteine is moved 5aa further from the PTC we begin to see pegylation 
occur, highlighted by the ~30% gel shift of the translation product. Following the trend of 
the prokaryotic system, we once again see pegylation rates steadily increase to ~80% of the 
translation product in the intermediate which places C15 40aa from the PTC (Figure 3.5). 
The results using the same assay with BO show an almost identical outcome. In the 
eukaryotic system however, both the 25 and 30aa intermediates were expressed, something 
that was not possible in the prokaryotic system. The results show, a pegylation shift in 
every intermediate length except for the 25aa construct, which is expected. Unlike the 
prokaryotic S-30 system, the 30aa intermediate is expressed and becomes pegylated with 
~30% efficiency. The quantified rate of pegylation follows closely the trends set in the 
prokaryotic assay with the subsequent intermediates. The 35aa length of BO becomes 
pegylated with ~50% efficiency, before the later lengths between 40-50aa from the PTC 
reach maximal rates of ~75% (Figure 3.6). The results shown above, coupled with those 
seen in section 3.2.1 suggest that the first TM domain of both GPR35 and BO exist in an 
extended conformation and hence show no sign of the formation of secondary structure, 
whilst traversing the ribosome tunnel. The results obtained agree with previous studies 
102 
 
suggesting an extended peptide (3.4Å per aa) would require ~30aa to traverse the ribosome 
tunnel, whereas a fully compacted peptide would require ~65aa (1.5Å/aa) to travel the 
same distance (Lu & Deutsch 2005b). As we know from both the sequence and the 
structure of the mature GPR35 and BO proteins, this region of the nascent will contain a 
combination of TM domains and loops. Therefore, we would expect that if secondary 
structure was to form whilst in the ribosome exit tunnel, pegylation would occur with the 
marker cysteine ~45aa from the PTC. As PEG-MAL binding is seen at C15 when it is ~30-
35aa from the PTC, the existence of significant secondary structure within the exit tunnel 
can be ruled out. 
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Figure 3.5 Analysis of the pegylaltion assay of GPR35 in the eukaryotic translation system.  (A) Intermediate lengths of GPR35 were expressed in the 
in vitro eukaryotic WG translation reaction. The reaction was split into two, with one half being incubated with 1mM PEG-MAL and the other half 
incubated in buffer as a control. Representative gel displays how the pegylated (1) and non-pegylated (0) samples were resolved by SDS-PAGE, measuring 
if pegylation had taken place by a gel-shift of the translation product by ~ 5kDa. (B) The average % pegylation of individual intermediates shows 
pegylation of cysteine 15 occurs as early as 30 amino acids from the PTC. The % pegylation of intermediates shows an increase between 30 and 40 amino 
acids before it plateaus. All % pegylation values were calculated using [pegylated/(unpegylated + pegylated)] adjusted for background. Average percentage 
pegylation is calculated from an n of 3. Error bars indicate standard deviation.  
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Figure 3.6. Analysis of the pegylaltion assay of Bacterioopsin in the eukaryotic translation system. (A) Intermediate lengths of BO were expressed in 
the in vitro eukaryotic WG translation reaction. The reaction was split into two, with one half being incubated with 1mM PEG-MAL and the other half 
incubated in buffer as a control. Representative gel displays how the pegylated (1) and non-pegylated (0) samples were resolved by SDS-PAGE, measuring 
if pegylation had taken place by a gel-shift of the translation product by ~ 5kDa. (B) The average % pegylation of individual intermediates shows 
pegylation of cysteine 15 occurs as early as 30 amino acids from the PTC. The % pegylation of intermediates shows an increase between 30 and 40 amino 
acids before it plateaus. All % pegylation values were calculated using [pegylated/(unpegylated + pegylated)] adjusted for background. Average percentage 
pegylation is calculated from an n of 3. Error bars indicate standard deviation  
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3.2.3. F0c- pegylation of a bacterial membrane protein known to 
fold in the ribosome exit tunnel. 
The investigation of secondary structure using the pegylation assay has so far shown the 
lack of significant -helical structure within the first TM domain of two large integral 
membrane proteins; a GPCR, GPR35 and a prokaryotic opsin, BO. As both had previously 
unknown co-translational folding profiles, it was decided to use a membrane protein shown 
previously to fold whilst traversing the ribosome exit tunnel to ensure the assay was valid. 
This protein, F0c, is a bacterial membrane protein, specifically subunit c of the Fo 
component of the ATP synthase. F0c is a 79 amino acid protein and contains two TM 
domains both known to be inserted into the bacterial periplasm (Van Der Laan et al. 2004). 
FRET and cross-linking studies carried out by Robinson et al (2012) show the first TM 
domain of F0c undergoes compaction in the distal regions of the ribosome tunnel. Cross-
linking to the ribosomal protein uL23 determined that F0c required ~48aa to traverse the 
length of the ribosome tunnel. 
The F0c pegylation assay also required a specifically placed single cysteine residue 
downstream of the first TM domain. A construct was designed previously with a cysteine 
substituted at position 5 by SDM. Therefore, intermediates of F0c will be named by size 
from cysteine 5 (the marker cysteine) to the PTC. As F0c has previously been shown to 
fold in the tunnel (Robinson et al. 2012), intermediate lengths between 35-70aa were 
generated with the 35aa intermediate expected to act as a negative control for pegylation 
and the 70aa acting as a positive control. As predicted, there was no sign of a shift in the 
translation product at 35aa, a length at which both GPR35 and BO were shown to interact 
strongly with PEG-MAL (Figure 3.7). Using Robinson et al (2012) as a guide, the first 
length at which we expected the marker cysteine to emerge from the ribosome tunnel was 
~45aa from the PTC. Upon pegylation of this length we saw a translation shift correlating 
with GPR35 and BO intermediates of 35aa, with ~50% pegylation showing the marker 
cysteine was outwith the tunnel and capable of interacting with PEG-MAL (Figure 3.7). 
Further intermediate lengths of 50, 55 and 70aa were expressed and showed higher 
pegylation levels of ~75%, similar to the latter intermediates of 40, 45 and 50aa in GPR35 
and BO (Figure 3.3 and 3.4). This indicates that the marker cysteine outside the ribosome 
exit tunnel and was capable of interacting with PEG-MAL efficiently.  
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Figure 3.7.  Pegylaltion assay control using F0c in the prokaryotic S-30 transcription/translation system. (A) Schematic diagram of the F0c gene 
highlighting the substitution mutations made by SDM to place a single cysteine (marker cysteine) at position 5 for pegylation. From the marker cysteine, 
the position of the reverse primers generating various lengths of intermediates can be seen. TM domains are indicated (yellow), with emphasis on the 1
st
 
TM of which compaction will be measured by pegylation.(B) Intermediate lengths of F0c were expressed in the in vitro S-30 couple transcription/translation 
reaction. The reaction was split into two, with one half being incubated with 1mM PEG-MAL and the other half incubated in buffer as a control. 
Representative gel displays how the pegylated (1) and non-pegylated (0) samples were resolved by SDS-PAGE, measuring if pegylation had taken place by 
a gel-shift of the translation product by ~ 5kDa. (C) The average % pegylation of individual intermediates shows pegylation of cysteine 5 occurs at 45 
amino acids from the PTC. The % pegylation of intermediates shows an increase between 35 and 50 amino acids before it plateaus. All % pegylation values 
were calculated using [pegylated/(unpegylated + pegylated)] adjusted for background. Average percentage pegylation is calculated from an n of 3. Error 
bars indicate standard deviation.  
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The results of the pegylation assay of the F0c membrane protein indicates that PEG-MAL 
is a tool capable of detecting compaction within the TM domains of integral membrane 
proteins. Not only does it confirm that F0c, as described in Robinson et al. (2012), exists in 
a compacted conformation within the ribosome ET, but it also confirms that pegylation is 
an adequate tool assessing structure in the TM domains of GPR35 and BO were there 
appears to be none (see section 3.2.1 and 3.2.2). 
 
3.2.4. Is the lack of isoleucines in the first TM of GPR35 and BO 
linked to the lack of secondary structure formation in the 
ribosome exit tunnel? 
As previously discussed in this chapter, pegylation assays determined that the first TM 
domains of GPR35 and BO are not capable of forming secondary structure within the 
ribosome ET. Pegylation assays in both eukaryotic and prokaryotic ribosomes were carried 
out to determine the importance of the tunnel environment in forming secondary structure. 
Whilst many studies have indeed confirmed the ribosome tunnel environment was essential 
for the formation of structure within the nascent peptide (Woolhead et al. 2006; Lu & 
Deutsch 2005b; Lu & Deutsch 2005a), it does not seem to have an effect on the folding 
profile of the two model proteins. This raises the question as to what can make some 
domains fold early in the ribosome tunnel, while others remain extended until they exit the 
ribosome.  
As the sequences of our model proteins seemed to favour an extended nascent peptide in 
the ribosome tunnel, it was decided to analyse the sequences of nascent peptides deemed to 
be „known folders‟ in the ribosome tunnel and investigate whether any sequence 
similarities or differences could be detected. A search of the literature was carried out to 
obtain the sequences of -helical domains previously shown to fold in the ribosome exit 
tunnel (Table 3.1). The compacted peptides were selected from a wide range of non-
synthetic domains (transmembrane segments, signal peptides and stalling peptides). 
A comparison of the individual sequences highlighted a clear lack of sequence 
complementarity, even within segments of the same protein and varying degrees of 
hydrophobicity and size. A noticeable similarity, however, between all the domains shown 
in Table 3.1, was the high number of amino acids deemed to have a high helical propensity 
(Pace & Scholtz 1998). At this point it, was noticed, that although TM1 of both GPR35  
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Domain Type Name Sequence (Folded domain red)  Reference 
Signal Peptide  EspP(1-25) MNKIYSLKYHITGGLIAVSELSGRVSSR (Peterson et al. 2010) 
    
    
TM Domain    
 F0c AAAVMMGLAAIGAAIGIGILGGKFLEGAAR (Robinson et al. 2012) 
 111p (VSVG) NELDRSSIASFFFIIKLIIGLFLVLREFRLQ (Woolhead et al. 2004) 
 S1 Kv 1.3 GPARGIAIVSVLVILISIVIFCLETLP (Kosolapov et al. 2004) 
 S3 Kv 1.3 SRNIMNLIDIVAIIPYFTFITLGTELAERQGN (Tu & Deutsch 2010) 
 S4 Kv1.3 GQQAMSLAILRVIRLVRVFRIFKLSHRHSKGLQI (Tu & Deutsch 2010) 
 S5 Kv1.3 KASMRELGLLIFFLFIGVILFSSAVYFAEADDP (Tu & Deutsch 2010) 
 S6 KV 1.3 GGKIVGSLCAIAGVLTIALPVPVIVSNFNYF (Lu & Deutsch 2005a) 
 Bovine Opsin 
TM2 
HPLNWILVNLAIADLAETIIASTISVVNQMYGYF (Lin et al. 2011) 
 Bovine Opsin 
TM3 
CVVEGYTVSLCGITGLWSLAIISWERWM (Lin et al. 2011) 
Stalling Peptide SecM PQAKFSTPVWISQAQGIRAGPQRLT (Woolhead et al. 2006) 
 CGS1 SIKARRNCSNIGVAQIVAAKWS (Onoue et al . 2011) 
Model Proteins GPR35 TM1 LGFYAYLGVLLVLGLLLNSLALWVFCCRM This study 
 (Non-folders) BO TM1 GRPEWIWLALGTALMGLGTLYFLVKGMGV This study 
Table 3.1. Transmembrane domains known to fold whilst in the ribosome tunnel.  A literature review highlighted numerous 
domains capable of folding in the ribosome tunnel. The sequence of individual domains are shown, with regions that form secondary 
structure highlighted in red.  
109 
 
and BO are made up primarily of residues with a high helical propensity, unlike the other 
domains in Table 3.1, they lack central isoleucine residues. Although isoleucine residues 
do not have the greatest helical propensity, it was queried as to whether this residue and 
other important factors in helix formation, such as the hydrophobicity of environment 
(Blaber et al. 1994), steric contacts in the helix (Hermans et al. 1992) and favourable side 
chain-helix VDW interactions (Wang & Purisima 1996; Lu & Deutsch 2005b) could alter 
the formation of a helix.  
To investigate if isoleucine residues generated a nascent peptide more favourable for the 
formation of an -helix within the ribosome tunnel, SDM within the first TM domain was 
carried out to substitute leucine 27,31,36 and 40 to isoleucine residues (GPR35 4I). 
Although leucines have a greater helical propensity than isoleucines (Pace & Scholtz 
1998), the change was made on the basis that they are isomers and only differ in structure 
due to the position of their methyl groups. Upon creation of the new construct, a pegylation 
assay was carried out as before in the WG extract translation system. Intermediates 
increasing in size by 5aa from 25-50aa were generated and the pegylation results were 
analysed by gel-shift on an SDS-PAGE gel.  
As with previous assays, the 25aa intermediate was used as the negative control for 
pegylation as the marker cysteine would be inaccessible to PEG-MAL regardless of 
compaction in the tunnel. From 30aa onwards, the pegylation profile of 4I was shown to 
occur in a similar manner as the WT peptide (Figure 3.8). Pegylation beginning when C15 
was 30aa from the PTC suggests that once again we have a TM domain that lacks 
secondary structure and the substitutions from Leu to Ile had no effect on the ability of 
TM1 to fold whilst traversing the ribosome tunnel. Although many domains of large TM 
proteins have been shown to fold whilst making their way through the ribosome tunnel 
(Table 3.1), the results throughout the chapter consistently suggest this is not the case for 
GPR35. 
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. 
Figure 3.8 Analysis of the pegylation assay of GPR35 4I in the eukaryotic 
translation system.  Intermediate lengths of GPR35 4I were expressed in the in vitro 
eukaryotic WG translation reaction. The reaction was split into two, with one half being 
incubated with 1mM PEG-MAL and the other half incubated in buffer as a control. 
Representative gel displays how the pegylated (1) and non-pegylated (0) samples were resolved 
by SDS-PAGE, measuring if pegylation had taken place by a gel-shift of the translation product 
by ~ 5kDa.  
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3.3. Discussion 
The formation of secondary structure within TM domains of integral membrane proteins 
has been shown to occur in several other studies (Kosolapov & Deutsch 2003; Woolhead et 
al. 2004; Lu & Deutsch 2005b). However, until now, there have been no studies into the 
early folding events, which occur while the nascent chain makes its way through the 
ribosome tunnel, of the largest class of eukaryotic integral membrane proteins; GPCRs. In 
the mature protein of both GPR35 and BO, the first TM domain contains secondary 
structure in the form of an -helix. As this is the case, it is possible that secondary 
structure which makes up the mature protein structure begins to form within the ribosome 
tunnel as witnessed in other peptides (Woolhead et al. 2004; Lu & Deutsch 2005b; 
Robinson et al. 2012). Previous research carried out in proteins with a similar TM domain 
secondary structure suggests that the first TM domain of the chosen model proteins could 
be likely to form secondary structure within the exit tunnel of the ribosome. Previously, Lu 
and Deutsch (2005a) used cysteine modification by PEG-MAL to detect conformational 
changes in the domains of a K+ channel. In this chapter, we used a similar pegylation assay 
investigate the compaction within TM1 of GPR35 and BO as it traversed the ribosome exit 
tunnel.  
The pegylation results in chapter 3.2.1 reveal that the first TM domain in both BO and 
GPR35 show no sign of forming structure in the prokaryotic ribosome tunnel. Two 
intermediate lengths placing the marker cysteine at 25aa and 50aa acids from the PTC 
provided us with a negative and positive control respectively. In a fully extended form of 
both GPR35 and BO, the marker cysteine when 25aa from the PTC would be expected to 
be buried deep within the ribosome tunnel and hence inaccessible to becoming mass-
tagged by the PEG-MAL molecule. If compaction of the TM domains were to occur, the 
intermediate presenting the marker cysteine 50aa from the PTC should provide enough 
length to place C15 out with the ribosome tunnel and fully accessible to PEG-MAL 
(approximately 80% pegylation is has been shown to be maximal (Kosolapov et al. 2004)). 
The 25aa intermediate of both model proteins fails to pegylate in either the eukaryotic or 
prokaryotic expression system, thus proving the cysteine was indeed located within the 
ribosome tunnel and inaccessible to PEG-MAL (Figure 3.3 -3.6) (BO intermediates of 
25aa and 30aa lengths, however, failed to express in the S-30 system, but did express in the 
eukaryotic WG system). As the nascent chain was extended by 5aa, placing C15 30aa from 
the PTC, pegylation of the translated product could first be recognised at relatively low 
levels (~30% in comparison to the 50aa construct which was ~80%) (Figure 3.3 and 3.4). 
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At this point, the first TM of both GPR35 and BO would be passing the constriction point 
or residing in the upper regions of the lower tunnel suggesting compaction of the nascent 
chain in the upper tunnel, as witnessed previously by Woolhead et al (2004), had not 
occurred. The low efficiency of pegylation was believed to be due to the marker cysteine 
residing in the distal regions of the ribosome tunnel, hence making the interaction between 
the SH group of the cysteine and the PEG-MAL molecule difficult. Although a molecule 
of PEG-MAL has a radius of ~15Å and could theoretically protrude into the vestibule of 
the ribosome, the 8Å backbone of the nascent chain makes this increasingly difficult, 
hence the low efficiency of pegylation. An increase in distance of the marker cysteine from 
the PTC by 5aa sees an instant increase in pegylation to ~50%, suggesting steric exclusion 
from the tunnel may reflect the changes in pegylation (Kosolapov & Deutsch 2003). As the 
marker cysteine is moved 5aa further from the PTC, pegylation rates increase to ~75%, 
levels matching the maximal rate of pegylation shown to occur in the 50aa intermediate 
(Kosolapov et al. 2004; Lu & Deutsch 2005a). At intermediate lengths of 35aa and 40aa, 
the TM domain would be residing in the lower and distal regions of the tunnel respectively. 
If compaction of the TM domain had have occurred at this point, as has been discussed in a 
number of studies (Lu and Deutsch 2005a; Bhushan et al 2010), we would have expected 
to see little to no pegylation of the nascent chain. Hence, we suggest that until the point at 
which the N-terminus of GPR35 TM1 reaches the lower tunnel, secondary structure is not 
present.  
With the first TM domains of both GPR35 and BO producing pegylation results indicative 
of an extended peptide, something that is often not seen in large TM proteins (Tu & 
Deutsch 2010), a control membrane protein F0c known to fold in the ribosome tunnel was 
used to ensure pegylation was a valid assay to determine secondary structure within the 
ribosome. The F0c results confirmed previous studies by Robinson et al (2012), with 
comparative pegylation results to other large TM domains shown to compact within the 
ribosome tunnel (Kosolapov et al. 2004; Tu & Deutsch 2010). Unlike GPR35 and BO 
intermediates, at 35aa from the PTC there is no PEG-MAL shift in the translation product 
(Figure 3.7). Not until 45aa from the PTC do we see pegylation of nascent chain at rates 
comparable to the GPR35 and BO 35aa constructs of ~40% and also in agreement with 
previous CL assays carried out by Robinson et al (2012). Maximal pegylation at ~80% of 
the F0c intermediates occurs with the marker cysteine 50aa from the PTC highlighting the 
difference between an extended peptide and a peptide containing a TM domain capable of 
folding in the ribosome tunnel.  
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What is clearly stated in many studies involving co-translationally folded peptides is the 
numerous factors believed to be involved to enable nascent peptides to fold in the ribosome 
exit tunnel; none more important than the roles played by the ribosome tunnel and nascent 
chain itself. The molecular environment that makes up the ribosome exit tunnel (rRNA, 
ribosomal proteins, water and ions) is specialised for housing the nascent chain and in 
doing so executing functions (such as peptide elongation, folding, nascent chain 
recognition and targeting) essential in the biogenesis of proteins. The nascent chain is also 
specialised, containing specific sequences whose precise order acts like a barcode, 
transmitting important information that enables the correct biogenesis of the mature protein 
(Gong & Yanofsky 2002; Cruz-Vera et al. 2011; Lin et al. 2011). With these two important 
factors in mind we explored the critical role two different populations of ribosome have on 
the folding profile of GPR35 and BO, analysing whether ribosome environment or nascent 
chain sequence plays a more significant role in the formation of secondary structure.   
Comparisons between the prokaryotic and eukaryotic ribosome shows much evolutionary 
conservation, as well as numerous areas with not such a high degree of conservation (Ban 
et al 2000, Yuspov et al). The eukaryotic ribosome is believed to be approximately 40% 
bigger than that of the prokaryotic ribosome, with its core structure made up of eukaryotic 
specific proteins (Ben-Shem et al 2011). Although this is the case, the ribosome tunnel, a 
region essential for the formation of secondary structure is believed to be highly conserved 
in terms of size and make-up (Ban et al 2000, Nissan et al 2000, Ben-Shem et al 2011). 
Indeed, multiple studies have shown that folding within the nascent chain can occur in both 
subsets of ribosome (Woolhead et al 2004, Robinson et al 2010). This conservation 
between the two tunnel environments may go some way to explaining the results seen in 
section 3.2.2. determining that both GPR35 and BO intermediates exist as extended 
nascent chains, whilst ribosome bound in the prokaryotic translation system and show an 
identical folding profile in the eukaryotic WG system (Figure 3.5 and 3.6). Therefore, even 
though the prokaryotic ribosome tunnel was not viewed as a native environment for the 
expression of a eukaryotic GPCR and hence postulated to be less favourable for the 
formation of structure within the nascent peptide, this seems not to be the case. With this in 
mind, it could be suggested that a nascent chain seen to fold in the prokaryotic ribosome 
should be fully capable of interacting in the same way within the eukaryotic ribosome, and 
vice-versa. 
As we have seen from the results in section 3.2.2. the differences between prokaryotic and 
eukaryotic ribosomes have little impact on the formation of secondary structure within 
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TM1 of GPR35 and BO. With this being the case, it would seem only natural to suggest 
that the sequence within the nascent chain of the two model proteins plays a substantial 
role in how they are structured within the ribosome. Reviewing numerous domains capable 
of folding in the ribosome tunnel led us to a wide variety proteins; signal sequences 
(Peterson et al 2010), TM domains (signal anchors) (Kosolapov et al 2004, Woolhead et al 
2004, Lu and Deutsch 2005, Robinson et al 2010, Lin et al 2011) and stalling peptides 
(Woolhead et al 2006, Onoue 2011). Analysis of these sequences showed neither sequence 
complementarity, nor consistency in size, but did show consistency with high levels of 
hydrophobicity and residues of a high -helical propensity, two important factors (Pace 
and Sholtz 1998). The ability of signal sequences and TM signal anchors to form α-helical 
structures has also been suggested as a possible factor when targeting proteins to their 
desired organelle. Specifically, SRP-dependant targeting is believed to require a short 
region of α-helical peptide (~10aa in length) to bind and target nascent peptides to the ER 
membrane. This suggests forming secondary structure within the ribosome tunnel may be a 
necessity in the case of some proteins.  
When comparing peptides that were „known folders‟ in the ribosome tunnel, an 
observation was made concerning the lack of isoleucines in the two model proteins; 
GPR35 and BO (Table 3.1). Isoleucine has a helical propensity of 0.41 kcal/mol (Pace and 
Scholtz 1998) and although it does not have greatest propensity to form a helix (eg. Ala 0, 
Leu 0.21 kcal/mol), it is possible that interactions between the aliphatic side chains of the 
residue and the ribosome tunnel may be favourable in the formation of structure within a 
nascent chain. With little else to go on, it was decided to introduce 4 isoleucine residues in 
place of leucines, generating the GPR35 4ΔI construct. As before, a pegylation assay was 
carried out on 25-50aa intermediates of 4ΔI, assessing if the change the substitutions of 
isoleucine residues had any effect of the folding of TM1. Results suggested that it did not, 
with a folding profile very similar to GPR35 WT seen once again (Figure 3.5). This 
highlights the complexity within the sequence of the nascent chain and suggests it is very 
unlikely that single amino acids are essential for the formation of secondary structure 
within the ribosome. In fact Pace and Scholtz (1998) suggest that conformational entropy 
of residues within a peptide is key for formation of helical structures, alluding to the fact 
that a stretch of amino acids favouring a helical formation may be more essential than just 
one. Alongside this, other factors such as hydrophobicity, environment and side-chain 
interactions all may impact on how structure forms within the nascent chain (Hermans et al 
1992, Blaber et al 1994, Wang and Purisma 1996). Together, the studies in section 3.2.2 
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and 3.2.4 reinforce the idea that if the sequence within the nascent chain does not code for 
the formation secondary structure within the ribosome tunnel, then it will not be present. 
In summary, the work carried out in this section has showed that the first TM domain of 
two large TM proteins, GPR35 and BO, exists in an extended conformation as they make 
their way through the ribosome tunnel. Using the biochemical method of pegylation, both 
model proteins were shown to take up an extended conformation in the prokaryotic and 
eukaryotic ribosome tunnel, until the point at which the N-terminus of TM1 is in the lower 
tunnel. Using two different species of ribosome enabled us to determine that both ribosome 
environment and nascent chain sequence are essential for generating secondary structure 
within the TM domains of an IMP.
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4. The importance of secondary structure for SRP-
mediated targeting? 
4.1. Introduction 
Approximately 30 % of all proteins synthesised are IMPs, which are destined to be 
transported to either the eukaryotic ER or bacterial plasma membrane (PM). Although 
these IMPs may be structurally diverse, they share a common feature; their hydrophobic 
TM domains, structures that need to reside within the lipid bilayer (White and von Heijne 
2005). This poses a problem for IMPs as insertion into biological membranes requires 
transport from the aqueous cytosol where they are synthesized, to an environment where 
they are energetically stable. One major route of IMP targeting is carried out by a 
specialized system known as the signal recognition particle (SRP) pathway that has been 
shown to play a vital role in the protection, targeting and integration of TM domains into 
the lipid bilayer (Bibi 2011). 
The SRP pathway is made up from a number of distinct steps (as previously described in 
section 1.2 in more detail) (Wild et al. 2004; Egea et al. 2005) (Figure 4.1). In the 
eukaryotic pathway, the first step begins as the SRP docks to the ribosome and binds the 
nascent chain, creating a SRP-Ribosome nascent chain complex (RNC), in turn inducing a 
translation arrest. Following this, the complex is targeted to the ER membrane, where GTP 
binding to SRP triggers an interaction between itself and the SRP receptor (SR), creating 
the SRP-SR complex. At this point, the RNC can then be transferred to the Sec61 
translocon, where translation process is re-engaged and translocation can begin. The final 
step in the SRP pathway sees dissociation of SRP from the SR via GTP hydrolysis, 
recycling SRP back into the cytosol (Figure 4.1) 
The initial stages of SRP-mediated targeting are believed to begin in a co-translational 
manner whilst the nascent chain makes its way through the ribosome exit tunnel. The exit 
tunnel, once believed to be simply a passive water-filled channel, is now known to be key 
in many co-translational interactions involving the translating peptide (Woolhead et al. 
2004; Lu et al. 2007). In the initial stages of SRP mediated targeting, the tunnel is believed 
to have a sensory role. Studies have shown as the nascent chain nears the exit of the 
ribosome, the ribosomal protein L39e in eukaryotes and the tunnel loop domain of uL23 in 
the prokaryotic ribosome interact specifically with hydrophobic membrane segments  
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Figure 4.1 Schematic diagram describing how integral membrane proteins are co-translationally targeted to the membrane. 
(1) Protein transport begins as nascent chain containing a signal peptide emerges from the ribosome. (2) The signal peptide is 
recognised by SRP and the SRP/ribosome-nascent-chain complex is formed. (3) The SRP/ribosome nascent chain complex then 
binds to the SRP receptor (SR). For the formation of a stable SRP/SR complex, GTP has to be present. (4) The SRP/RNC complex 
docks to the translocon, where the signal peptide is transferred from SRP to the translocation channel. (5) GTP hydrolysis in both, 
SRP and SR, leads to the dissociation of the SRP/SR complex.  
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(Woolhead et al. 2004; Robinson et al. 2012). These interactions within the tunnel of the 
ribosome are believed to begin SRP recruitment to the exit site, positioning it for the 
capture and protection of the emerging TM domain. Experiments have shown that 
translation of a nascent chain drives conformational changes within the large subunit of the 
ribosome and increases the affinity for an interaction with SRP (Flanagan et al. 2003; 
Bornemann et al. 2008). Specifically, a hydrophobic segment within a nascent peptide, 
known as the signal sequence enables the translating ribosome to enter the SRP pathway. 
These hydrophobic stretches of amino acids usually span between 10-20 residues and often 
make up cleavable signal sequences or signal anchor domains. 
SRP interaction with the ribosome begins as the nascent chain makes its way through the 
tunnel and nears the exit point. SRP, a large ribonucleoprotein, composed of RNA and 
protein (6 protein subunits in eukaryotic SRP and one in bacteria) has a high affinity for 
the translating ribosome. It binds uL23 and uL29 through its 54 kD subunit(SRP54 in 
eukaryotes and Ffh in bacteria) near the exit of the tunnel, in doing so placing the M 
domain in a position to capture the exiting nascent chain. The M domain is made up of four 
central helices, ordered around a central hydrophobic core which houses the hydrophobic 
stretch of the emerging nascent chain (Keenan et al. 1998; Janda et al. 2010; Hainzl et al. 
2011) 
With a high level of diversity in length, shape and sequence within signal sequences 
(Zheng & Gierasch 1996), early studies showed that peptides containing a hydrophobic 
domain with a high helical propensity were the most likely candidates for SRP recognition 
(von Heijne 1985; Hatsuzawa et al. 1997). Recent work, however, suggests that although 
important, hydrophobicity alone may not be enough to determine an SRP interaction or 
indicate if a peptide is targeted by the SRP pathway. In fact, work carried out by Huber et 
al (2005) calculated the hydrophobicity of signal sequences required for SRP-dependant 
and SRP-independent targeting pathways were similar and found no way of determining 
through hydrophobicity alone whether an SRP interaction was capable. Evidence also 
suggested that sequences containing hydrophobicity above a certain threshold had an 
adverse effect on SRP binding, suggesting the possibility of additional factors involved in 
SRP targeting (Huber et al. 2005). Indeed, other features have been postulated to be 
required to enhance SRP-nascent chain interaction such as helical propensity, the presence 
of secondary structure (Tu et al. 2000), the presence of basic residues at the N-terminus of 
a signal sequence (Peterson et al. 2010), as well as additional factors that have not yet been 
determined. 
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Figure 4.2 Cross-linking assay to measure the level of interaction with components of the SRP targeting pathway. (A) 
Chemical cross-linking BS
3
 molecule reacts with the amino group of the single lysine residue in the nascent chain and the free 
amino groups in SRP targeting components. The succinimidyl groups at either end of the BS
3
 molecule are cleaved and two 
proteins are crosslinked by the 6 carbon fatty acid chain (Adapted from Sarngardharan et al 2003). (B1) Schematic diagram 
representing the protection offered to the single lysine (red circle) in the nascent chain from a molecule of BS3 by the 
ribosome tunnel and (B2) the cross-linking interaction between BS3, SRP and the lysine when exposed from the ribosome exit 
tunnel. 
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Alongside hydrophobicity, a feature that has often been remarked upon as enhancing the 
affinity for a SRP-nascent chain interaction is the presence of an α-helix within the signal 
sequence. Crystal structures of the M domain within SRP54 show the presence of a 
hydrophobic groove thought to accommodate mainly α-helical signal sequences (Keenan et 
al. 1998). With a number of studies now showing the formation of α-helicies occurring 
within hydrophobic stretches that make up TM domains of IMPs, whilst in the ribosome 
tunnel (Kosolapov et al. 2004; Lu & Deutsch 2005; Robinson et al. 2012), it is surely a 
possibility that this feature could increase the selectivity for the SRP-dependant pathway 
(Tu et al. 2000; Berndt et al. 2009). 
Although the final destination for GPR35 is the PM, not much work has been carried out to 
understand its targeting to the ER membrane. To assess if the GPR35 nascent chain is 
capable of using the SRP-dependant pathway and if so what features within the nascent 
chain are required, the method of chemical cross-linking will be utilized. Chemical cross-
linking, as well as photo cross-linking have been used by a number of groups to show 
interactions between the nascent chain and components required to initiate or carry out 
SRP mediated targeting (Houben et al. 2005; Robinson et al. 2012; Nilsson et al. 2014). In 
particular, I will be following a similar chemical cross-linking method to that carried out 
by Robinson et al (2012), attempting to determine if an interaction can take place between 
Ffh/SRP54 protein (prokaryotic/eukaryotic SRP) and the ribosomal protein uL23. The 
chemical bis(sulfosuccinimidyl)suberate (BS
3
) will be used to investigate the proximity 
between the nascent chain and selected proteins. The assay itself relies on two ester-
reactive sulfo-NHS groups at either end of the BS
3
 molecule reacting with proteins 
containing primary amines. When proteins are in close enough proximity, a bond is formed 
between the succinimdyl groups of BS
3
 and free amines of lysine residues within the 
nascent chain (Figure 4.2A). BS
3
 has a diameter of ~20Å, making it incapable of entering 
far into the ribosome tunnel. Therefore, as explained for the pegylation assay, the tunnel 
offers protection to the nascent chain form BS
3
 (Figure 4.1 B1). Only once the lysine 
residues within the nascent chain reach the distal regions of the tunnel can BS
3
 generate 
cross-links with proteins in close enough proximity (Figure 4.1 B2) (Robinson et al. 2012). 
Therefore, the overall aim of this chapter will be to identify, via cross-linking assays, if 
interactions occur between components of the SRP mediated pathway and the translating 
GPR35 nascent chain. Specifically, we aim to investigate the importance of features such 
as secondary structure and hydrophobicity within the 1st TM domain and how they impact 
of SRP binding.  
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4.2.1 Is the GPR35 nascent chain capable of interacting with 
SRP? 
The folding profile of GPR35 was assessed by pegylation assays in chapter 3 and showed 
the nascent chain to exist in a linear conformation as it made its way through the ribosome 
tunnel. As this is the case, experiments were carried out to investigate how the lack of 
secondary structure within the first TM domain of GPR35 impacted on targeting the ER 
membrane. As seen with many membrane proteins, the SRP pathway is the major route of 
targeting to the membrane and we would hypothesize that it would be the most likely 
method of targeting GPR35. To investigate if this is the case and whether the lack of 
secondary structure within the first TM domain has an effect, cross-linking assays were set 
up to analyse the interactions between the nascent chain and components of the SRP 
pathway.  
A construct capable of generating cross-links with BS
3
 was required to carry out this cross-
linking assay. GPR35 contains a single lysine residue 5aa upstream of the 1
st
 TM domain 
in GPR35 (K20- marker lysine) (Figure 4.3A). This lysine provided a free amino group 
within the nascent chain for the formation of cross-links between itself, BS
3
, and other 
proteins. K20 is the only lysine present in the N-terminal sequence of GPR35, therefore it 
will also be capable of indicating the length of the nascent chain required to span the 
ribosome tunnel before cross-linking takes place. Therefore, as in chapter 3, intermediate 
lengths of the nascent chain used in the cross-linking assay will be named from the 
peptidyl-transferase centre (PTC) to the marker lysine (K20).  
Initially, cross-linking experiments were set up in the prokaryotic S-30 in vitro 
transcription/translation expression system, as antibodies for the detection of SRP targeting 
components uL23 and Ffh (bacterial SRP54) were available (western blots displaying the 
specificity of respective antibodies are displayed in Appendix 4: Figure 1A and B). As the 
bacterial and eukaryotic SRP pathways share common ancestry we were confident that we 
could reliably show an interaction between GPR35 and the components of a prokaryotic 
system. Radiolabelled RNCs were once again synthesized from linear DNA lacking a 
termination codon and producing stable nascent chains of predetermined length. The RNC 
intermediates ranged from 25-65aa (from the PTC to K20), increasing at intervals of 10aa.. 
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Figure 4.3 Cross-linking assay of GPR35 to uL23 and Ffh in the prokaryotic S-30 transcription/translation system. (A) Schematic diagram of 
the GPR35 gene highlighting the substitution mutation made by SDM to place a single lysine (marker cysteine) at position 20 for cross-linking to 
BS3. (B) Ribosomes displaying radiolabelled N-terminal intermediates between 25-65aa of GPR35 at intervals of 10 amino acids can been seen 
before (B1) and after (B2) treatment with BS3 when resolved on a 10% tricine gel. Crosslinks displaying the correct molecular weight for GPR35 
translation products, GPR35-uL23 and GPR35-Ffh complexes have been marked N/C, * and + respectively. (C) Immunoprecipitation of cross-linking 
assay of GPR35 to components of the SRP pathway (C1) Products shown in the cross-linking assay of GPR35 were subjected to immunoprecipitation 
with anti-uL23 serum. (C2) Products shown in the cross-linking assay of GPR35 were subjected to immunoprecipitation with anti-Ffh serum.  
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This range allowed us to explore the interactions taking place both during and after TM1 
has made its way through the ribosome tunnel. The results of the GPR35 cross-linking 
assay can be seen in Figure 4.3B1 and 4.3B2. In the absence of the cross-linker molecule 
BS
3
, the translated nascent peptides can be seen to steadily increase as they range from 25-
65aa (Figure 4.3 B1). Also present are weak background bands believed to result from 
endogenous DNA/RNA in S-30 extract, which can be detected in the absence of input 
DNA. In the presence of BS
3
 the translated nascent peptides can once again be detected, 
with the first evidence of cross-linking apparent when the marker lysine is 35aa from the 
PTC, suggesting the K20 is extremely close to the exit of the ribosome at this point (Figure 
4.3B2). This band can be immunoprecipitated with an antibody raised to the uL23 protein 
and is the first sign of cross-linking to a protein involved in the targeting of GPR35 (Figure 
4.3C1). The same band representing cross-links between the nascent chain and uL23, also 
exists at intermediates of length of 45aa and 55aa, suggesting the nascent chain may reside 
in the distal regions of the tunnel for an extended period of time. Also between the lengths 
of 45-55aa, higher cross-link appears at ~55 kDa and can again be detected in the 65aa 
sample (Figure 4.3 B). These larger cross-links can be immunoprecipitated by the 
antibodies raised to the Ffh protein (Figure 4.3C2). The results seem to show a sequential 
interaction for the nascent chain passing from the uL23 to Ffh protein, with cross-links 
weakening in uL23 and strengthening in Ffh after ~55aa in a „handover‟-like manner of the 
nascent chain. 
To confirm the results of the GPR35 cross-linking assay in the S-30 expression system, the 
same assay was carried out with Bacterioopsin (BO) as a prokaryotic control protein. The 
first TM domain of BO was seen to have a similar folding profile to that of GRP35 and 
therefore we would hypothesize that the cross-linking between the nascent chain, uL23 and 
Ffh proteins would follow a similar pattern. Unlike GPR35, BO has a signal peptide which 
we would expect to be the targeting signal to SRP (Figure 4.4A). As this was the case, the 
single lysine required at the N-terminus for cross-linking with BS
3
 was placed C-terminally 
to the signal peptide at residue 20 (K20-marker lysine). As well as this, two lysine residues 
(K43 and 59) found at the C-terminus of TM1 were mutated to arginines to ensure that no 
further cross-links could form during the synthesis of later intermediates. As hypothesized, 
in the presence of BS
3
, bands representing the nascent chain cross-linked to components of 
the SRP pathway appeared in an identical pattern to those in GPR35 (Figure 4.4 B1 and 
B2). Confirmed once again by immunoprecipitation, cross-links between the nascent chain 
and uL23 could be detected when the marker lysine was between 35 and 55aa from the 
PTC (Figure 4.4 C1). As with GPR35, immunoprecipitations showed cross-links after 55aa  
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Figure 4.4 Cross-linking assay of BO to uL23 and Ffh in the prokaryotic S-30 transcription/translation system. (A) Schematic diagram of 
the BO gene highlighting the substitution mutations made by SDM to place a single lysine (marker cysteine) at position 20 for cross-linking to 
BS3 and removal of two native lysines downstream of the 1st TM domain. The TM domain and signal-peptide of BO are highlighted (yellow 
and red respectively).  (B) Ribosomes displaying radiolabelled N-terminal intermediates between 25-65 amino acids of BO at intervals of 10 
amino acids can been seen before (B1) and after (B2) treatment with BS3 when resolved on a 10% tricine gel. Crosslinks displaying the correct 
molecular weight for GPR35-uL23 and GPR35-Ffh complexes have been marked * and + respectively. (C) Immunoprecipitation of cross-linking 
assay of BO to components of the SRP pathway (C1) Products shown in the cross-linking assay of BO were subjected to immunoprecipitation 
with anti-uL23 serum. (C2) Products shown in the cross-linking assay of BO were subjected to immunoprecipitation with anti-Ffh serum.  
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began to weaken between the nascent chain and uL23, at the same time as an interaction 
with Ffh was seen to strengthen (Figure 4.4 C2). This again suggests a sequential 
interaction between the nascent chain of BO and uL23 as it nears the distal regions of the 
tunnel, followed by an interaction with Ffh as the nascent chain begins to exit the 
ribosome. The similarity between the results in GPR35 and BO suggest that the GPCR is 
fully capable of interacting with components of the prokaryotic SRP pathway, indicating 
that the first TM domain of GPR35 acts as a signal anchor for membrane targeting. 
The similarity in the cross-linking patterns shown by GPR35 and BO suggests a high level 
of homology may exist between the key mechanisms that enable prokaryotic and 
eukaryotic SRP targeting. In particular, the M domain of Ffh and SRP54, the region 
essential for signal sequence binding, has been shown through crystallographic studies to 
be exceptionally well conserved (Keenan et al 1998, Janda et al 2010, Hainzl et al 2011). 
With this being the case, we hypothesized that similar results would be obtained when the 
same cross-linking assay is carried out in the eukaryotic Rabbit Reticulocyte Lysate (RRL) 
expression system (see section 2.5.4). The assay once again relied on intermediates 
containing a lysine at residue 20 and ranged in length from 25-65aa from the PTC. In the 
absence of BS
3
, translation product representative of each intermediate could be detected. 
Also present in each sample at ~16 kDa was a double band representative of the protein 
heam (found in all RRL samples isolated by centrifugation through a sucrose cushion) and 
an unknown band at ~28 kDa (Figure 4.5A1). In the presence of BS
3
, cross-links between 
the nascent chain at lengths 55 and 65aa could be detected with a protein of ~50 kDa 
(Figure 4.5A2). These bands that could be seen in the cross-linked samples and were 
immunoprecipitated with an antibody raised to SRP54 (Appendix: Figure 1C), indicating 
an interaction is taking place between the nascent chain and eukaryotic SRP (Figure 4.5 B). 
The results from cross-linking assays in both prokaryotic and eukaryotic expression 
systems show that the nascent chain interacts with the SRP pathway. Results from the 
assay in the prokaryotic system show the nascent chain cross-linking with uL23, a protein 
found in the most distal regions of the ribosome tunnel, whilst the marker lysine is 35aa 
from the PTC. This would suggest the nascent chain is in a linear conformation when the 
first cross-links were observed and is in agreement with previous results seen in chapter 3. 
Interactions between the nascent chain and SRP proteins (Ffh and SRP54) occurred later, 
beginning when the K20 was 45aa from the PTC. A previous study, carried out by 
Robinson et al (2012), used a similar cross-linking assay with a membrane protein capable 
of forming secondary structure in the ribosome tunnel. In this study, IPs were also carried 
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out for the proteins uL23 and Ffh, showing interactions between the two proteins and the 
nascent chain to occur when the marker lysine was ~ 48 and 59aa from the PTC 
respectively. This highlights the difference in length required for an extended and 
compacted nascent chain to interact with SRP, but also indicates that GPR35 is able to 
interact with SRP regardless of secondary structure formation within the tunnel. The 
extended times in which the nascent chain interacts with both uL23and SRP may indicate 
the first folding events occurring within the 1
st
 TM domain of GPR35. 
Figure 4.5 Cross-linking assay of GPR35 to SRP54 in rabbit reticulocyte lysate system. 
Ribosomes displaying radiolabelled N-terminal intermediates between 25-65aa of GPR35 at intervals 
of 10 amino acids can been seen before (A1) and after (A2) treatment with BS3 when resolved on a 
10-20% SDS-PAGE gel. Cross-links displaying the correct molecular weight for GPR35-SRP54 
complexes have been marked with a *. (B) Products shown in the cross-linking assay of GPR35 were 
subjected to immunoprecipitation with anti-SRP54 serum.  
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4.2.2. Does hydrophobicity drive the interaction between SRP and 
the first TM of GPR35? 
The cross-linking experiments carried out in section 4.2.1 showed that SRP is able to 
interact with the nascent chain of GPR35, despite the lack of secondary structure within the 
first TM domain (the predicted signal anchor). Therefore, we set out to determine what 
drives the interaction between the nascent peptide and the SRP54 protein. The interaction 
between SRP and its targets is believed to be influenced by a number of factors, one of 
which was believed to the helicity of the nascent chain. As we have shown, the nascent 
chain of GPR35 does not seem to compact whilst inside the ribosome tunnel, yet is still 
capable of interacting with SRP. Therefore, we seek to investigate another factor 
previously presented as being a key feature in signal anchors and signal sequences (Keenan 
et al. 1998), hydrophobicity, and its effect on the interaction between GPR35 and SRP. 
To investigate exactly how critical the need for a hydrophobic first TM domain within 
GPR35 is for targeting via the SRP pathway, we set out to reduce the hydrophobicity of 
TM1 and analyse the effects this had on SRP cross-linking to the nascent chain. Firstly, we 
had to generate a construct which we believed could no longer act as a signal anchor 
domain. As signal anchors are generally found to be integral TM domains of the mature 
protein, the „Dense Alignment Surface‟ (DAS) - TM filter server was used to assess the 
changes required to decrease the hydrophobicity in TM1(Cserzö et al. 1997). The 
algorithm used in the DAS-TM filter is designed to identify TM domains based on their 
hydrophobicity and provides a high precision hydrophobic profile of individual domains. 
Using this tool, the WT GPR35 sequence containing the first 85 residues (first and second 
TM domain included) was entered and a DAS profile score was obtained (Figure 4.5). The 
WT GPR35 protein can be seen to contain an extremely hydrophobic first TM domain that 
well exceeds the 2.2 „strict cut-off‟ DAS profile score recommended for a TM segment. 
Therefore, to lower the hydrophobicity of the TM domain and make it unrecognisable as a 
signal anchor for SRP, we aim to generate a peptide whose hydrophobicity falls below the 
„strict cut-off‟ rate. 
Lowering the hydrophobicity of TM1 sufficiently and generating a domain unrecognisable 
as a TM sequence required changes to several of the most hydrophobic residues. Using the 
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Figure 4.6 Cross-linking assay of GPR35Δ4E mutant to uL23 and 
Ffh in the prokaryotic S-30 transcription/translation system. (A) 
Site-directed mutagenesis of hydrophobic leucine residues at position 
27,31,36 and 40 to glutamic acids with GPR35 reduce the 
hydrophobicity of the 1st TM domain below the strict cut off point set 
out by the Dense Alignment  Surface (DAS) method indicating the 
presence of a TM domain (Cserzö et al. 1997). Ribosomes displaying 
radiolabelled N-terminal intermediates between 25-65aa of TM1 of the 
Δ4E mutant at intervals of 10 amino acids can been seen before (B1) 
and after (B2) treatment with BS3 when resolved on a 10% tricine gel. 
Crosslinks displaying the correct molecular weight for GPR35Δ4E -
uL23 and GPR35Δ4E -Ffh complexes have been marked * and + 
respectively. (C) Immunoprecipitation of cross-linking assay of Δ4E 
to components of the SRP pathway (C1) Products shown in the cross-
linking assay of Δ4E were subjected to immunoprecipitation with anti-
uL23 serum. (C2) Products shown in the cross-linking assay of Δ4E 
were subjected to immunoprecipitation with anti-Ffh serum. (C3) 
Products shown in the cross-linking assay of Δ4E were subjected to 
immunoprecipitation with anti-SRP54 serum.  
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DAS-TM filter, we could postulate the effect substitutions in a number of regions within 
the TM domain would have on its overall hydrophobicity. Several methods of lowering the 
hydrophobicity below the „strict cut-off‟ point were attempted, with the results often 
leading to the substitution of over half the residues within the WT TM segment. These 
consisted of polar residues grouped in threes throughtout TM1 or polar residues 
sporatically placed throughout the entire TM domain, both of which required a high 
number of changes to have an effect. Finally, it was decided that substituting four Leucine 
residues for Glutamic Acids (at positions 27, 31, 36 and 40) to create the construct 
GPR35Δ4E, would minimize the number of mutations required to maximize the effect on 
the overall hydrophobicity, leaving the majority of the TM sequence intact (Figure 4.6A).  
The GRP35 Δ4E construct was used to carry out cross-linking assays to SRP in both 
prokaryotic and eukaryotic in vitro expression systems. The single lysine required for BS
3
 
cross-linking was again located at residue 20 and intermediate lengths ranging from 25-
65aa to the PTC were once again generated. Initial assays were carried out in the S-30 
expression system, enabling us to use the uL23 protein as a cross-linking control. As uL23 
is found in the distal regions of the tunnel, we would expect the nascent peptide to be in 
close enough proximity for cross-linking to occur regardless of an interaction with TM1. 
This was indeed the case, as the reactions containing the 35-55aa Δ4E nascent peptides 
showed a similar pattern of cross-linking to that seen in the WT GPR35 intermediates, 
when immunoprecipitated with an antibody raised to uL23 (Figure 4.6 C1). In cross-linked 
samples containing the 45-65aa Δ4E intermediates, the ~55 kDa band representative of Ffh 
that could be detected in the WT nascent peptides, no-longer existed in the mutated 
constructs suggesting the interaction with SRP was no-longer occurring (Figure 4.6C2). 
The assay was also carried out using the eukaryotic RRL expression system and cross-links 
detected by immunoprecipitation with an antibody raised to SRP54. This assay confirmed 
the effect a loss of hydrophobicity within TM1 had on the cross-linking of GPR35 with 
SRP, as the cross-links were completely abolished in the 45-65aa samples (Figure 4.6).  
The results obtained from the cross-linking assay using the GPR35Δ4E construct have 
clearly indicated the importance of hydrophobicity within the first TM domain of GPR35. 
Substitution of the four hydrophobic leucine residues to hydrophilic glutamic acids, 
lowering the overall hydrophobicity within the segment has abolished the interaction 
between the nascent chain and SRP. The strategically placed mutations, disguising first 
TM domain‟s role as a signal anchor, highlight its importance in the SRP targeting process, 
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as well as providing insights into how the SRP molecule relies on hydrophobicity within a 
nascent chain to target a peptide to the membrane.  
4.2.3 Does SRP bind preferentially to a region of the first TM 
domain in GPR35? 
Cross-linking assays to investigate SRP interaction with the GPR35 first TM domain has 
shown us that hydrophobicity over secondary structure formation is the critical driving 
force for the interaction between the SRP and the nascent chain. Mutagenesis to reduce the 
hydrophobicity in the entire 1
st
 TM domain was enough to abolish the interaction between 
SRP and the signal anchor of GPR35. Indeed, similar studies in signal peptides are in 
agreement with results displayed in section 4.2.2 (Janda et al. 2010; Ataide et al. 2011; 
Nilsson et al. 2015). This being said, the hydrophobic h-domain of a signal peptide spans 
~10aa and is often much smaller than the signal anchor domain of an integral membrane 
protein. Coupling this with studies that predict the hydrophobic groove of the M-domain, 
in both eukaryotic and prokaryotic SRP, is capable of encapsulating a sequence of ~10aa in 
length (Janda et al 2010, Keenan et al 1998), we suggest that it is possible that only a 
portion of the first TM domain may be required for SRP binding and postulate that the N-
terminal region would be likely to be more critical as it will interact first. 
To test if a region within the signal anchor domain of GPR35 did indeed play a more 
essential role in the binding of SRP, two further constructs were generated containing 
leucine to glutamic acid substitutions in either the N- or C-terminus of the 1
st
 TM domain. 
The construct GRP35ΔNT contained two leucine to glutamic acid mutations at residues 27 
and 31 (Figure 4.7B), whilst the GPR35ΔCT construct contained two leucine to glutamic 
acid mutations at residues 36 and 40 (Figure 4.7C). The two constructs once again enabled 
the analysis of the interaction taking place between the nascent chain and SRP by cross-
linking. The 55aa intermediate (K20 is 55aa from the PTC) was selected as the length of 
nascent chain to carry out this cross-linking assay, as it has been shown to interact with 
uL23, Ffh and SRP54. 
Expression of the ΔNT and ΔCT intermediates, along with the WT and Δ4E intermediates, 
and cross-linking with BS
3
 provided the opportunity to compare the different binding 
affinities of each intermediate length to SRP. As before, the uL23 protein was used as a 
cross-linking control in the S-30 expression system and was shown to interact in the same 
manner with all four intermediates following an immunoprecipitation (Figure 4.8B and 
C1). However, differences can be noticed between the four intermediates when cross-
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linked with both eukaryotic (Figure 4.8A and B) and prokaryotic SRP (Figure 4.8B). 
Immunoprecipitations were carried out using antibodies raised to either Ffh or SRP54, and 
were used to detect the efficiency at which each intermediate bound SRP. In the 
prokaryotic S-30 system, both the ΔNT and ΔCT intermediates form a much weaker 
interaction with Ffh (Figure 4.8B) and were quantified to bind with lower than 50% 
affinity than WT GPR35 (Figure 4.8 C2). Although this is the case, both intermediates are 
capable of rescuing the loss of Ffh binding seen with the Δ4E intermediate. When the same 
experiment was carried out in the eukaryotic RRL system, a different effect could be seen 
when comparing the four intermediates. The WT and Δ4E intermediates produced near 
identical results, with the four leucine to glutamic acid mutations generating a complete 
loss in SRP54 cross-linking to GPR35 intermediates. However, a noticeable difference was 
detected between the binding of SRP54 to the ΔNT and ΔCT intermediates. The ΔNT 
intermediate can be seen interact with SRP54 in a manner that is more representative of the 
Δ4E intermediate, barely rescuing the SRP interaction at all (Figure 4.8B). The cross-
linking efficiency between the nascent chain and SRP54 is reduced to approximately 20% 
(Figure 4.8 C3), a much greater effect than the one that occurred between the same 
construct and Ffh. The opposite effect occurs between the ΔCT intermediate and SRP54, 
with SRP binding approximately 75% of that seen with the WT construct (Figure 4.8B and 
C3). The results show a major difference between prokaryotic and eukaryotic SRP cross-
linking, possibly alluding to a different mechanism of recognition or simply a higher level 
of complexity behind SRP binding in eukaryotes.  
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Figure 4.7 Negatively charged amino acids reduce the 
hydrophobicity in TM domain 1. (A) Site-directed 
mutagenesis of hydrophobic leucine residues at position 
27,31,36 and 40 to glutamic acids with GPR35 reduce the 
hydrophobicity of the 1st TM domain below the strict cut 
off point set out by the Dense Alignment  Surface (DAS) 
method indicating the presence of a TM domain (Cerzo et 
al 1994). (B) Two mutations substituting leucine 27 and 
31 to glutamic acid residues provided a construct with a 
reduction in hydrophobicity within the N-terminal region 
of TM1. (C) Two mutations substituting leucine 36 and 40 
to glutamic acid residues provided a construct with a 
reduction in hydrophobicity within the C-terminal region 
of TM1.  
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Figure 4.8 Cross-linking assay of GPR35 hydrophobic mutants to SRP54 in rabbit reticulocyte 
lysate system. Ribosomes displaying radiolabelled N-terminal intermediates of GPR35 hydrophobic 
mutants at (as described in Figure 4.8) at lengths of 55 amino acids can been seen before (A1) and 
after (A2) treatment with BS3 when resolved on a 10-20% SDS-PAGE gel. The uncross-linked 
nascent chain is marked N/C and cross-links displaying the correct molecular weight for GPR35-
SRP54 complexes have been marked with a *. (B) Immunoprecipitation of cross-linking assay to 
components of the SRP pathway (B1) Products shown in the cross-linking assay were subjected to 
immunoprecipitation with anti-L23 serum, anti-Ffh serum or anti-SRP54 serum. A representative 
commassie blot acts as a loading control and indicates how IP gels are normalised for subsequent 
quanifiction (C) Bar graphs show the average % cross-linking to L23 (C1), Ffh (C2) or SRP54 (C3) 
for  individual intermediates IP results were quantified using Image J software. All % cross-linking 
values were calculated using [IP product/commassie loading control] and adjusted for background. 
Average percentage cross-linking is calculated from an n of 3. Error bars indicate standard deviation 
and groups were compared using one-way ANOVA with Tukey‟s post hoc comparisons. *p< 0.05, 
**p<0.005, ***p < 0.001.  
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4.3 Discussion 
The targeting of integral membrane proteins (IMPs) to their destinations within the 
membrane in both eukaryotes and prokaryotes has been extensively studied. The SRP 
pathway is conserved in both and has been shown to be the mode of targeting to ensure the 
majority of membrane proteins find their correct location. The SRP pathway relies on a 
number of key interactions occurring between the nascent chain and the SRP molecule to 
enable the targeting process to proceed efficiently. SRP recognizes a signal sequence 
within the nascent chain‟s N-terminal region to carryout targeting effectively. Signal 
sequences, however, have a wide range of diversity with little conservation in their 
sequence. This being said, they do have various features such as charge, hydrophobicity 
and structure all known to play key roles in targeting of membrane proteins. In this 
chapter, we investigate the properties of a signal anchor sequence within GPR35 and 
highlight the key relationships occurring between the nascent chain and components of the 
SRP pathway. 
In vitro cross-linking data confirmed what had previously been suspected for GPR35; like 
other GPCRs it was capable of interacting with SRP (Friedlander & Blobel 1985; Audigier 
et al. 1987) and therefore likely to be targeted through the SRP pathway. Intermediate 
lengths of GPR35 highlighted the sequential events believed to be taking place to trigger 
the SRP targeting pathway. As described in a number of studies (Ban 2000; Woolhead et 
al. 2004; Robinson et al. 2012), the nascent chain is believed to be exposed to and possibly 
interact with a number of sensory ribosomal proteins, uL23 and uL22, as it makes its way 
through the ribosome tunnel. In prokaryotes, uL23 has been shown to interact with the 
nascent chain to initiate the SRP targeting pathway. Cross-linking assays of GPR35 
intermediates, with the reactive lysine at residue 20, confirm prior structural and 
biochemical data that positions the uL23 protein in the distal regions of the tunnel. The 
25aa intermediate of GPR35, which was previously shown to exist as an extended nascent 
chain, fails to cross-link with uL23. At this point the reactive lysine residue should be 
positioned ~30Å from the exit site and suggests it is still buried too far inside the ribosome 
to contact BS
3
 and uL23 simultaneously. As the length progressed to 35aa, the first cross-
links between uL23 and the nascent chain appeared, placing the signal anchor domain 30aa 
from the PTC and close to the bottom of the ribosome. This would suggest a nascent chain 
length of between 25aa and 30aa from the PTC would be required for the GPR35 signal 
anchor to come into contact with uL23 and potentially trigger the start of the SRP pathway. 
At this point, the nascent chain is still believed to be an extended peptide and indeed 
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similar cross-linking studies can confirm this (Houben et al. 2005; Robinson et al. 2012). 
Previously, experiments using a TM segment proven to compact within the ribosome 
tunnel required 48aa to traverse the distance between the PTC and the uL23 protein 
(Robinson et al. 2012), whilst a non-compacted bacterial membrane protein required ~27aa 
to reach uL23 (Houben et al. 2005). Therefore, it would appear that the first interactions 
between GPR35 and components of the SRP pathway occur with the nascent chain in an 
extended conformation and do not rely on prior structural formation within the ribosome. 
The sensing of a nascent chain making its way through the ribosome is an essential process 
in initiating the binding of SRP to the ribosome. Affinity assays highlight the differences 
between translating and non-translating ribosomes and have confirmed the detection of the 
nascent chain by ribosomal proteins is vital for SRP docking (Flanagan et al. 2003). In 
prokaryotic ribosomes, conformational changes are believed to occur in the globular 
domain of uL23, driven by a finger loop domain that protrudes into the distal regions of the 
exit tunnel, therefore increasing the affinity for SRP binding (Gu 2003; Ullers et al. 2003; 
Bornemann et al. 2008). Bornemann et al. (2008) showed that by mutating the sensory 
finger loop region of uL23 in the prokaryotic ribosome, a subset of ribosomes could be 
generated that could no longer recognize cargo for the SRP pathway and failed to recruit 
SRP to the exit tunnel.  The failure of SRP to bind to the ribosome leaves the first TM 
domain exposed as it exits the tunnel, likely to aggregate as it meets the cytosol. Therefore, 
events taking place as the nascent chain contacts uL23 and moves towards binding SRP 
must be co-ordinated, something that can be observed during the cross-linking assay. As 
the intermediate lengths increase from 55aa, cross-links to uL23 begin to weaken. At the 
same time, both prokaryotic and eukaryotic SRP begin to show the initial signs of cross-
linking to the nascent chain. This seems to represent the nascent chain moving from its 
position of contact with uL23 at the lower regions of the tunnel, to taking up its position 
within the hydrophobic groove of the M-domain where TM1 will be protected from the 
cytosol. Again, when similar studies were carried out using a compacted TM domain in the 
nascent chain, cross-linking to SRP was not witnessed until the marker lysine was ~63aa 
from the PTC (Robinson et al. 2012). Once more, this shows a considerable difference in 
length upon interacting with SRP, suggesting that the GPR35 nascent chain remains 
extended. This data presents another example of how the nascent chain is sensed by uL23, 
which then prepares the ribosome environment for the binding of SRP and the capture of 
the nascent chain.  
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SRP cross-linking to the GPR35 nascent chain begins at 45aa to 65aa from the PTC. This 
is likely to represent the initial interaction with an extended GPR35 nascent chain, leading 
to the capture of the nascent chain by the hydrophobic groove in the M-domain of SRP. 
Crystallographic studies have shown that as the nascent chain emerges from the ribosome, 
the hydrophobic groove of SRP encapsulates the signal sequence, protecting it from the 
cytosolic environment (Keenan et al. 1998). The length of the interaction between the 
nascent chain and SRP may be an indication that the signal anchor of GPR35 begins to 
form secondary structure upon binding SRP. Although we can only speculate, compaction 
on binding of the signal sequence to SRP has been previously documented to occur within 
TM proteins and signal peptides (Houben et al. 2005; Halic et al. 2006a). Structural data 
provide dimensions of the hydrophobic groove supporting the hypothesis that compaction 
may be required to enable SRP to protect the nascent chain from the cytosol (Batey et al. 
2000). Although this may be the case, it seems unlikely from the results seen here that the 
structure of the GPR35 nascent chain drives the SRP interaction. Therefore, further 
experiments were carried out to explore what properties of the nascent chain are critical for 
a SRP interaction. 
Hydrophobicity is a feature that is common within all signal sequences, whether they are 
integral signal anchors or cleavable signal peptides (Keenan & Freymann 2001). All signal 
sequences contain a hydrophobic stretch of residues which many cite as being essential in 
driving the SRP binding. To test if this is also the case for GPR35, the hydrophobic core of 
the 1
st
 TM domain was altered to reduce its levels of hydrophobicity and analyse the effect 
it had on SRP binding. Four leucine residues, made up of hydrophobic hydrocarbon side 
chains, were substituted to glutamic acid residues containing carboxylic acid side groups, 
to produce a construct of reduced hydrophobicity; GPR35 Δ4E (Figure 4.6A). Translation 
intermediates from Δ4E were used to carry out similar cross-linking experiments as 
described previously. Cross-links to uL23 were detected in a similar pattern to those seen 
with the WT intermediates (Figure 4.6B2 and C). The proximity of the nascent chain to 
uL23 as it passes through the ribosome tunnel and the diameter of the BS
3
 cross-linker 
makes it impossible to know if a loss in hydrophobicity with the 1
st
 TM domain would 
have impacted on any possible interaction taking place between the nascent chain and 
uL23.  
The interaction between the nascent chain and SRP was, however, impacted upon by the 
loss of hydrophobicity. No interactions between the nascent chain and SRP could be 
detected at any intermediate length between 25aa and 65aa (Figure 4.6B2 and C). These 
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results were in agreement with previous studies carried out in signal peptides, suggesting 
the hydrophobic core (h-domain) was essential for SRP targeting (Janda et al. 2010; Ataide 
et al. 2011; Nilsson et al. 2015). In a similar experiment, Nilsson et al (2015) showed  by 
deleting 3 or more hydrophobic leucine residues within a signal peptide was enough to 
drive SRP binding efficiencies below 25% of that seen in the WT protein. It was also 
enough to prevent targeting and translocation of the nascent chains into ER membrane 
representative rough microsomes (Nilsson et al. 2015). This suggests that hydrophobicity 
within a signal sequence is critical for the recognition, binding and also the targeting of a 
nascent chain by SRP, as well generating problems with translocation.  
The exact reason as to why the loss in hydrophobicity within the signal anchor of GPR35 
leads to an inefficient SRP binding could have been due to two reasons: the nascent chain 
may not be recognised as a membrane protein 1) by the ribosome or 2) by SRP. Nascent 
chain recognition by proteins of the ribosome exit tunnel has been shown to be an essential 
step in the SRP pathway (Woolhead et al. 2004; Berndt et al. 2009; Robinson et al. 2012). 
Altering the hydrophobicity of a TM domain however, may impact on how it is treated 
within the tunnel. Evidence suggests that detection of hydrophobic TM domain by the 
sensory proteins in the ribosome drives an increased affinity for SRP docking at the exit 
tunnel (Berndt et al. 2009). If this is the case, loss of hydrophobicity within GPR35 TM1 
may result in a loss of recruitment of SRP to the ribosome. Alternatively, cross-linking and 
affinity assays have suggested that all translating ribosomes have a similarly high affinity 
to SRP and the presence of any nascent chain in the tunnel, creates a conformational 
change that enables SRP binding (Flanagan et al. 2003; Bornemann et al. 2008). This data 
would therefore suggest that SRP has a scanning mechanism that detects a hydrophobic 
segment as it exits the ribosome tunnel, rather than initial detection occurring within the 
tunnel itself.  
To provide a greater insight as to whether SRP possesses a scanning mechanism for 
detecting the hydrophobic nascent chain as it exits the ribosome, two further hydrophobic 
mutant constructs were generated (4.7 B and C). Cross-linking assays showed both 
mutants, by restoring hydrophobicity to either half of the first TM domain, were capable of 
rescuing the SRP-NC interaction to some degree (Figure 4.8). However, differences 
between the eukaryotic and prokaryotic SRP binding to the ΔNT and ΔCT intermediates 
may suggest differences in the SRP recognition mechanism. In prokaryotes, both mutants 
showed binding efficiencies below 50% of the WT TM1, although the ΔCT intermediate 
showed a slightly greater cross-linking efficiency to Ffh than that of the ΔNT intermediate. 
138 
 
However, the difference between the SRP cross-linking to the individual intermediates in 
the eukaryotic system indicates a greater complexity in the recognition of a signal 
sequence (Figure 4.8). The ΔCT intermediate on this occasion cross-linked with ~80% 
efficiency to the WT, whereas the ΔNT intermediate represented a nascent chain much 
more like the Δ4E intermediate. This suggests that the SRP molecule may have a more 
localised mode of scanning for stretches of hydrophobicity within the nascent chain, whilst 
it exits the ribosome. Eukaryotic SRP, due to its more complex structure, may not be 
capable of interacting with the hydrophobic region of the ΔNT intermediate in the same 
way as Ffh. Alternatively, it could allude to a different form of interaction between the 
ribosome and the nascent chain, in which it no longer recognises the ΔNT intermediate as 
SRP-dependant peptide. Nonetheless, these results provide increasing evidence that the 
signal anchor of GPR35 relies heavily on hydrophobicity to direct SRP targeting. 
Therefore, by restoring some hydrophobicity within TM1 of GPR35, an interaction 
between the nascent chain and the hydrophobic groove of SRP is rescued. How the 
alterations in hydrophobicity impact on the downstream effects of SRP targeting and 
translocation remain unknown. Nilsson et al (2015) carried out experiments using a 
hydrophobically-altered signal peptide and showed targeting and translocation to be 
significantly inhibited  (Nilsson et al. 2015).  
In summary, the results from this chapter have provided evidence for the targeting of 
GPR35 to occur in a SRP-dependant manner. Like many other membrane proteins, GPR35 
can be shown to interact with SRP and other recognized components of the SRP pathway. 
Cross-linking to uL23 and SRP have indicated that the GRP35 nascent chain is likely to 
encounter the SRP pathway in a linear conformation and may at the point of SRP 
interaction begin to form a compacted helix. As this is the case, we are confident that the 
conformation of the nascent chain does not drive the SRP-NC interaction. Through the 
generation of mutants altering the hydrophobicity of the GPR35 signal anchor, it seems 
that hydrophobicity within TM1 is key for an SRP interaction and targeting to the ER 
membrane. 
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5: Targeting and integration of GPR35 to the 
Endoplasmic Reticulum 
5.1 Introduction 
The final steps in the biogenesis of a membrane protein begin as it becomes co-
translationally inserted and integrated into the lipid bilayer. It is at this point that the 
TM domains of IMPs are moved into the membrane, their topology determined and 
their final structure achieved (Alder & Johnson 2004; Shao & Hegde 2011). In 
eukaryotes, this event occurs most often at the Sec61 translocon and is coupled to the 
co-translational targeting pathway as discussed in Chapter 4. A sequence of co-
ordinated events between proteins synthesis and nascent chain integration allows for 
the safe passage of the hydrophobic TM segments into the lipid bilayer, preventing 
exposure to the hydrophilic cytosol (Halic et al. 2006a). 
Targeting of most eukaryotic proteins (both soluble and membrane proteins) is 
centred on the movement of the peptides through the Sec61 translocon. The 
translocon resides in the ER membrane and is a heterotrimer, made up of α, β and γ-
subunits (Figure 5.1B and C). High resolution structures of the Sec61 translocon have 
enabled us to deduce that the translocation of proteins across the membrane occurs 
through a narrow pore within the complex. This pore is believed to be made entirely 
of Sec61α-subunits and is gated by a subdomain, known as the „plug‟ (Berg et al. 
2004). Interactions between the RNC and the translocon are believed to initiate the 
opening of the channel in preparation for translocation. As the ribosome engages the 
Sec61 translocon, a structural change occurs, switching the channel from a „closed‟ to 
an „open‟ conformation (Berg et al. 2004; Tsukazaki et al. 2008). Photo-crosslinking 
experiments have shown that the movement of TM helices 2b/3 and 7/8, within the α-
subunit pore, open the Sec61 translocon to enable lateral movement of the nascent 
chain into the ER membrane (Plath et al. 1998). Originally, elongation of the nascent 
chain through the Sec61 channel was believed to aid the switch to the „open‟ 
conformation by displacing the α subdomain „plug‟ (Cannon et al. 2005), but recent   
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A. B. 
C. 
Figure 5.1 Sec61 translocon located in the 
mammalian ER membrane. (A) CryoEM 
structure of the translocation complex 
associated with the ER membrane. 40S 
(yellow), 60S (light blue), elongation factors 
(purple) Sec61 translocon (blue) TRAP (green) 
and OST (red). (Adapted from Pfeffer et al 
2014) (B) Cryo-EM structure of mammalian 
Sec61 translocon (lateral view) (C) Cryo-EM 
structure of mammalian Sec61 translocon from 
the cytosol. PDB (4CG7). 
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cryo-EM data has deemed this may not be necessary, as the Sec61 channel has been 
captured in the „open‟ state without the presence of a nascent chain (Pfeffer et al. 
2015). Although a single Sec61 complex has been shown to permit insertion of small 
or single spanning membrane proteins into the ER, many suggest this is not the case 
for more complex membrane proteins. In fact, in prokaryotic systems, both structural 
and biochemical data show that oligomers of the SecY translocon may be necessary 
for the insertion of multi-domain membrane proteins, something that is also believed 
to be likely in eukaryotic systems (Mitra et al. 2005; Ménétret et al. 2005; Osborne & 
Rapoport 2007). Not only is it likely that Sec61 oligomers are involved in 
translocating polytopic membrane proteins, but it has been shown that a broader 
translocon complex exists. This is made up of membrane chaperones (such as BiP and 
Calnexin), accessory factors (such TRAM and TRAP), and enzymes (such as the 
oligiosacchardyl transferase complex (OST)) (Figure 5.1A). 
Insertion of the nascent chain begins as the RNC complex docks on the cytosolic 
surface of the Sec61 channel. Upon binding, the translation process, which is 
temporally stalled by SRP, is re-engaged and the nascent chain makes its way into the 
channel of the translocon. Photo-crosslinking studies have shown the Sec61 channel 
to be capable of housing the nascent chain, separating it from the lipid bilayer until 
such a time as it is to be released laterally into the ER membrane (McCormick et al. 
2003; Sadlish et al. 2005). This lateral movement through TM domains 2/3 and 7/8 of 
the Sec61α, which is known as the „lateral gate‟ of the translocon, is most commonly 
used by hydrophobic TM segments and seems to have been designed as a method of 
separating the aqueous translocon pore from the hydrophobic bilayer. This lateral 
movement of membrane proteins has been well studied using both single spanning 
and polytopic membrane proteins. The movement of single spanning proteins has 
been proven to be relatively straightforward, something that cannot be said for multi 
domain membrane proteins (Booth & High 2004; Higy et al. 2004). Increased size 
and number of domains, coupled with obtaining the correct orientation and correct 
secondary structure before integration into the membrane, instantly makes a polytopic 
protein more challenging for the translocon to process.  
 
142 
 
The integration of IMPs into the ER presents a number of problems. IMPs contain 
multiple domains with vastly different properties i.e. hydrophobic TM domains, 
charged signal sequences and hydrophilic internal and external loops, making 
integration into the membrane more challenging. As previously stated, the final 
secondary structure of membrane proteins must be obtained before integration can 
begin, therefore TM domains in many IMPs must obtain their correct structure and 
orientation before translocation comes to an end. As discussed in previous chapters, 
large TM segments have been shown to be capable of taking up secondary structure 
prior to entering the translocon, either whilst in the ribosome tunnel (Woolhead et al. 
2004; Lu & Deutsch 2005b) or upon interacting with SRP, when emerging from the 
ribosome (Robinson et al. 2012). This is not known to be the case for all TM proteins 
and hence it is plausible that the translocon pore, in some cases, may aid domain 
folding. Secondary structure within the Sec61 translocon is also poorly understood, 
but there is evidence that the environment provided by the pore could enable TM 
domains to sample multiple conformations. Cross-linking experiments show 
stabilizing interactions with the Sec61 α-subunits of the translocon (McCormick et al. 
2003), as well as interactions with accessory proteins such as TRAM (Heinrich et al. 
2000; Sadlish et al. 2005) which may impact on folding within the translocon. The 
preference towards a helical structure by the Sec translocon has been seen in both 
eukaryotic and prokaryotic systems. Indeed, experiments using proton motive force 
(PMF) calculations showed that the Sec61 channel, due to spatial confinement and 
surface properties, greatly favoured a helical over and an extended nascent chain 
(White & Von Heijne 2005). In the SecY channel, a 27 residue, hydrophobic peptide 
was used to show that the translocon could provide an environment capable of 
generating an α-helical conformation within a protein. The structure of the channel, 
resulting in the confinement of the peptide, was believed to be key in driving the 
peptide from an extended to helical conformation (Ulmschneider et al. 2014). As 
integration of membrane proteins relies on the correct formation of secondary 
structure with TM domains, the translocon could play a significant role in ensuring 
that this is in place. 
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Once the orientation and secondary structure of TM domains are in place within the 
translocon, integration into the ER bilayer can begin. Early models of protein 
integration proposed a sequential mechanism, in which each TM domain moved into 
the membrane as it emerges from the ribosome (Blobel 1980). This is the simplest of 
the proposed models, relying on the intrinsic hydrophobic sequence of the individual 
TM segments to drive the insertion process (Alder & Johnson 2004; Sadlish et al. 
2005; Ismail 2006). However, in the case of most polytopic membrane proteins, a 
number of TM segments must interact before they can be stably inserted into the ER. 
One possible mode of integration relies on the packing and assembly of the TM 
domains within the translocon before release (Lecomte et al. 2003). A second relies 
on the full translocation of a segment into the ER lumen before being „pulled‟ back 
into the membrane upon the insertion of subsequent domains (Lu et al. 2000). Finally, 
in one case it could be seen that a first TM domain can enter the ER membrane alone, 
remaining close to the translocon and upon the presence of a second TM domain, 
return to aid its entry into the bilayer (Heinrich & Rapoport 2003).  
In this chapter, the issues of TM domain folding and mode of integration of GPR35 
will be accessed. Experiments will be carried out to investigate if GPR35 is capable of 
being successfully translocated and integrated into the ER membrane (dog pancreas 
microsomes (DPMs) used as representative ER membranes). Experiments taking 
advantage of the protection offered by the ER membrane, using a protease assay, will 
assess if translocation and insertion into the membrane was successful. Proteinase K, 
a digestive enzyme with broad specificity, was used to detect the integration of full 
length GPR35 into the DPM membrane by digestion assays targeting protein 
components exposed to the cytosolic environment. Further experiments to determine 
orientation and secondary structure within the TM domains of GPR35 during 
translocation will take advantage of the enzymatic complex found on the luminal side 
of the ER membrane, the OST complex (Figure 5.2 A). This complex transfers a 14-
sugar oligosaccharide dolichol within the ER membrane to an asparagine within the 
nascent protein at a NXT site. This process, N-linked glycosylation, changes the MW 
of the nascent chain enabling the detection of this post-translocational modification by 
gel-shift. The position of the OST complex, relative to the translocon, (requiring 
approximately 15aa to be translocated into the ER before glycosylation can occur 
(Whitley et al. 1996)) is known and when coupled with the known distance required 
144 
 
to traverse the ribosome tunnel and translocon we can accurately access if a nascent 
chain is compacted or extended within the translocon (Figure 5.2 A). The final 
experiments to be carried out in this chapter will be to assess how GPR35 is 
integrated into the ER membrane. Chemical cross-linking assays, using the cysteine 
specific cross-linker bismaleimidohexane (BMH, spacer arm length: 13Å), which can 
enter the Sec61 translocon channel, were carried out to determine the point at which 
integration of TM domains 1 and 2 took place (Figure 5.2 B). Through the assessment 
of interactions with Sec61 α-subunits in the channel pore with the nascent peptide, we 
can propose the mechanism by which the N-terminus of GPR35 integrates into the ER 
membrane. 
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A 
B 
Figure 5.2 Experimental design of glycosylation and chemical cross-linking assays (A) Schematic diagram displaying the distance required to 
bridge the gap between the P-site of the ribosome and the OST site for glycosylation. (B) Chemical cross-linking molecule BMH reacts with the SH 
group of the single cysteine residue in the nascent chain and the free SH groups in components of the Sec61 translocon. The α-β double bond 
undergoes nucleophilic addiction by the nascent peptide and protein thiols yielding a stable thioether linkage (Zucca & Sanjust 2014). 
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5.2 Results 
5.2.1 Proteinase K digestion to determine successful targeting 
and integration of GPR35 to DPMs 
  
Cross-linking experiments in chapter 4 have determined that GPR35 is most likely to 
be targeted to the ER membrane by the SRP pathway. As this is the case, experiments 
were carried out to investigate if GPR35 could be successfully targeted and integrated 
to the representative ER membranes, DPMs. Due to the interaction detected between 
GPR35 and SRP54, we expect translocation into the ER membrane to occur through 
the Sec61 translocon, as seen in the majority of other polytopic membrane proteins. 
To ensure successful integration, digestion and glycosylation experiments were set up 
to confirm GPR35 is in its correct orientation. 
The initial experiment to test the success of insertion of GPR35 into DPMs was 
carried out using proteinase K (PK) and relied on the protection from digestion given 
by the membrane bilayer upon successful insertion. For the digestion and 
glycosylation experiments, radiolabelled GPR35 nascent chains were generated using 
the RRL in vitro translation system, to which DPMs were added to provide an ER 
membrane component and the end point for GPR35 insertion. On this occasion, full-
length GPR35 RNCs were generated. The N-terminus of GPR35 contains a N-
glycosylation site at residue Asn-2; therefore both insertion and correct orientation of 
the GPCR should be detectable upon isolating the membrane fraction. 
The results of the digestion assay can be seen in Figure 5.3A. In the absence of PK, 
the translated full length GPR35 can be detected at approximately 30kD, in the 
presence of DPMs (Lane 1). Full length GPR35, however, showed no sign of a higher 
molecular weight (MW) band indicative of glycosylation occurring upon 
translocation. This suggested the GPCR N-terminus was not interacting with the OST 
complex, hence we could not determine if the correct orientation of GPR35 had been 
obtained. However, insertion of full length GPR35 was confirmed upon the addition   
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Figure 5.3 Assay to assess insertion and orientation of GPR35 into DPMs. (A) 
Radiolabelled full-length GPR35 was targeted to DPMs that were added to the RRL 
translation mix. Digestion assays using proteinase K assessed insertion of GPR35 into DPMs. 
(B) Schematic to show the expected orientation of the 182aa intermediate designed for 
glycosylation, when inserted into the ER membrane. (C) Selective release and glycosylation 
of the 182aa intermediate by RNaseA, shows GPR35 is orientated correctly in DPMs. * 
denotes glycosylation of C-terminus upon release from the PTC. 
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of PK (Lane 2) at which point the 30 kD band was no longer seen to exist and was 
replaced by bands at ~7 kD. These bands represent fragments of the GPR35 that have 
been protected from PK degradation by the lipid bilayer of the DPMs. Insertion of 
GPR35 into the membrane was further confirmed upon disrupting the permeability of 
the bilayer by a detergent (Lane 3). The bands present in lanes 1 and 2 could no 
longer be detected suggesting disruption of the membrane allows for the degradation 
of GPR35. Finally, a control experiment in the absence of DPMs was carried out to 
ensure GPR35 could not be isolated unless it was associated with the membrane 
(Lane 4). This resulted in no full-length GPR35, indicating that the appearance of any 
intermediates previously was due to its association with the DPM bilayer. The results 
therefore indicate that GPR35 can be successfully targeted and inserted into DPMs; 
however, the glycosylation of site Asn-2 is highly inefficient, therefore the orientation 
of the full-length protein remains unconfirmed.   
To investigate whether the orientation of GPR35 after integrating into the membrane 
bilayer was correct, a further glycosylation assay was designed. On this occasion an 
engineered glycosylation site was placed on the C-terminal end of an 182aa 
intermediate (Figure 5.3 B). This glycosylation site was incorporated into the reverse 
primer, which was designed to be specific for extracellular loop 2 (positioned on the 
luminal side of the ER) of the mature GPR35. The reverse primer extended 
extracellular loop 2 by 18aa, with the glycosylation site situated 16aa downstream 
from TM4 and theoretically in range of the OST complex (Figure 5.3 B). The reverse 
primer was designed without a stop codon, generating a ribosome-bound nascent 
chain that could only be fully translocated by the addition of RNaseA and EDTA to 
the translation mix. This selective release from the ribosome enables the comparison 
between the glycosylated and unglycosylated ribosome-bound peptides, confirming if 
indeed GPR35 is inserted in the correct orientation.  
The results of this assay show convincingly that, GPR35 is capable of inserting into 
DPMs with the correct orientation (Figure 5.3 C). Upon translation and isolation of 
the membrane integrated 182aa intermediate, a single band could be detected at ~16 
kDa representing an unglycosylated ribosome bound peptide. Upon addition of 
RNaseA and EDTA to the translation mix, breaking the peptidyl-tRNA bond and 
removing the ribosomal subunits, the C-terminus is released and translocation of the 
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engineered glycosylation site occurs across the DPM membrane. Translocation of the 
C-terminal end produced 2 bands when analysed by gel electrophoresis, one 
representative of the 182aa intermediate and a second higher band representative of 
the glycosylated product. The appearance of the higher product suggests that the 
glycosylation site in loop 2 of GPR35 was capable of interacting with the OST 
complex on the lumenal side of the DPM membrane, therefore confirming GPR35 
was in the correct orientation.  
Experiments set up to investigate the targeting and insertion of GPR35 into the 
membrane of DPMs shows that the protein is capable of efficiently integrating and 
adopting the correct orientation within the membrane. Protease experiments show that 
GPR35 is targeted to DPMs in the translation mix and offered protection from 
Proteinase K by insertion into the membrane. Insertion of GPR35 in the correct 
orientation was confirmed by the glycosylation of the NST site placed specifically in 
extracellular loop 2. Translocation of the C-terminal end of this 182aa intermediate 
across the membrane enables the interaction of the peptide with the OST complex, a 
complex which will become a useful tool in the future experiments to assess structure 
and movement of GPR35 within the DPM membrane.  
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5.2.3. Does a loss of hydrophobicity in the 1st TM domain 
result in a loss of insertion into the translocon? 
 
Upon showing GPR35 could be successfully inserted into the ER membrane, an 
experiment was set up to assess what impact disrupting the hydrophobicity of a signal 
anchor domain would have on insertion. As seen in Chapter 4.2.3, the hydrophobicity 
of the 1
st
 TM domain in GPR35 was critical for driving the interaction between the 
nascent chain and SRP. Reducing the hydrophobicity at either terminus of the TM 
domain or removing hydrophobicity entirely, so it was no longer recognised as a TM 
domain, adversely affected its interaction with SRP. As GPCRs are thought to be 
targeted to the ER membrane almost exclusively via the SRP pathway, experiments 
were set up to investigate how the loss of hydrophobicity would impact on the 
targeting and subsequent integration of GPR35 intermediates into the ER membrane. 
The four constructs designed for cross-linking experiments in Chapter 4.2.3 will be 
used (GPR35 WT, ΔNT, ΔCT and Δ4E). The constructs were once again expressed in 
the RRL in vitro translation system and targeted to DPMs. Each intermediate was a 
total length of 75aa and would contain the native glycosylation site at residue 2. A 
new batch of DPMs was used in this experiment and provided a much more efficient 
rate of glycosylation at Asn-2 than had been previously seen in Section 5.2.1. 
Successful targeting and translocation would enable the individual intermediates to 
interact with the OST complex and become glycosylated, hence producing an 
intermediate with a higher MW.  
The effect of a loss of hydrophobicity in the 1
st
 TM domain was clear to see in the 
resulting translocation reactions (Figure 5.4). In the absence of DPMs, on one band 
representative of the translation band exists (Figure 5.4 A). Upon the addition of 
DPMs to the RRL translation reaction, the GPR35 WT intermediate, as expected, 
becomes targeted and successfully inserted. Approximately half the translation 
product shows a shift in MW from ~7 to ~14 kD, representative of glycosylation of at 
the N-terminal glycosylation site, within the nascent peptide (Figure 5.4 B and D). To 
ensure the higher MW band was indeed due to the translation product becoming  
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Figure 5.4 Glycosylation assay to assess translocation of GPR35 TM1 hydrophobic mutants. 
Ribosomes displaying radiolabelled N-terminal intermediates of GPR35 hydrophobic mutants (as 
described in Figure 4.8) at lengths of 75 amino acids before (A) and after insertion into DPMs (B 
and C). The addition of endoH to the DPMs results in a loss of the glycosylated translation product 
(C). Translation product and glycoslyated translation product are indicated by 1 and 2 respectively, 
with the presence of the background heme band marked with a <. Products were resolved on a 10-
20% SDS-PAGE gel. (D) Bar graph showing the average % of glycosylated translation product in 
the presence of DPMs. Glycosylation results were quantified using Image J software. All % 
glycosylation values were calculated using [glycosylated product/total translation product] and 
adjusted for background. Average percentage of glycosylation is calculated from an n of 3. Error 
bars indicate standard deviation and groups were compared using one-way ANOVA with Tukey‟s 
post hoc comparisons. *p< 0.05, **p<0.005, ***p < 0.001.  
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glycosylated, the DPMs were incubated with the enzyme Endo H, which is capable of 
removing sugar group generated from a glycosylation event. In the presence of Endo 
H, the higher MW bands associated with glycosylation were successfully removed 
(Figure 5.4 C). GPR35ΔNT and ΔCT intermediates were also successfully inserted 
into the ER membrane (Figure 5B and D). However, both intermediates showed a 
reduction in translocated product in comparison to the WT GPR35 intermediate, 
which may have been representative of a loss of interaction between the nascent chain 
and SRP, as seen in the cross-linking results (Figure 4.8 B). Generally, the effect on 
translocation in the ΔNT intermediate was significantly greater when compared to the 
WT intermediate, than what was seen in the ΔCT intermediate (Figure 5.4 D). Finally, 
the Δ4E intermediate shows a much lower level of translation product isolated within 
the DPMs, with extremely low levels of the higher MW product reprenting 
glycosylation being detected when compared to each of the other intermediates 
(Figure 5.4 B and D). This would suggest that the N-terminus of the Δ4E intermediate 
was unsuccessfully translocated across the ER membrane as a result of a loss in 
hydrophobicity leading to poor SRP targeting or poor insertion into the DPM 
membrane. 
The results of this experiment highlight the importance of the hydrophobic signal as a 
requirement for targeting and translocation of the nascent chain into the ER 
membrane. As with the cross-linking assay in Chapter 4.2.3, the absence of 
hydrophobicity in the N-Terminus and C-Terminus reduced the levels of translation 
product that was successfully inserted into the ER membrane. The ΔCT intermediate 
is less affected, than the ΔCT intermediate, with WT like levels becoming 
successfully targeted. However, the complete reduction in hydrophobicity in the Δ4E 
intermediate resulted in a complete loss translocated product, possibly due to the SRP 
no longer recognising TM1 as a signal anchor and hence generating a loss in targeting 
to the translocon machinery.  
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5.2.2 Assessing the secondary structure of GRP35 
transmembrane domain 1 during translocation. 
 
Throughout this study, one of the primary aims was to assess the structure and folding 
at the N-terminus of a model GPCR as it undergoes biogenesis. Through pegylation 
and chemical cross-linking experiments in chapter 3 and 4 respectively, we have 
shown as GPR35 makes its way through the ribosome tunnel and first makes contact 
with SRP while the nascent chain exists in an extended conformation. Upon 
interaction with SRP and throughout the process of targeting, it remains unclear as to 
whether the helical secondary structure of TM1 begins to form. To investigate if 
secondary structure exists prior to or takes place during insertion, we initially set out 
to use a photo-crosslinking assay set up by McCormick et al (2003). This assay relied 
on three successive probe sites being placed within the centre of the first TM domain. 
To detect whether or not a helical TM domain was present within the Sec61 channel, 
the symmetry of photoadducts was to be measured. A symmetrical pattern in cross-
linking suggests the presence of an extended nascent chain; however assymetrical 
cross-linking patterns would allude to the presence of an α-helical TM domain 
(Mccormick et al. 2003). However, upon attemped incorporation of the fluorescent 
probes into the GPR35 intermediates only truncated peptides, due to the existence of 
an amber stop codon, could be detected, suggesting a failure of the probes to 
incorporate. Therefore, a change in experimental design was in order and we decided 
to utilize the known spanning distance between the PTC and the OST complex, with 
glycosylation as a marker of distance. 
To use glycosylation as a marker of distance, we can take advantage of the previous 
work carried out by several groups who have mapped the distance of a number of key 
components that make up the RNC-translocon complex. Firstly, the ribosome tunnel 
has been shown experimentally to be ~100Å in length, requiring a total of ~30 
residues in an extended conformation to traverse this distance (Lu & Deutsch 2005b). 
Secondly, the length of the Sec61 translocon channel has mapped by cryo-EM 
experiments and shown to ~70Å (Pfeffer et al. 2015), suggesting that ~20aa in an 
extended conformation would be capable of covering this distance. Thirdly, the point 
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at which a peptide becomes glycosylated at the OST complex is believed to require 
~15aa of additionally translocated protein to have passed through the Sec61 
translocon and into the ER lumen. Finally, a controversial space between the 
cytoplasmic face of the translocon and the bottom of the ribosome upon formation of 
the RNC-translocon complex is believed to exist, spanning ~15Å in distance 
(Patterson et al. 2015). In total the RNC must traverse a distance of ~200Å to become 
glycosylated, requiring ~65 residues of an extended peptide (Whitley et al. 1996). 
Therefore, whether or not the nascent chain contains secondary structure while 
spanning the Sec61 complex can be calculated by the length at which an intermediate 
of GPR35 first becomes glycosylated.  
As glycosylation of the N-terminus in full-length GPR35 could not be recognised in 
the initial experiments of Chapter 5, it was decided that another site further from the 
start codon should be inserted to enable an increased likelihood that glycosylation 
would occur. As the wild type GPR35 already contained an Asn (N) and Tyr (T) at 
residues 5 and 6 respectively, a Ser (S) was inserted between the two residues by site-
directed mutagenesis (see section 2.4.6.1), generating an artificial glycosylation 
(NST) site. As in previous experiments, reverse primers without a stop codon were 
designed to generate ribosome bound intermediates of various lengths. The length of 
each intermediate was calculated from the PTC to the first residue in the artificial 
glycosylation sequence (N6). Expression of the intermediates was carried out in the 
RRL in vitro translation system containing DPMs, with lengths ranging from 65-
100aa.  
The results of the glycosylation experiment to assess the folding profile of GPR35 
during translocation can be seen in Figure 5.3 A and B. In the absence of DPMs from 
the RRL translation system, a band correlating to the size of each unglycosylated 
intermediate could be detected. Also present was the background haem band (~16 kD) 
seen previously arise upon isolation of RNCs without DPMs present (Figure 5.5 Lane 
1). Upon the addition of DPMs, the appearance of two bands of increased molecular 
weight (MW) could be detected along with the unglycosylated intermediate (Figure 
5.5 Lane 2). The two bands of increased MW were believed to be the result of a single 
or double glycosylation event taking place at the N-terminus. A change in source of 
DPMs was believed to be a possible cause for glycosylation now occurring at the first 
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Figure 5.5. Analysis GPR35 glycosylation in DPMs to 
detect the formation of secondary structure in the Sec61 
translocon. Intermediate lengths ranging from 65-100aa of 
GPR35 were expressed in an in vitro RRL translation 
reaction. Reactions were split into three, with one third being 
incubated without DPMs (Lane A), another being incubated 
in the presence of DPMs (Lane B) and the the final third 
being incubated in the presence of DPMs and Endo H (Lane 
C). Lane A contains the unglycosylated translation product 
(0). Also present in Lane A is a background band at ~14 kD, 
which is representative of heme, indicated by a <. Lane B 
represents glycosylation occurring in the translated product. 
The translated product (O) has two glycosylation sites 
present. In the presence of DPMs a single (1) or double (2) 
glycosylation event can be detected by a gel-shift of the 
translation product by ~ 5kDa. Lane C represents EndoH 
treated DPMs, removing glycans (1 and 2) and returning the 
glycosylated producted to the intial MW of the translated 
product (0). 
 
156 
 
site (which could not be seen in original glycosylation assays with FL GPR35). The 
65aa intermediate shows no sign of glycosylation at either glycosylation site, 
suggesting that it is long enough at this point to interact with the OST complex. 
Although the first glycosylation site within this intermediate is 70aa from the PTC 
and theoretically should be capable of low levels of glycosylation, there is none to be 
detected. This could indicate that this site imparticular does not become glycosylated 
efficiently or may not be recognised by the OST due to its close proximity to the start 
codon, as suggested by Bano-Polo et al (2011).  In the 70aa intermediate however, 
signs of weak glycosylation can be detected at both Asn-2 and Asn-6, suggesting that 
~70 residues are required for glycosylation to occur. Glycosylation then appears to 
occur at increased levels in the 75aa intermediate, suggesting it is at an optimum 
length for interaction with the OST; this level of glycosylation which was maintained 
throughout the longer peptide lengths. To ensure the two higher MW bands were 
indeed as a result of glycosylation, the isolated DPMs were treated with the enzyme 
endoglycosidase H (endoH) which is capable of removing glycans from the native 
protein (Figure 5.5 Lane 3). Upon addition of the enzyme, endoH, the existence of the 
two higher MW bands were no longer present, hence suggesting that they were indeed 
a result of glycosylation in the native intermediate.  
Glycosylation as a marker for the presence of secondary structure in translocating 
intermediates of GPR35 was capable of determining that the N-terminus and 
specifically the first TM domain forms a compacted structure in the Sec61 translocon. 
The lack of glycosylation products at 65aa from the PTC and the presence of 
glycosylated intermediates at 70aa, and increasingly at 75aa, indicate the presence of 
a helix-like domain during translocation. At this point we are unable to confirm 
whether it is due to an interaction with SRP or the translocation events that begins 
folding of TM1. In either case, it is an essential event in the biogenesis of GPR35, 
preparing it for integration.
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5.2.4. Analysis of GPR35 integration into the ER membrane by 
site-specific cross-linking. 
The integration of TM domains into the ER membrane is a critical step in the 
biogenesis of polytopic membrane proteins. To address this point, with GPR35, we 
have shown it can be successfully translocated and integrated into the membrane of 
DPMs; however, the mechanism of integration remains unknown. Integration of 
polytopic membrane proteins tends to be complex and in many cases differs between 
proteins, hence making it difficult to hypothesize a model of integration. However, as 
GPCRs are one of the largest and most widely studied classes of eukaryotic 
membrane proteins, a model of their integration may be of significant interest. 
Therefore, the aim of the following set of experiments is to study the mode and timing 
of integration of the first 2 TM domains of GPR35, enabling us to establish if 
integration is a co-ordinated event between domains.  
In this study we examine the movement of the first 2 TM domains of GPR35 using a 
site-specific cross-linking assay that relies on the reagent bismaleimidohexane 
(BMH); a sulfhydryl-to-sulfhydryl cross-linker. A single cysteine residue was inserted 
into the 1
st
 or 2
nd
 TM domain of GPR35 and was capable of being cross-linked to 
multiple cysteines in the Sec61α domains of the translocon. To make the cross-linking 
site-specific, multi-site mutagenesis was carried out to remove other native cysteines 
within GPR35. Various lengths of truncated mRNA lacking a stop codon were 
expressed in the RRL in vitro translation system generating stable RNCs, which 
provided intermediates that could be trapped in the process of integration. 
Intermediates between 75 and 155aa were generated to assess the environment 
surrounding the nascent chain during integration and hence elucidate the timing of 
movement of individual TM domains. 
To assess the mode of integration used by TM1 of GPR35, a construct containing a 
single cysteine in TM1 (GPR35-TM1) was used. The results of the TM1 cross-linking 
with BMH can be seen in Figure 5.6A and B. In the absence of the cross-linker, 
translated peptides can be detected in their unglycosylated and glycosylated states. 
The N-gycosylation, at the site found at the N-terminus of GPR35, indicates a 
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Figure 5.6.  Integration GPR35 TM domain 1 into the DPM membrane. (A) Schematic to show the expected position 
of TM1 and TM2 of GPR35 at different intermediate lengths in the DPM membrane. (B) Ribosomes displaying 
radiolabelled N-terminal intermediates between 75-155aa of GPR35 at intervals of 20 amino acids can been seen before 
(B1) and after (B2 and B3) treatment with BMH when resolved on a 10-20% Bis-Tris gel. Crosslinks displaying the 
correct molecular weight for GPR35-Sec61 α complexes have been marked *. Glycosylated nascent chain is indicated 
with a + and is consistently reduced in intermediates 135 and 155aa. 
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successful integration of the GPR35 intermediates into the DPM membrane (Figure 
5.6B1). In the presence of BMH, the translated peptides can once again be detected, 
as well as strong higher MW band at ~45 kD, at intermediate lengths ranging from 
75-115aa. This higher band can also be detected weakly in the 135aa intermediate. 
These bands correspond to a possible cross-linking reaction taking place between the 
nascent chain and components of the Sec61 channel. (Figure 5.6 B2). 
Immunoprecipitations with the antibody raised to the Sec61α protein were attempted 
to determine if indeed this was an interaction between TM domain and the Sec61 
channel. Unfortunately due to weak IP results and time mitigating factors, we were 
unable to confirm that the ~45 kD band was due to an interaction with Sec61α. 
However, a band of near identical size was seen in similar cross-linking assays carried 
out by Watson et al (2013) and was shown to be an interaction between the nascent 
chain and Sec61α (Watson et al. 2013). A weakening of the band at ~45 kD after the 
115aa intermediate suggests it is at this point that GPR35 TM1 is moved out of the 
Sec61 channel and possibly into the lipid bilayer of the ER membrane. Although there 
is a strong possibility that the 45 kD band is indeed Sec61α, due to the timing and 
positioning of the nascent chain in the translocon, the protein TRAM also produces 
putative cross-links at this MW. The TRAM protein has been shown reside close to 
the translocon (Ismail 2006; Ismail et al. 2008), as well as cross-link to the nascent 
chain as it moves through the lateral gate (Mccormick et al. 2003). However, it is 
unusual to see an interaction between TRAM and the nascent chain at such early 
lengths as 75aa from the PTC; hence I would suggest it is unlikely to be the cause of 
this higher MW band. The reduction in glycosylation in the longer intermediates may 
also suggest that the N-terminus, containing the N-glycosylation site, is being moved 
away from the OST which has been shown to be located near and interacting with the 
translocon (Pfeiffer et al. 2013). 
The same experiment was carried out with TM2 (GPR35-TM2) to investigate the 
mode of integration of GPR35 TM domains; do they integrate sequentially or is it co-
ordinated by the interaction of more than one domain? The GPR35-TM2 construct 
again contained a single cysteine residue in the middle of the 2
nd
 TM domain. This 
ensured cross-linking was only capable when TM2 resided in the environment of the 
Sec61 translocon. The same intermediate lengths ranging from 75-155aa were used to 
investigate the timing of the TM2 insertion and whether TM1 was still present in the 
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translocon environment. Upon the addition of BMH, a higher MW band 
corresponding to that believed to be the cross-linked nascent chain and Sec61α, was 
again detected but on this occasion at lengths 115-155aa (Figure 5.6 B3). The cross-
links between Sec61α and nascent chain at TM2 remain until 155aa, suggesting that 
TM2 is remains in the Sec61 channel as TM1 is integrated into the lipid bilayer. This 
suggests synthesis and insertion of TM2 may be required for the integration of TM1 
into the ER membrane.  
The results of this set of experiments provide the basis for a model of integration at 
the N-terminus of GPR35. The possible interaction between the nascent chain and 
Sec61α would be consistent with the TM domains taking up a position within the 
channel of Sec61.  A loss in the perceived cross-linking between Sec61α subunits and 
the nascent chain could be seen as the partitioning to TM domains from the protein 
environment of the translocon, into the lipid bilayer of the ER. The loss in putative 
cross-linking between TM1 and the Sec61 coincides with appearance of cross-links in 
TM2; therefore suggesting a co-ordinated mode of integration occurs between the TM 
domains. Finally, glycosylation of the Asn-2 glycosylation site begins to become 
reduced after synthesis of the 115aa intermediate, coinciding with the lateral 
movement of TM1 from its position within the translocon. This would represent the 
N-terminus moving away from the OST site, as TM1 integration begins, hence 
agreeing with the described model of integration of the GPR35 N-terminus. 
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5.3. Discussion 
The insertion and integration of TM domains into the ER membrane is an essential 
step in the biogenesis of polytopic membrane proteins that either reside in the ER or 
are trafficked along the secretory pathway. As this is the case, integration has been 
extensively studied using a variety of proteins, providing several different models. 
Prior to release from the translocon, membrane proteins are required to ensure their 
TM domains are in the correct orientation and have obtained the necessary secondary 
structure; once this has occurred integration can proceed. An increased number of TM 
domains in polytopic proteins adds to the complexity of integration, with several 
studies revealing a number of mechanisms for lateral release. As it was uncertain 
whether GPR35 had formed secondary structure prior to translocation and a model for 
its integration into the ER membrane was unknown, this chapter aimed to use a 
variety of techniques to shed light on what are key steps in the biogenesis of this 
GPCR. 
Initial experiments were set up to confirm that full length GPR35 intermediates could 
be effectively targeted and integrated into the membrane of DPMs. Cross-linking 
results from chapter 4 suggested, as with many other integral membrane proteins, a 
SRP-dependant mode of targeting and therefore integration through the Sec61 
translocon machinery. Indeed previous studies investigating the integration of 
GPCRs, specifically Opsin, have shown insertion into the ER membrane to be 
exclusively via the Sec61 translocon (Ismail 2006). Digestion assays using the broad 
specificity of proteinase K suggested, through partial protection of the full length 
GPR35, insertion and integration into the membrane of DPMs had taken place 
efficiently (Figure 5.2 A). The orientation of GPR35 at this point remained unknown 
as glycosylated intermediates had failed to be detected. This was believed to be due to 
a number of possibilities; the close proximity of the N-glycosylation site to the start 
codon, the quality of DPMs or, as discovered later, the supressed rate in glycosylation 
of larger intermediates due to their movement away from the OST site at the Sec61 
translocon. As the correct orientation for future experiments was essential, a second 
assay was set up to assess glycosylation at the C-terminus of an 182aa intermediate 
containing the first 4 TM domains. An engineered N-glycosylation site added to the 
extracellular loop 2 of GPR35 (found on the lumenal face of the ER membrane) was 
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then used to assess the orientation of GPR35 in the membrane (Figure 5.3 B). 
Glycosylation of this intermediate, upon ribosome release, provided evidence that 
integration of GPR35 was occurring in the correct orientation (Figure 5.3 C); 
therefore further experiments investigating GPR35 translocation and integration could 
be carried out. 
Successful targeting of polytopic membrane proteins to the ER membrane is essential 
for efficient integration. This process involves the presentation and transfer of the 
signal anchor from SRP to the Sec61 translocon in a highly co-ordinated series of 
events. Although the exact mechanism is poorly understood, the combination of 
translating ribosome, SRP and translocon is essential to begin the process of insertion. 
The recognition of a TM domain by the ribosome and the resulting structural changes 
is thought to prepare both the SRP and translocon for the incoming membrane protein 
(Liao et al. 1997; Pool 2009). The amino acid sequence and in particular the 
hydrophobicity of a TM domain has been proven to be essential for its recognition by 
SRP (see chapter 4). The amino acid sequence has also been proposed to be of high 
importance in directing the nascent chain to the translocon and deciding its orientation 
(Hessa et al. 2005; Nilsson et al. 2014). To test if altering the amino acid sequence in 
the first TM domain of GPR35 resulted in a loss of translocation, the hydrophobic 
mutants (GPR35 ΔNT, ΔCT and Δ4E) designed for the cross-linking experiment in 
chapter 4.2.3 were used in insertion assays. The results followed similar patterns to 
that seen with the cross-linking to SRP, with N-glycosylation used as the marker for 
translocation. The ΔCT mutant was translocated with the highest efficiency out of the 
3 mutants, followed by the ΔNT mutant (Figure 5.4). Both had suffered a loss in 
translocated product when compared to the WT intermediate, however, a loss of 
hydrophobicity at the N-terminus had a far greater effect than at the C-terminus. The 
Δ4E intermediate unsurprisingly showed glycosylation levels no higher than 
background level, correlating exactly to the total loss of cross-linking with SRP 
witnessed in the previous chapter (Figure 5.4). The loss of efficiency in translocation 
correlates well with a similar study carried out to assess the impact of specific amino 
acid changes within the hydrophobic core of a signal sequence (Nilsson et al. 2014). 
In this study, deletions of Leu residues in the hydrophobic core result in a dramatic 
loss in both SRP targeting and insertion. This does raise the question as to whether a 
loss in SRP targeting has a direct effect on the interaction between the ribosome and 
163 
 
translocon, therefore preventing the nascent chain from being in a position to become 
translocated. However, biophysical studies have also shown that replacing polar 
residues with non-polar or charged residues can have an adverse effect on TM domain 
insertion, with position of certain amino acids within a TM domain crucial. Asn 
residues for example, have a far more detrimental effect on insertion when they are 
placed at the centre of a TM domain than when at either end (Hessa et al. 2005; Hessa 
et al. 2007). This has been suggested, along with cross-linking data, to upset the 
orientation of possible α-helicies forming in the translocon and hence preventing 
specific interactions from occurring between the nascent chain and the translocon 
channel that enable integration (Hessa et al. 2005; McCormick et al. 2003). The 
formation of secondary structure within TM domains is essential before a peptide can 
leave the translocon and become integrated into the ER membrane. With GPR35 it 
had yet to be seen as to when α-helix formation began; therefore, the following 
experiments were set up to assess if it was occurring during translocation.  
The secondary structure of TM domains whilst in the translocon is poorly understood. 
Much research in recent years has focused on the folding environment provided by 
the ribosome tunnel with secondary structure formation prior to insertion is a better 
understood process (Woolhead et al. 2004; Robinson et al. 2012). TM domains within 
the translocon are believed to be highly dynamic and studies show that they are 
capable of sampling a number of conformations (Goder & Spiess 2001). Secondary 
structure within membrane proteins is a requirement before integration into the ER 
can begin, something that was unseen in GPR35 prior to insertion into the translocon. 
Therefore, to test if secondary structure within TM1 of GPR35 was occurring during 
translocation, glycosylation assays were carried out. Previous work carried out by 
Whitley et al 1996, provides evidence that 65 amino acids in an extended 
conformation (3.5Å/aa) is sufficient to bridge the gap between the P-site and the site 
of glycosylation at the OST complex. Intermediates of GPR35 witness glycosylation 
first occurring weakly when the construct is 70 residues in length (Figure 5.5), which 
is approximately a 5 amino acid increase on a fully extended nascent chain, and an 
intermediate of 75aa increases the level of glycosylation substantially. These results 
are in agreement data described by Whitley et al (1996) who suggest that, when an 
18aa hydrophobic segment is believed to compact in the Sec61 translocon, 75aa are 
required to span the distance from the PST to the OST. With the first TM domain of 
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GPR35 being 20 residues in length, compaction within the translocon would delay 
glycosylation by ~10 residues. As the TM domains of GPCRs are known to form α-
helices, it is likely that the first TM domain of GPR35 has compacted to form a helix 
in preparation for integration into the ER membrane. Indeed, cross-linking assays 
provide evidence of stabilizing forces within the translocon that could induce helix 
formation (McCormick et al. 2003). Biophysical assays have also suggestted a helical 
structure will position the most hydrophobic residues towards the lipid bilayer and 
least hydrophobic towards the polar surface of the translocon channel (Hessa et al 05). 
Positioning of the α-helical TM domain in this manner, prepares the TM segment for 
integration into the lipid bilayer of the ER. 
The integration process is one of the final steps in IMP biogenesis at the ER 
membrane. Integration has been studied in a number of model proteins, with various 
models of integration being suggested (Audigier et al. 1987; Friedlander & Blobel 
1985; Ismail et al. 2008). TM domains upon integration into the ER membrane have 
previously been shown to partition laterally from the Sec61 translocon, through the 
lateral gate, into the phospholipid environment of the ER (Mothes et al. 1997; 
McCormick et al. 2003). Previous studies have used chemical and photo-crosslinking 
techniques to investigate the timing of TM domain integration, demonstrating the 
movement of nascent chain from the protein environment of the Sec61 channel to the 
lipid environment of the ER membrane (Meacock et al. 2002; McCormick et al. 2003; 
Ismail 2006; Ismail et al. 2008; Hou et al. 2012). Using a similar assay to those 
mentioned above, the movement of GPR35 domains 1 and 2 from the translocon to 
lipid bilayer was demonstrated by the loss of single cross-linking adducts to Sec61α.  
In the case of TM1 of GPR35, we demonstrate by cross-linking with Sec61α, that it 
resides in the vicinity translocon pore until the point at which the entire TM2 domain 
is inserted (~115aa). At this point, cross-links between TM1 and Sec61α weaken at 
~135aa and an interaction can no longer be detected at 155aa, suggesting a relocation 
of TM1 into the lipid bilayer (Figure 5.6B2). The efficiency of glycosylation at the N-
terminal N-glycoylation site may also be a means of measuring the timing at which 
TM1 is laterally partitioned from the translocon (Figure 5.6). Glycosylation in 
intermediates 75-125aa is much stronger than that detected in either the 135aa or 
155aa intermediate. This may be due to length of RNCs artificially holding the N-
terminus of GPR35 in a position where it will exposed to the OST for a longer period 
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of time. The 2nd TM domain begins to show cross-linking adducts to Sec61α at the 
same time as the TM1 adducts begin to weaken (Figure 5.7A). This suggests that 
completion of insertion of TM2 into the translocon triggers the relocation of TM1 
domain into the lipid bilayer. Previous studies have shown that integration of one TM 
domain is often dependant on the synthesis and insertion of the subsequent domains 
(Ismail et al 2006). Cross-links in TM2 remain beyond 135aa, suggesting TM2 
remains in the vicinity of the channel and does not get portioned out along with TM 
(Figure 5.7A2). This could suggest a sequential model of insertion, but subsequent 
experiments would be required to determine this fully.
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6. Final Discussion 
6.1 Analysing secondary structure formation within the ribosome 
tunnel of TM 1 in a model GPCR.  
A major aim of this thesis was to investigate the early folding events taking place in the N-
terminal 1
st
 TM domain of GPR35. As very little is known about the co-translational 
folding of these GPCRs, this work strived to shed light on how this major class of 
eukaryotic membrane protein folds during translation and whether like other IMPs they are 
likely to form structure in the ribosome tunnel. Using GPR35 as a model GPCR, assays 
were set up in both prokaryotic and eukaryotic in vitro translation systems to determine if 
the first TM domain was capable of folding, as well as investigating differences that may 
exist between the tunnel environment of prokaryotic and eukaryotic ribosomes.  
Experiments investigating the folding profile of GPR35 were carried out in both 
prokaryotic and eukaryotic ribosomes (refer to Figures 3.3 and 3.5). Extensive structural 
studies have suggested a high level of conservation between different ribosome species 
(Ben-Shem et al. 2010; Jenner et al. 2012; Ban 2000), including that of the role played by 
the ribosome tunnel in nascent chain compaction (Woolhead et al. 2004; Houben et al. 
2005; Bhushan et al. 2010). Following the outcome of studies in both GPR35 and 
Bacterioopsin, we too believe a high level of conservation exists in the ribosome tunnel, as 
the experiments discussed below provide nearly identical results in both prokaryotic and 
eukaryotic ribosomes. 
A number of studies have highlighted the role played by the ribosome tunnel in aiding the 
formation of secondary structure within TM segments of a translating nascent chain 
(Woolhead et al. 2004; Lu & Deutsch 2005a; Robinson et al. 2012). In particular, several 
studies have provided evidence for preferred „folding zones‟ within the tunnel where 
compaction of the nascent chain takes place. Woolhead et al (2004) were first to provide 
evidence through energy transfer experiments that the upper tunnel, near the PTC, is one 
such region where folding can exist. Following the synthesis of the final residues of the 
VSV-G TM domain in the 111p peptide, compaction of the nascent chain occurred. 
Photocrosslinking studies were capable of demonstrating a possible interaction between the 
nascent chain and ribosomal proteins, uL4 and uL22. As these interactions could not be 
seen with the extended peptide pPL, this suggested that the interaction was driven due to 
the existence of secondary structure in the upper regions of the tunnel. Studies carried out 
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by Lu and Deutsch (2005) using a polyalanine nascent chain, also confirmed the upper 
tunnel as a viable region for the formation of secondary structure and further suggested it 
was the strongest zone for supporting compaction. The upper tunnel has also been shown 
to compact TM segments of IMPs, with the C-terminus of TM domain 6 in Kv1.3, a 
voltage-gated potassium channel, one such example (Lu & Deutsch 2005b). From the work 
in this thesis, we established that neither GPR35 nor BO, a structurally similar prokaryotic 
protein, can compact in the upper region of the ribosome tunnel (refer to Figures 3.3-3.6). 
Based on the structure of the large ribosomal subunit, the exit tunnel is known to be ~100Å 
in length from the PTC to the ribosome exit point, both pegylation and cross-linking assays 
suggest that compaction of GPR35 in the upper tunnel is highly unlikely. Both nascent 
peptides can be pegylated at ~30aa and cross-linked to uL23 as early as 25aa from the PTC 
(refer to Figure 4.3). At this point the entire TM1 domain would be synthesised and shows 
little evidence of secondary structure formation during the early stages of synthesis.  
The subsequent regions of the ribosome tunnel have also been assessed for their ability to 
form compacted nascent chains. Approximately 30Å from the PTC is a constriction point, 
which has been shown to be an area of the tunnel where compaction of a nascent chain 
cannot take place (Lu & Deutsch 2005a; Bhushan et al. 2010). However, it has been 
suggested that the uL4 and uL22 r-proteins may play a role in stabilizing a structure that 
had previously formed during the early stages of synthesis. As this is the case, it was 
highly unlikely that GPR35 or BO would begin to compact in this region of the tunnel. 
Pegylation and cross-linking data can confirm this, adding to the data already published 
suggesting the central region of the tunnel is not a viable „folding zone‟(refer to Chapter 4 
and 5).  
The lower region of the tunnel however, has been highlighted as a „folding zone‟ for 
nascent chains, with both secondary and tertiary structure capable of forming whilst close 
to the exit point (Lu & Deutsch 2005a; Bhushan et al. 2010; Tu et al. 2014; O. B. Nilsson 
et al. 2015) . This region of the tunnel has been the most frequently described „folding 
zone‟ for  secondary structure in TM domains of IMPs and the only region described for 
the formation of tertiary structure, such a β-hairpins or the complete formation of small 
proteins (Tu et al. 2014; Nilsson et al. 2015; Marino et al. 2016). Tu and Deutsch (2009) 
indicate that the lower region of the tunnel is critical for compaction of all six TM helices 
of the Kv1.3 potassium channel. However, their studies show that individual TM segments 
do not fold equivocally or in a sequential manner, whilst making their way through the 
tunnel. Nascent chain compaction within the distal regions of the tunnel has been described 
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to occur in a number of ways; firstly, some TM domains can begin folding upon entry of 
their N-terminus into the lower regions of the tunnel (Tu and Deutsch 2009; Bhushan et al 
2010; Robinson et al 2012). Secondly, a TM domain can reach the exit port of the 
ribosome in an extended conformation before beginning to form secondary structure 
(Houben et al. 2005). Finally, at least one example exists of a TM domain having an 
extended N-terminus, whilst its C-terminus compacts upon reaching the final 20Å of the 
ribosome tunnel (Tu & Deutsch 2010). Our investigation into the folding profile of the first 
TM domain of GPR35, suggested that the nascent chain remains as an extended peptide 
until the point at which the 1
st
 TM domain reaches the exit port of the ribosome. Pegylation 
of the N-terminal TM 1 in F0c, previously shown to fold upon entering the lower regions of 
the ribosome tunnel (Robinson et al 2012), provided us with a control for what would be 
expected if the 1
st
 TM of GPR35 were fold as it moved into the lower tunnel (refer to 
Figure 3.7). A delay in pegylation of ~10aa between F0c and GPR35 intermediates, 
confirmed the first TM of GPR35 exists as an extended peptide as it passes into the lower 
regions of the tunnel. Subsequent experiments cross-linking GPR35 to uL23 suggested the 
1
st
 TM domain remains as an extended peptide as it reaches the ribosome exit (refer to 
Figure 4.3). At this point we suggest one of two scenarios could occur; 1) TM1 of GPR35 
exits the ribosome as an extended peptide, where it interacts with SRP and begins the co-
translational targeting process (Figure 6.1A) or 2) the N-terminus GPR35 begins to 
compact upon arrival at the exit port, possibly forming a helical nascent chain which binds 
to SRP (Figure 6.1 B).  
The two scenarios above, suggest the 1
st
 TM domain of GPR35 could exit the ribosome in 
two contrasting conformations, thus relying on two entirely different mechanisms of 
interacting with SRP. A number of studies have highlighted hydrophobicity and α-helical 
structure as two key features within the nascent chain for enabling an interaction with SRP. 
The first scenario would require SRP to bind an extended nascent chain as it leaves the exit 
tunnel, thus relying solely on intrinsic hydrophobicity within the 1
st
 TM domain. A number 
of biochemical studies cite the importance of hydrophobicity within the nascent chain for 
recognition by SRP (Hessa et al., 2005, 2007; Nilsson et al., 2014). Indeed, the binding 
groove of SRP has been suggested to accommodate hydrophobic stretches of nascent 
chain, which normally correspond to signal sequences and signal anchor domains (Keenan 
et al. 1998). SRP binding at this point in time enables the safe passage of a hydrophobic 
stretch of amino acids from the ribosome to the target membrane, preventing aggregation 
upon exposure to the cytosol. Cross-linking results between GPR35 and Ffh or SRP54 
begin as the marker lysine reaches 45aa from the PTC, suggesting the N-terminus of the 1
st
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TM domain is 40aa from to the PTC (refer to Figures 4.3 and 4.5). Therefore, given the 
results of previous experiments carried out in GPR35 and the dimensions of the exit tunnel, 
it would be expected that ~10aa of TM1 would be out with the tunnel and interacting with 
SRP. However, structural data analysing the interaction between a signal sequence and the 
M domain of SRP suggests 10 extended residues would be unlikely to fit in the 
hydrophobic groove (Janda et al. 2010).  
To date, most structural data suggests that the binding groove of SRP, which interacts 
directly with the nascent chain as it exits the ribosome, is likely to house an α-helical 
peptide of approximately 10aa in length (Keenan et al. 1998; Halic, Blau, et al. 2006; 
Janda et al. 2010; Voorhees & Hegde 2015). Therefore, based on the structure of SRP, 
scenario 2 suggesting a compacted N-terminus in the 1
st
 TM of GPR35 would be more 
favourable. Cross-linking data suggests GPR35 encounters both uL23 and SRP as an 
extended peptide (refer to Figures 4.3 and 4.5); however cross-links remain between the 
nascent chain and both proteins for extended periods of time. This would suggest that the 
nascent chain takes up multiple conformations whilst making its way through the tunnel. 
This model of TM domain folding in the ribosome tunnel is consistent with previous 
experiments by Houben et al (2005), in which the TM domain of the Lep protein reached 
the exit of the ribosome before compacting at the N-terminus. Cryo-EM structures of the 
SRP54 protein interacting with the signal anchor sequence of the yeast dipeptidyl 
aminopeptidase B protein, also showed a compacted N-terminal region interacting with 
SRP54, but no further secondary structure in the remainder of the TM domain (Janda et al. 
2010). This suggests that only a short stretch of amino acids require α-helical structure for 
an interaction with SRP and would agree with this model of GPR35 folding in the 
ribosome tunnel. 
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Figure 6.1: Schematic diagram of two possible scenarios describing the folding profile occurring in the 1st TM domain of GPR35 as it 
makes its way through the ribosome exit tunnel. (A) Scenario 1: suggesting an extended TM1 of GPR35 is capable if interacting with SRP 
(B) Scenario 2: upon reaching the distal regions of the ribosome tunnel, folding at the N-terminus of GPR35 TM1 occurs and an interaction 
with SRP takes place. The position of important r-proteins in the tunnel has been specified. The N-terminus or hydrophilic loop regions of the 
nascent chain are coloured blue, an extended TM1 is a solid red line and a compacted TM1 is represented by a red helix. 
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6.2 Co-translational targeting and TM domain biogenesis in 
GPR35.  
Following on from the investigations into the early folding events within TM1 of GPR35, 
subsequent experiments were carried out to study the co-translational targeting and 
biogenesis of this model GPCR. As with all IMPs, correct targeting and biogenesis is 
essential for the production of a fully functional protein. Assays analysing GPR35-SRP 
interactions were set up both in prokaryotic and eukaryotic systems, enabling us to 
investigate similarities and differences that may arise between the different species of SRP.   
Initially we set out to investigate if GPR35 followed the traditional route of IMP targeting 
to the ER, via the SRP-dependant pathway. Previous studies into the GPCR Opsin have 
indicated an SRP-dependant mechanism of ER targeting (Audigier et al. 1987; Laird & 
High 1997). Cross-linking of GPR35 intermediates with both prokaryotic and eukaryotic 
SRP have confirmed it to can also be targeted in an SRP-dependant manner. Indeed results 
in the prokaryotic system confirm previous studies (Houben et al. 2005; Bornemann et al. 
2008; Robinson et al. 2012), suggesting nascent chains interacting with proteins of the 
ribosome tunnel are essential for the recruitment of SRP. In these assays we show that the 
TM domain of GPR35 is in the vicinity of uL23, before a subsequent interaction with SRP 
(Ffh) occurs (refer to Figure 4.3). This is consistent with previous studies suggesting that 
uL23 plays a role in recognition of the nascent chain and acts as a docking point for SRP. 
A prolonged interaction with uL23 may suggest, as earlier discussed, a conformational 
change within the nascent chain. An α-helical nascent chain has often been suggested as a 
prerequisite for SRP binding and previous studies have indicated that uL23 may play a key 
role generating a compacted peptide (Robinson et al 2012). An overlap in cross-linking of 
the nascent chain from uL23 to SRP highlights the sequential and co-ordinated manner in 
which the peptide is recognised by the ribosome before its capture by SRP.  
The efficient capture of the nascent chain by SRP is required to protect hydrophobically 
sensitive segments of the nascent chain during the targeting process. For SRP to carry out 
this role effectively, it must be capable of distinguishing between regions such as 
hydrophilic loops and TM domains within the nascent chain as they leave the ribosome. 
Cross-linking of both prokaryotic and eukaryotic SRP to GRP35 intermediates confirm 
recognition of the 1
st
 TM domain as the signal anchor sequence. Similarities in the cross-
linking patterns of SRP to GPR35 in both systems suggest a conserved mechanism for the 
recognition and binding of the nascent chain (refer to Figures 4.3 and 4.5). Previous studies 
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investigating the interaction between SRP and signal sequences cited the importance of 
hydrophobicity within the nascent chain for its recognition by SRP (Nilsson et al. 2014).  
As SRP-dependant targeting and translocation is highly reliant on a hydrophobic stretch of 
residues within the signal sequence/signal anchor of IMPs, alterations to the 
hydrophobicity of the 1
st
 TM domain of GPR35 was carried out. Previous studies 
investigating the effect of lowering the hydrophobicity of h-region within a signal 
sequence found both SRP binding and nascent chain translocation to be reduced (Nilsson 
et al. 2014). By lowering the hydrophobicity of GPR35 TM1, as described in chapter 4, to 
the point at which it was no longer recognisable as a TM domain (Δ4E), resulted in the 
complete loss of cross-linking to both Ffh and SRP54, as well as a loss in translocated 
product thus showing a similar trend to the studies in signal sequences (Nilsson et al. 
2014). The lack of hydrophobicity within the nascent chain would most likely prevent SRP 
from recognising it as potential cargo, therefore successful binding and targeting is 
unlikely to occur (refer to Figures 4.6 and 4.8).  
Reducing the hydrophobicity at either the N-terminus (ΔNT) or C-terminus (ΔCT) of the 
1
st
 TM domain had substantially different results in binding efficiencies with Ffh and 
SRP54. In bacterial SRP, the efficiency of cross-linking had decreased to below 50% in 
both cases in comparison to the WT GPR35. However, reducing the hydrophobicity in the 
N-terminus of GPR35 had a far more dramatic effect on cross-linking to SRP54 and 
therefore the subsequent translocation of the N-terminus across the ER membrane. The 
cross-linking efficiency in the ΔNT intermediate was reduced to ~25% of that of the WT, 
were as the ΔCT intermediate was only reduced to ~80% (refer to Figure 4.8). These 
differences in SRP cross-linking efficiencies between species could suggest additional 
layers of complexity in the recognition and binding process of SRP. Indeed structurally, 
eukaryotic SRP is known to be a far more complex molecule than bacterial Ffh (Pool 
2005), therefore it may contain an added degree of complexity with regards to signal 
sequence recognition. Equally, the role of the ribosome in recognising a signal sequence 
for SRP-dependant targeting should not be forgotten. A large number of studies have 
suggested the importance of cross-talk between the ribosome and SRP as a signal sequence 
makes its way through the tunnel (Woolhead et al. 2004; Houben et al. 2005; Robinson et 
al. 2012), therefore it is plausible that a loss in hydrophobicity could impact upon the 
affinity with which SRP binds to the ribosome, hence reducing the efficiency at which SRP 
captures the nascent chain.  Alternatively, the reduced hydrophobicity within the N-
terminus of the nascent chain may encourage the binding of different eukaryotic protein 
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biogenesis factors that are not available in prokaryotes. Recent research has suggested that 
the exit site in both the prokaryotic and eukaryotic ribosomes becomes increasingly 
crowded as the nascent chain emerges; therefore it may be possible another targeting factor 
or chaperone competes to interact with the less hydrophobic ΔNT intermediate (Kramer et 
al 2009 rev).  Although a number of the above reasons may be possible, it still remains 
unclear as to what properties, along with hydrophobicity drive the SRP interaction and how 
this is regulated in the absence of critical driving force such as hydrophobicity.  
Following a successful co-translational targeting process, insertion and integration of IMPs 
take place at the ER membrane, as shown in Chapter 5. In GPCRs, Opsin has been the 
most frequently studied protein to investigate this process, with a model for its integration 
being produced in the last 10 years (Ismail 2006; Ismail et al. 2008). However, the 
biogenesis of polytopic membrane proteins is complex, with individual TM domains being 
required to complete the formation of their secondary structure during insertion, before 
being partitioned into the ER membrane. Previous studies have been capable of detecting 
the folding of peptides within the Sec61 translocon, by using N-linked glycosylation as a 
marker (Whitley et al. 1996). In the 1
st
 TM of GPR35, the exact timing of when the full 
formation of secondary structure takes place has been uncertain. Leading on from previous 
studies regarding N-terminal compaction of GPR35, it is most likely that the 1
st
 TM 
domain enters the translocon in a partially folded state. However, as the N-terminus of 
GPR35 enters the translocon, which is known to favour compacted or α-helical peptides 
(Hessa et al. 2005), it is likely that the nascent chain becomes nucleated and forms 
secondary structure throughout the entire 1
st
 TM domain (refer to Figure 5.5). 
Glycosylation results suggest TM1 of GPR35 is compacted in the translocon, with the 
timing of the glycosylation event agreeing with the model described by Whitley et al 
(1996). This is the first point at which the full formation of a compacted TM1 can be 
detected, most likely preparing the nascent TM for integration into the lipid bilayer.  
The final stage in the biogenesis of a polytopic membrane protein is the integration 
process. Various modes of integration have been described in a number of IMPs and it is 
clear that much variability exists between individual TM domains. Previous models have 
shown that TM domains of polytopic membrane proteins can be co-translationally 
integrated sequentially, in pairs or in bulk (McCormick et al 2005; Ismail et al 2008; Hou 
et al 2010). As shown in chapter 5, site-specific chemical cross-linking assays detected a 
possible interaction between TM1 and TM2 of GPR35, and the Sec61α subunit of the 
translocon channel (refer to Figure 5.6 B).  These assays determined that GPR35 TM1 
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leaves the translocon channel, upon the insertion of the following TM domain, in what 
appears to be a sequential mode of integration. This correlates with results previously 
described for another GPCR, opsin. In this set of experiments Ismail et al (2006) used a 
similar cross-linking technique to suggest TM1-3 in Opsin, integrates into the lipid bilayer 
of the ER sequentially. Further experiments by the same group (2008) produced a complete 
model for the integration of Opsin protein, suggesting TM domains 5-7 integrate in bulk 
(Ismail et al. 2008). Time restrictions prevented further studies investigating the integration 
of subsequent GPR35 TM domains; however initial results suggest a similar pattern of 
integration to opsin could be possible. This would be increasingly interesting as it may 
suggest model of integration followed specifically by GPCRs. 
 
6.3 Conclusion 
The use of GPR35 as a model protein to study the early folding events and biogenesis of a 
GPCR highlights the complexity of processes such IMPs go through to take up their 
mature form. The results I have obtained have enabled me to produce what I believe could 
be a working model for folding and biogenesis of the GPR35 N-terminus (Figure 6.2). The 
N-terminus containing the first TM domain displays an extended structure until it reaches 
the distal regions of the ribosome tunnel. Upon interaction with UL23 and SRP a 
compaction of the nascent chain seems to occur. SRP binds to the 1
st
 TM domain as it 
emerges from the ribosome and targets of GPR35 to the Sec61 translocon. GPR35 is 
successfully inserted into the ER translocon, with TM1 taking up a compacted (most likely 
helical) structure in preparation for integration into the lipid bilayer. Finally, partitioning of 
GPR35 TM1 into the lipid bilayer occurs due to the synthesis and arrival of TM2 into the 
translocon, producing a sequential mode of integration at the N-terminus of GPR3
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Figure 6.2: Schematic diagram of our suggested model of biogenesis at the N-terminus of GPR35. (1) As the nascent chain is synthesised it elongates 
through the tunnel in an extended conformation. (2) As the extended N-terminus reaches the exit point of the ribosome, an interaction with uL23 and SRP 
drives a conformational change. (3) Interaction between the compacted N-terminus of the GPR35 TM1 and SRP drives a co-translation targeting event. (4) 
The GPR35 TM1 is inserted into the Sec61 translocon, where it takes up its full α-helical conformation. (5) Synthesis and insertion of TM2 into Sec61 
drives the lateral partitioning of TM1 from the translocon into the lipid bilayer. 
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6.4 Future directions 
GPCRs are a major source of interest throughout scientific research, particularly in 
the field of pharmaceuticals, with the diversity of their function, despite the 
consistency of their structure, a major factor.  The work in this thesis has attempted to 
increase the understanding of the early folding, targeting and biogenesis events in 
GPCRs, that directly impacts on the formation of their mature 7 TM domain structure. 
Following on from the research presented in this thesis, a number of directions could 
be taken to further investigate the early biogenetic processes of a GPCR and in 
particular GPR35. 
Firstly, there is still much work to be done in investigating the folding profiles of 
individual GPR35 TM domains. Although we have speculated that TM1 may begin to 
fold in the distal regions of the ribosome and most certainly completes folding upon 
entry into the Sec61 translocon, the precise timings of such an event cannot be given. 
With many structural or bio-physical techniques available, such as crystallography, 
cryo-EM and FRET, the specific timing of TM domain folding could be investigated, 
as well as the specific interactions taking place between the nascent chain and the 
ribosome tunnel. Previously, high-resolution structures within the ribosome tunnel 
have been visualised by crystallography and cryo-EM (Bhushan et al. 2010; O. B. 
Nilsson et al. 2015), however none have been of the scale of an integral TM domain, 
which may be a considerable problem in itself. Obtaining clear structural data during 
the early stages of folding within the WT GPR35 could potentially allow us to 
investigate known mutations within TM domains that may generate disease 
phenotypes. This would enable us to discover how big a role the early folding events 
have in generating a mature GPCR structure. 
Secondly, this thesis aimed to investigate the initial integration of the N-terminus of 
GPR35 from the translocon into the ER membrane. Previous studies investigating the 
integration of a number of IMPs, have suggested various models for the integration of 
TM domains (Laird & High 1997; Meacock et al. 2002; Ismail et al. 2008). We have 
suggested that N-terminus (TM1 followed by TM2) leaves the Sec61 translocon in 
sequential fashion as it is integrated into the ER membrane. The 1
st
 TM domain relies 
of the insertion of TM2 in the translocon to aid its partitioning into the lipid bilayer. 
However, integration into the ER membrane has been shown to differ between TM 
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domains (Ismail et al. 2008); therefore it is feasible that the remaining TM domains 
do not follow the mode of integration seen at the N-terminus of GPR35. Producing a 
more thorough study on TM integration of GPR35 would enable a comparison with 
other integration models available, hence possibly moving a step closer to providing a 
known mode of integration for GPCRs as a family.  
Finally, the investigation into the biogenesis of a mature GPR35 could be taken 
further by studying the effect of post-translational modifications whilst in the ER 
membrane. It has been previously shown that modifications such as glycosylation and 
disulphide bonds play a vital role in generating the structure of mature IMPS. In 
GPCRs, a number of studies highlighted the importance of the role played by two 
conserved cysteines in the extracellular loops (ECL) 1 and 2 (Hwa et al. 2001; Peeters 
et al. 2012). Investigations have shown that an impaired disulphide bonds between the 
two cysteines, impacts on the ability of mature receptors to generate their correct 
conformation in the ER and therefore leads to topological defects, poor trafficking to 
the plasma membrane and impaired ligand binding. Further experiments investigating 
the role of these two conserved mutations in GPR35 (work not shown in this thesis) 
have confirmed the importance of the conserved disulphide bond between ECL 1 and 
2. In vivo studies showed a mutagenesis of the conserved Cys 89 and 162 to Ala, 
generated a GPR35 that could no longer be trafficked to the ER membrane. This 
could lead on to future work investigating if biogenesis at the ER membrane occurs, 
or if the aberration in the mature GPR35 generates an ER trapped substrate. 
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Appendix 
Appendix 1: Table of constructs 
Constructs for the generation of intermediates for use in the S30 in vitro 
transcription/translation system are in the pTrc99a plasmid. 
Constructs for the generation of intermediates for use in the RRL translation system are in 
the pcDNA3.1 plasmid. 
 
Appendix 1.1: Chapter 3 constructs 
 
Construct 
name 
Amino 
acid 
change 
Original nucleotide 
sequence 
Mutated nucleotide 
sequence 
GPR35 C15 C8A CTGTGTCCA CTGGCTCCA 
 A15C ACCGCTCCC ACCTGTCCC 
    
GPR35Δ4I L27I TACTTGGGC TACATTGGC 
 L31I CTGCTGGTG CTGATCGTG 
 
L36I CTGCTGCTC CTGATCCTC 
 
L40E AGCCTGGCG AGCATCGCG 
 
 
 
Table A1.1. GPR35 construct mutations for pegylation assays. 
179 
 
 
 
Appendix 1.2: Chapter 4 constructs 
 
Construct 
name 
Amino acid 
change 
Original nucleotide 
sequence 
Mutated nucleotide 
sequence 
BO SRP 
R20K GGACGTCCG GGAAAACCG 
 
K43R GTTAAAGGT GTTAGAGGT 
 
K59R GCGAAAAAA GCGAGAAAA 
 
 
 
 
 
 
 
 
Construct 
name 
Amino acid 
change 
Original nucleotide 
sequence 
Mutated nucleotide 
sequence 
BO C15 A15C CAGGCCAGA CAGTGCAGA 
Foc C5 A5C CTGAATATG CTGTGTATG 
Table A1.3. BO construct mutations for L23 and SRP cross-linking assays. 
Table A1.2. BO and F0c construct mutations for pegylation assays. 
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Appendix 1.2: Chapter 5 constructs 
 
 
 
  
Construct 
name 
Amino acid 
change 
Original nucleotide 
sequence 
Mutated nucleotide 
sequence 
GPR35Δ4E L27E TACTTGGGC TACGAGGGC 
 
L31E CTGCTGGTG CTGGAGGTG 
 
L36E CTGCTGCTC CTGGAGCTC 
 
L40E AGCCTGGCG AGCGAGGCG 
Construct 
name 
Amino acid 
change 
Original nucleotide 
sequence 
Mutated nucleotide 
sequence 
N-linked 
Glycosylation  
NS
7
T AACACC AACTCCACC 
Cysteine BMH 
cross-linking 
L37C  (TM1 
only) 
CTGCTCAAC CTGTGCAAC 
 
C46F, C47G TTCTGCTGCCGC TTCTTCGGCCGC 
 
R56C ACCCGCATC ACCTGCATC 
Table A1.5. GPR35 construct mutations for N-linked glycosylation assays. 
Table A1.4.  GPR35 ΔNT, ΔCT and Δ4E construct mutations for L23 and SRP 
cross-linking assays. 
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Appendix 2: Primers used for the generation of linear DNA 
intermediates. 
Linear DNA for use in S30 in vitro transcription/translation system used the pTrc99a 
forward primer: 5‟ CTG AAA TGA GCT GTT GAC AAT TAA TCA TCC GG‟3 
Linear DNA for the generation of mRNA intermediates for use in RRL in vitro translation 
system used the pcDNA 3.1 forward primer: 5‟ GCA GAG CTC TCT GGC TAA CTA 
GAG AAC CCA C „3 
 
Appendix 2.1: Chapter 3  
 
Experiment Primer 
Name 
Primer Sequence (5'--->3') 
Pegylation GPR35 25aa rev CAGGCTGTTGAGCAGCAGG 
 
GPR35 30aa  rev GAACACCCAGAGCGCCAGGC 
 
GPR35 35aa  rev CACTGCTGCATGCGGCAGC 
 
GPR35 40aa  rev  ATGCGGGTCTCCGTCCAC 
 
GPR35 45aa  rev  AGGTTGGTCATGTAGATGC 
 
GPR35 50aa  rev AGGTCGGCCACCGCCAGGTTGG 
 
  
Table A2.1. Primers used in to generate GPR35 intermediates for pegylation assays. 
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Experiment Primer Name Primer Sequence (5'--->3') 
Pegylation F0c 35aa rev CGCTGCGCCTTCCAGGAATTTAC 
 
F0c 45aa  rev GCAGAGGAATCAGATCAG 
 
F0c 50aa  rev AGAACTGAGTACGCAGCAG 
 
F0c 55aa  rev  GACCCATAACGATAAAGAAC 
 
F0c 70aa  rev  GAACATCACGTACAGACCC 
 
 
 
Experiment Primer Name Primer Sequence (5'--->3') 
Pegylation BO 25aa rev CATCATGAAGTACAGGGGTGC  
 
BO 30aa  rev CATCATCATACCTTTAACCAG 
 
BO 35aa  rev CATCATCGGATCCGAAACACC 
 
BO 40aa  rev  CATCATGAATTTTTTCGCATC 
 
BO 45aa  rev  CATCATGGTGGTGATAGCGTA G 
 
BO 50aa  rev CATCATGATAGCCGGCACCAC 
Table A2.2. Primers used in to generate BO intermediates for pegylation assays. 
Table A2.3. Primers used in to generate F0c intermediates for pegylation assays. 
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Appendix 2.2: Chapter 4  
 
Experiment Primer Name Primer Sequence (5'--->3') 
SRP cross-linking GPR35 25aa rev CATCATCACCCAGAGCGC 
 
GPR35 35aa rev CATCATCTCCGTCCACTG 
 
GPR35 45aa rev CATCATCACCGCCAGGTTGG 
 
GPR35 55aa rev CATCATGGGCAAGGTGCAC 
 
GPR35 65aa rev CATCATTGAGGTGTCTCG 
 
 
Experiment Primer Name Primer Sequence (5'--->3') 
SRP cross-linking BO 25aa rev CATCATACCTCTAACCAG  
 
BO 35aa rev CATCATTTTCTCGCATC  
 
BO 45aa rev CATCATAGCCGGGCACCAG 
 
BO 55aa rev CATCATCAGCATAGACAG    
 
BO 65aa rev CATCATACCGAACGGTAC  
 
 
 
Table A2.4. Primers used in to generate GPR35 intermediates for SRP cross-
linking assays. 
Table A2.5. Primers used in to generate BO intermediates for SRP cross-linking 
assays. 
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Appendix 2.3: Chapter 5 
 
 
 
 
 
 
Experiment Primer 
Name 
Primer Sequence (5'--->3') 
PK Digestion Full-length 
GPR35 rev 
TTAGGCGAGGGTCACGCAC 
Glycosylation GPR35 182aa rev AACAGCACCCGGCACAATTCATACACTGAT 
ACTAGATCTGATAACAGCACCTTATGTCAA 
Experiment Primer Name Primer Sequence (5'--->3') 
N-terminal 
Glycosylation 
65aa NT Gly Rev CGACAGCAGGCAGAGGTC 
 
70aa NT Gly Rev GAAGGGCAAGGTGCACAG 
 
75aa NT Gly Rev CAGGGAGTGCAGCACGAA 
 
80aa NT Gly Rev GTCTGAGGTGTCTCGCAG 
 
90aa NT Gly Rev GATGCCCTGGGAGAGCTG 
 
100aa NT Gly Rev GCTGATGCTCATGTACC 
Table A2.6. Primers used in to generate GPR35 intermediates for PK digestion 
and C-terminal N-linked glycosylation assays. 
Table A2.7. Primers used in to generate GPR35 intermediates for N-terminal  
N-linked glycosylation assays. 
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Experiment Primer Name Primer Sequence (5'--->3') 
Integration Cysteine CL 55aa  rev CATCATCGTCCACTGCTGCAT 
 
Cysteine CL 75aa (TM1) 
rev  
CATCATCAAGGTGCCCAGCAG 
 
Cysteine CL 75aa (TM2) 
rev 
CATCATCAAGGTGCACAGCAG 
 
Cysteine CL 95aa rev  CATCATTGGGAGAGCTGGCAC 
 
Cysteine CL 115aa rev CATCATGTCCACGGCGATGGC 
 
Cysteine CL 135aa rev CATCATAGCCTGCCTGGG 
 
Cysteine CL 155aa rev CATCATCCCCAGGAGCCAGCG 
Table A2.8. Primers used in to generate GPR35 intermediates for site 
specific cysteine cross-linking in TM1 and TM2 of GPR35 
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Appendix 3: Gene Sequences 
GPR35  
Translated Sequence 
MNGTYNTCGSSDLTWPPAIKLGFYAYLGVLLVLGLLLNSLALWVFCCRMQQWTE
TRIYMTNLAVADLCLLCTLPFVLHSLRDTSDTPLCQLSQGIYLTNRYMSISLVTAIA
VDRYVAVRHPLRARGLRSPRQAAAVCAVLWVLVIGSLVARWLLGIQEGGFCFRS
TRHNFNSMAFPLLGFYLPLAVVVFCSLKVVTALAQRPPTDVGQAEATRKAARMV
WANLLVFVVCFLPLHVGLTVRLAVGWNACALLETIRRALYITSKLSDANCCLDAI
CYYYMAKEFQEASALAVAPSAKAHKSQDSLCVTLA 
 
ATGAATGGCACCTACAACACCGCTGGCTCCAGCGACCTCACCTGTCCCCCAGCGATCA
AGCTGGGCTTCTACGCCTACTTGGGCGTCCTGCTGGTGCTAGGCCTGCTGCTCAACAGC
CTGGCGCTCTGGGTGTTCTGCTGCCGCATGCAGCAGTGGACGGAGACCCGCATCTACA
TGACCAACCTGGCGGTGGCCGACCTCTGCCTGCTGTGCACCTTGCCCTTCGTGCTGCAC
TCCCTGCGAGACACCTCAGACACGCCGCTGTGCCAGCTCTCCCAGGGCATCTACCTGA
CCAACAGGTACATGAGCATCAGCCTGGTCACGGCCATCGCCGTGGACCGCTATGTGGC
CGTGCGGCACCCGCTGCGTGCCCGCGGGCTGCGGTCCCCCAGGCAGGCTGCGGCCGTG
TGCGCGGTCCTCTGGGTGCTGGTCATCGGCTCCCTGGTGGCTCGCTGGCTCCTGGGGAT
TCAGGAGGGCGGCTTCTGCTTCAGGAGCACCCGGCACAATTTCAACTCCATGCGGTTC
CCGCTGCTGGGATTCTACCTGCCCCTGGCCGTGGTGGTCTTCTGCTCCCTGAAGGTGGT
GACTGCCCTGGCCCAGAGGCCACCCACCGACGTGGGGCAGGCAGAGGCCACCCGCAA
GGCTGCCCGCATGGTCTGGGCCAACCTCCTGGTGTTCGTGGTCTGCTTCCTGCCCCTGC
ACGTGGGGCTGACAGTGCGCCTCGCAGTGGGCTGGAACGCCTGTGCCCTCCTGGAGAC
GATCCGTCGCGCCCTGTACATAACCAGCAAGCTCTCAGATGCCAACTGCTGCCTGGAC
GCCATCTGCTACTACTACATGGCCAAGGAGTTCCAGGAGGCGTCTGCACTGGCCGTGG
CTCCCCGTGCTAAGGCCCACAAAAGCCAGGACTCTCTGTGCGTGACCCTCGCCTAA 
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Bacterioopsin 
Translated Sequence 
MLELLPTAVEGVSQAQITGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKK
FYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLD
LALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYV
LFFGFTSKAESMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLL
FMVLDVSAKVGFGLILLRSRAIFGEAEAPEPSAGDGAAATSD 
 
ATGTTGGAGTTATTGCCAACAGCAGTGGAGGGGGTATCGCAGTGCCAGATCACCGGAC
GTCCGGAATGGATCTGGCTAGCTCTGGGCACCGCTCTGATGGGTCTGGGCACCCTGTA
CTTCCTGGTTAAAGGTATGGGTGTTTCGGATCCGGATGCGAAAAAATTCTACGCTATC
ACCACCCTGGTGCCGGCTATCGCATTCACCATGTACCTGTCTATGCTGCTGGGTTACGG
TCTGACCATGGTACCGTTCGGTGGTGAACAGAACCCGATCTACTGGGCCCGTTACGCT
GACTGGCTGTTCACCACCCCGCTGCTGCTGCTAGATCTGGCTCTGCTGGTTGACGCTGA
TCAGGGCACCATCCTGGCTCTGGTTGGCGCCGACGGTATCATGATCGGCACCGGCCTG
GTTGGCGCGCTGACCAAGGTTTACTCTTACCGTTTCGTTTGGTGGGCTATCTCTACTGC
AGGCATGCAAGCTTGGCTGTTTTGGCGGATGAGAGAAGATTTTCAGCCTGATACAGAT
TAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGC
GGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGCCGATGGT
AGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAA
GGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCC
TGAGTAGGACAAATCCGCCGGGAGCGGATTTGAACGTTGCGAAGCAACG 
 
F0c 
Translated Sequence 
MENLNMDLLYMAAAVMMGLAAIGAAIGIGILGGKFLEGAARQPDLIPLLRTQFFI
VMGLV DAIPMIAVGL GLYVMFAVA 
ATGGAAAACCTGAATATGGATCTGCTGTACATGGCTGCCGCTGTGATGATGGGTCTGG
CGGCAATCGGTGCTGCGATCGGTATCGGCATCCTCGGGGGTAAATTCCTGGAAGGCGC
AGCGCGTCAACCTGATCTGATTCCTCTGCTGCGTACTCAGTTCTTTATCGTTATGGGTC
TGGTGGATGCTATCCCGATGATCGCTGTAGGTCTGGGTCTGTACGTGATGTTCGCTGTC
GCGTGA 
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Appendix 4: Western blot analysis of antibodies used in 
chapter 4. 
 
 
Antibodies used to show the specific interaction of the GPR35 intermediates and 
components of the SRP targeting pathway in immunoprecipitation assays in chapter 4, can 
be shown to be specific to the proteins they are raised against using western blot analysis. 
Samples of S-30, WG and RRL extract were resolved on an SDS-PAGE gel, transferred to 
nitriocellulose membrane, before marking the target protein using a primary antibody 
(antibody raised to uL23, Ffh or SRP54) and a secondary antibody (antibody raised to 
HRP) to visualize by ECL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Western blot analysis of components of the SRP mediated pathway in the S-
30, WG and RRL extract. The proteins uL23(<), Ffh (*) and SRP54 (+) have been 
detected using specific antibodies raised to the respective proteins. 
 
 
 
 
 
 
 
 
189 
 
Bibliography 
 
Akopian, D., Shen, K., Zhang, X., & Shan, S. (2013). Signal recognition particle: an essential 
protein-targeting machine. Annual Review of Biochemistry, 82, 693–721.  
Alder, N. N., & Johnson, A. E. (2004). Cotranslational membrane protein biogenesis at the 
endoplasmic reticulum. Journal of Biological Chemistry, 279(22), 22787–22790.  
Alder, N. N., Shen, Y., Brodsky, J. L., Hendershot, L. M., & Johnson, A. E. (2005). The molecular 
mechanisms underlying BiP-mediated gating of the Sec61 translocon of the endoplasmic 
reticulum. Journal of Cell Biology, 168(3), 389–399.  
Alkalaeva, E. Z., Pisarev, A. V., Frolova, L. Y., Kisselev, L. L., & Pestova, T. V. (2006). In Vitro 
Reconstitution of Eukaryotic Translation Reveals Cooperativity between Release Factors 
eRF1 and eRF3. Cell, 125(6), 1125–1136.  
Anger, A. M., Armache, J. P., Berninghausen, O., Habeck, M., Subklewe, M., Wilson, D. N., & 
Beckmann, R. (2013). Structures of the human and Drosophila 80S ribosome. Nature, 
497(7447),  
Ataide, S. F., Schmitz, N., Shen, K., Ke, A., Shan, S., Doudna, J. a, & Ban, N. (2011). The crystal 
structure of the signal recognition particle in complex with its receptor. Science, 331(6019), 
881– 
Audigier, Y., Friedlander, M., & Blobel, G. (1987). Multiple topogenic sequences in bovine opsin. 
Proceedings of the National Academy of Sciences of the United States of America, 84(16), 
5783–5787. 
Bacher, G., Lütcke, H., Jungnickel, B., Rapoport, T. a, & Dobberstein, B. (1996). Regulation by the 
ribosome of the GTPase of the signal-recognition particle during protein targeting. Nature 
381(6579) 248-251.  
Ban, N. (2000). The Complete Atomic Structure of the Large Ribosomal Subunit at 2.4 A 
Resolution. Science, 289(5481), 905–920. 
Ban, N., Beckmann, R., Cate, J. H. D., Dinman, J. D., Dragon, F., Ellis, S. R., Lafontaine, D. L. J., 
Lindahl, L., Liljas, A., Lipton, J. M., McAlear, M. A., Moore, P. B., Noller, H. F., 
Ortega, J., Panse, V. G., Ramakrishnan, V., Steitz, T, A., Tchorzewski, M., 
Tollervey, D., Warren, A. J., Williamson, J. R., Wilson, D., Yonath, A., & Yusupov, 
M. (2014). A new system for naming ribosomal proteins. Current Opinion in Structural 
Biology, 24(1), 165–169.  
Bañó-Polo, M., Baldin, F., Tamborero, S., Marti-Renom, M. A., & Mingarro, I. (2011). N-
Glycosylation efficiency is determined by the distance to the C-terminus and the amino acid 
preceding an Asn-Ser-Thr sequon. Protein Science, 20(1), 179–186.  
Batey, R. T., Rambo, R. P., Lucast, L., Rha, B., & Doudna, J. A. (2000). Crystal Structure of the 
Ribonucleoprotein Core of the Signal Recognition Particle. Science, 287(5456), 1232–1239.  
Becker, T., Bhushan, S., Jarasch, A., Armache, J.-P., Funes, S., Jossinet, F., Gumbart, J., Mielke, 
T., Berninghausen, O., Schulten, K.,  Westhof, E., Gilmore, R., Mandon, E. C., & 
Beckmann, R. (2009). Structure of monomeric yeast and mammalian Sec61 complexes 
interacting with the translating ribosome. Science, 326(5958), 1369–1373. 
Beltzer, J. P., Fiedler, K., Fuhrer, C., Geffen, I., Handschin, C., Wessels, H. P., & Spiess, M. 
(1991). Charged residues are major determinants of the transmembrane orientation of a 
signal-anchor sequence. Journal of Biological Chemistry, 266(2), 973–978. 
Ben-Shem, A., Jenner, L., Yusupova, G., & Yusupov, M. (2010). Crystal Structure of the 
Eukaryotic Ribosome. Science, 330(6008), 1203–1209.  
Berg, B. Van Den, Clemons, W. M., Collinson, I., Modis, Y., Hartmann, E., Harrison, S. C. & 
Rapoport T. A. (2004). X-ray structure of a protein-conducting channel. Nature, 427(6969), 
36–44.  
Beringer, M., Bruell, C., Xiong, L., Pfister, P., Bieling, P., Katunin, V. I., Bottager, E. C., & 
Rodnina, M. V. (2005). Essential mechanisms in the catalysis of peptide bond formation on 
the ribosome. Journal of Biological Chemistry, 280(43), 36065–36072. 
Berndt, U., Oellerer, S., Zhang, Y., Johnson, A. E., & Rospert, S. (2009). A signal-anchor sequence 
stimulates signal recognition particle binding to ribosomes from inside the exit tunnel. 
Proceedings of the National Academy of Sciences of the United States of America, 106(5), 
1398–1403.  
 
190 
 
Bhushan, S., Gartmann, M., Halic, M., Armache, J.-P., Jarasch, A., Mielke, T., Berninghausen, O., 
Wilson, D., & Beckmann, R. (2010). alpha-Helical nascent polypeptide chains visualized 
within distinct regions of the ribosomal exit tunnel. Nature Structural & Molecular Biology, 
17(3), 313–317.  
Bibi, E. (2011). Early targeting events during membrane protein biogenesis in Escherichia coli. 
Biochimica et Biophysica Acta - Biomembranes, 1808(3), 841–850.  
Blaber, M., Zhang, X. J., Lindstrom, J. D., Pepiot, S. D., Baase, W. A, & Matthews, B. W. (1994). 
Determination of alpha-helix propensity within the context of a folded protein. Sites 44 and 
131 in bacteriophage T4 lysozyme. Journal of Molecular Biology 235 (2) 600-624 
Blanchard, S. C., Kim, H. D., Gonzalez, R. L., Puglisi, J. D., & Chu, S. (2004). tRNA dynamics on 
the ribosome during translation. Proceedings of the National Academy of Sciences of the 
United States of America, 101(35), 12893–12898.  
Blau, M., Mullapudi, S., Becker, T., Dudek, J., Zimmermann, R., Penczek, P. A, & Beckmann, R. 
(2005). ERj1p uses a universal ribosomal adaptor site to coordinate the 80S ribosome at the 
membrane. Nature Structural & Molecular Biology, 12(11), 1015–6. 
Blobel, G. (1980). Intracellular protein topogenesis. Proceedings of the National Academy of 
Sciences of the United States of America, 77(3), 1496–500.  
Booth, P. J., & High, S. (2004). Polytopic membrane protein folding and assembly in vitro and in 
vivo. Molecular Membrane Biology, 21(3), 163–170.  
Bornemann, T., Jöckel, J., Rodnina, M. V, & Wintermeyer, W. (2008). Signal sequence-
independent membrane targeting of ribosomes containing short nascent peptides within the 
exit tunnel. Nature Structural & Molecular Biology, 15(5), 494–499. 
Bousset, L., Mary, C., Brooks, M. a, Bousset, L. U. C., Scherrer, A., Strub, K., & Cusack, S. 
(2014). Crystal structure of a signal recognition particle Alu domain in the elongation arrest 
conformation. Rna, 20, 1–8.  
Braakman, I., & Bulleid, N. J. (2011). Protein folding and modification in the Mammalian 
endoplasmic reticulum. Annual Review of Biochemistry, 80, 71–99. 
Bradshaw, N., Neher, S. B., Booth, D. S., & Walter, P. (2009). Signal sequences activate the 
catalytic switch of SRP RNA. Science, 323(5910), 127–130.  
Breiman, A., Fieulaine, S., Meinnel, T., & Giglione, C. (2015). The intriguing realm of protein 
biogenesis: Facing the green co-translational protein maturation networks. Biochimica et 
Biophysica Acta, 1864(5), 531–550.  
Burda, P., & Aebi, M. (1999). The dolichol pathway of N-linked glycosylation. Biochimica et 
Biophysica Acta - General Subjects, 1426(2), 239–257. 
Buskiewicz, I. A., Jöckel, J., Rodnina, M. V, & Wintermeyer, W. (2009). Conformation of the 
signal recognition particle in ribosomal targeting complexes. RNA 15(1) 44-54.  
Calloni, G., Chen, T., Schermann, S. M., Chang, H. C., Genevaux, P., Agostini, F., Tartaglia, G. 
G., Hayer-Hartl, M., & Hartl, F. U. (2012). DnaK functions as a central hub in the E. coli 
chaperone network. Cell Reports, 1(3), 251–264.  
Cannon, K. S., Or, E., Clemons, W. M., Shibata, Y., & Rapoport, T. A. (2005). Disulfide bridge 
formation between SecY and a translocating polypeptide localizes the translocation pore to 
the center of SecY. Journal of Cell Biology, 169(2), 219–225.  
Clemons  Jr., W. M., Brodersen, D. E., McCutcheon, J. P., May, J. L., Carter, A. P., Morgan-
Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2001). Crystal structure of the 30 S 
ribosomal subunit from Thermus thermophilus: purification, crystallization and structure 
determination. J Mol Biol, 310(4), 827–843.  
Clérico, E. M., Szymanska, A., & Gierasch, L. M. (2009). Exploring the interactions between 
signal sequences and E. coli SRP by two distinct and complementary crosslinking methods. 
Biopolymers, 92(3), 201–211. 
Connell, S. R., Takemoto, C., Wilson, D. N., Wang, H., Murayama, K., Terada, T., Shirouzu, M.,  
Rost, M.,  Schuler, M., Giesebrecht, J., Dabrowski, M., Mielke, T., Fucini, P., 
Yokoyama, S., & Spahn, C. M. T. (2007). Structural Basis for Interaction of the Ribosome 
with the Switch Regions of GTP-Bound Elongation Factors. Molecular Cell, 25(5), 751–764.  
Conti, B. J., Devaraneni, P. K., Yang, Z., David, L. L., & Skach, W. R. (2015). Cotranslational 
Stabilization of Sec62/63 within the ER Sec61 Translocon Is Controlled by Distinct 
Substrate-Driven Translocation Events. Molecular Cell, 58(2), 269–283.  
 
 
191 
 
Conti, B. J., Elferich, J., Yang, Z., Shinde, U., & Skach, W. R. (2014). Cotranslational folding 
inhibits translocation from within the ribosome-Sec61 translocon complex. Nature Structural 
& Molecular Biology, 21(3), 228–35. 
Cornish, P. V., Ermolenko, D. N., Noller, H. F., & Ha, T. (2008). Spontaneous intersubunit rotation 
in single ribosomes. Molecular Cell, 30(5), 578–588.  
Cross, B. C. S., & High, S. (2009). Dissecting the physiological role of selective transmembrane-
segment retention at the ER translocon. Journal of Cell Science, 122(11), 1768–1777.  
Crowley, K. S., Liao, S., Worrell, V. E., Reinhart, G. D., & Johnson, A. E. (1994). Secretory 
proteins move through the endoplasmic reticulum membrane via an aqueous, gated pore. Cell, 
78(3), 461–471.  
Cruz-Vera, L. R., Sachs, M. S., Squires, C. L., & Yanofsky, C. (2011). Nascent polypeptide 
sequences that influence ribosome function. Current Opinion in Microbiology, 14(2), 160–
166.  
Cserzö, M., Wallin, E., Simon, I., von Heijne, G., & Elofsson, A. (1997). Prediction of 
transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface 
method. Protein Engineering, 10(6), 673–676.  
Dallas,  A, & Noller, H. F. (2001). Interaction of translation initiation factor 3 with the 30S 
ribosomal subunit. Molecular Cell, 8(4), 855–864.  
Denks, K., Vogt, A., Sachelaru, I., Petriman, N., Kudva, R., & Koch, H. (2014). The Sec translocon 
mediated protein transport in prokaryotes and eukaryotes. Molecular Membrane Biology, 
31(2-3), 58–84.  
Deshaies, R. J., Sanders, S. L., Feldheim, D. a, & Schekman, R. (1991). Assembly of yeast Sec 
proteins involved in translocation into the endoplasmic reticulum into a membrane-bound 
multisubunit complex. Nature, 349(6312), 806–808.  
Dunkle, J. A., Wang, L., Feldman, M. B., Pulk, A., Chen, V. B., Kapral, G. J., Noeske, J., 
Richardson, J. S., Blanchard, S. C., & Cate, J. H. D. (2011). Structures of the bacterial 
ribosome in classical and hybrid states of tRNA binding. Science, 332(6032), 981–984.  
Egea, P. F., Stroud, R. M., & Walter, P. (2005). Targeting proteins to membranes: Structure of the 
signal recognition particle. Current Opinion in Structural Biology. 15(2) 213-220 
Emr, S. D., Hanley-Way, S., & Silhavy, T. J. (1981). Suppressor mutations that restore export of a 
protein with a defective signal sequence. Cell, 23(1), 79–88.  
Fang, H., & Green, N. (1994). Nonlethal sec71-1 and sec72-1 mutations eliminate proteins 
associated with the Sec63p-BiP complex from S. cerevisiae. Molecular Biology of the Cell, 
5(9), 933–942.  
Finke, K., Plath, K., Panzner, S., Prehn, S., Rapoport, T. A., Hartmann, E., & Sommer, T. (1996). 
A second trimeric complex containing homologs of the Sec61p complex functions in protein 
transport across the ER membrane of S. cerevisiae. The EMBO Journal, 15(7), 1482–94.  
Flanagan, J. J., Chen, J. C., Miao, Y., Shao, Y., Lin, J., Bock, P. E., & Johnson, A. E. (2003). 
Signal recognition particle binds to ribosome-bound signal sequences with fluorescence-
detected subnanomolar affinity that does not diminish as the nascent chain lengthens. Journal 
of Biological Chemistry, 278(20), 18628–18637.  
Fons, R. D., Bogert, B. A., & Hegde, R. S. (2003). Substrate-specific function of the translocon-
associated protein complex during translocation across the ER membrane. Journal of Cell 
Biology, 160(4), 529–539.  
Foster, W., Helm, A., Turnbull, I., Gulati, H., Yang, B., Verkman, A. S., & Skach, W. R. (2000). 
Identification of sequence determinants that direct different intracellular folding pathways for 
aquaporin-1 and aquaporin-4. Journal of Biological Chemistry, 275(44), 34157–34165.  
Frank, J., & Agrawal, R. K. (2000). A ratchet-like inter-subunit reorganization of the ribosome 
during translocation. Nature, 406(6793), 318–322.  
Frank, J., Zhu, J., Penczek, P., Li, Y., Srivastava, S., Verschoor,  A, Radermacher, M., Grassucci, 
R., Lata, R. K., & Agrawal, R. K. (1995). A model of protein synthesis based on cryo-
electron microscopy of the E. coli ribosome. Nature 376(6539) 441-444.  
Frauenfeld, J., Gumbart, J., Sluis, E. O. van der, Funes, S., Gartmann, M., Beatrix, B., Meilke, T., 
Berninghausen, O., Schulten, K., & Beckmann, R. (2011). Cryo-EM structure of the 
ribosome-SecYE complex in the membrane environment. Nature Structural & Molecular 
Biology, 18(5), 614–621.  
 
 
192 
 
Freistroffer, D. V., Pavlov, M. Y., MacDougall, J., Buckingham, R. H., & Ehrenberg, M. (1997). 
Release factor RF3 in E. coli accelerates the dissociation of release factors RF1 and RF2 from 
the ribosome in a GTP-dependent manner. EMBO Journal, 16(13), 4126–4133. 
Friedlander, M., & Blobel, G. (1985). Bovine opsin has more than one signal sequence. Nature, 
318(6044), 338–343. 
Gerhardy, S., Menet, A. M., Pena, C., Petkowski, J. J., & Panse, V. G. (2014). Assembly and 
nuclear export of pre-ribosomal particles in budding yeast. Chromosoma, 123(4), 327–344.  
Goder, V., & Spiess, M. (2001). Topogenesis of membrane proteins: Determinants and dynamics. 
FEBS Letters, 504(3), 87–93.  
Gogala, M., Becker, T., Beatrix, B., Armache, J.-P., Barrio-Garcia, C., Berninghausen, O., & 
Beckmann, R. (2014). Structures of the Sec61 complex engaged in nascent peptide 
translocation or membrane insertion. Nature, 506(7486), 107–10.  
Gong, F., & Yanofsky, C. (2002). Instruction of translating ribosome by nascent peptide. Science 
(New York, N.Y.), 297(5588), 1864–1867.  
Görlich, D., Hartmann, E., Prehn, S., & Rapoport, T. A. (1992). A protein of the endoplasmic 
reticulum involved early in polypeptide translocation. Nature, 357(6373), 47–52.  
Görlich, D., & Rapoport, T. A. (1993). Protein translocation into proteoliposomes reconstituted 
from purified components of the endoplasmic reticulum membrane, Cell 75(Mdc), 615–630.  
Greber, B. J., Bieri, P., Leibundgut, M., Leitner, A., Aebersold, R., Boehringer, D., & Ban, N. 
(2015). The complete structure of the 55. Nature, 348(6232), 303–308.  
Green, R., & Noller, H. F. (1997). Ribosomes and translation. Annual Review of Biochemistry, 66, 
679–716. 
Gross, J. D., Moerke, N. J., Von Der Haar, T., Lugovskoy, A. A., Sachs, A. B., McCarthy, J. E. G., 
& Wagner, G. (2003). Ribosome loading onto the mRNA cap is driven by conformational 
coupling between eIF4G and eIF4E. Cell, 115(6), 739–750. 
Grosshans, H., Deinert, K., Hurt, E., & Simos, G. (2001). Biogenesis of the signal recognition 
particle (SRP) involves import of SRP proteins into the nucleolus, assembly with the SRP-
RNA, and Xpo1p-mediated export. Journal of Cell Biology, 153(4), 745–761.  
Grudnik, P., Bange, G., & Sinning, I. (2009). Protein targeting by the signal recognition particle. 
Biological Chemistry, 390(8), 775–782. 
Gu, S.-Q. (2003). The signal recognition particle binds to protein L23 at the peptide exit of the 
Escherichia coli ribosome. RNA, 9(5), 566–573.  
Gundelfinger, E. D., Krause, E., Melli, M., & Dobberstein, B. (1983). The organization of the 7SL 
RNA in the signal recognition particle. Nucleic Acids Research, 11(21), 7363–7374.  
Hainzl, T., Huang, S., Merilainen, G., Brannstrom, K., & Sauer-Eriksson, A. E. (2011). Structural 
basis of signal-sequence recognition by the signal recognition particle. Nature Structural 
Moecular Biology, 18(3), 389–391.  
Halic, M., Becker, T., Pool, M. R., Spahn, C. M. T., Grassucci, R. a, Frank, J., & Beckmann, R. 
(2004). Structure of the signal recognition particle interacting with the elongation-arrested 
ribosome. Nature, 427(6977), 808–14.  
Halic, M., Blau, M., Becker, T., Mielke, T., Pool, M. R., Wild, K., Sinning, I., & Beckmann, R. 
(2006a). Following the signal sequence from ribosomal tunnel exit to signal recognition 
particle. Nature, 444(7118), 507–511.  
Halic, M., Gartmann, M., Schlenker, O., Mielke, T., Pool, M. R., Sinning, I., & Beckmann, R. 
(2006b). Signal recognition particle receptor exposes the ribosomal translocon binding site. 
Science, 312(5774), 745–747.  
Hamman, B. D., Hendershot, L. M., & Johnson, A. E. (1998). BiP maintains the permeability 
barrier of the ER membrane by sealing the lumenal end of the translocon pore before and 
early in translocation. Cell, 92(6), 747–758.  
Harada, Y., Li, H., Li, H., & Lennarz, W. J. (2009). Oligosaccharyltransferase directly binds to 
ribosome at a location near the translocon-binding site. Proceedings of the National Academy 
of Sciences of the United States of America, 106(17), 6945–6949.  
Harley, C. A., Holt, J. A., Turner, R., & Tipper, D. J. (1998). Transmembrane protein insertion 
orientation in yeast depends on the charge difference across transmembrane segments, their 
total hydrophobicity, and its distribution. Journal of Biological Chemistry, 273(38), 24963–
24971.  
 
 
193 
 
Hartmann, E., Görlich, D., Kostka, S., Otto, A., Kraft, R., Knespel, S., Burger, E., Rapoprt, T. A., 
& Prehn, S. (1993). A tetrameric complex of membrane proteins in the endoplasmic 
reticulum. European Journal of Biochemistry / FEBS, 214(2), 375–381. 
Hartmann, E., Rapoport, T. A., & Lodish, H. F. (1989). Predicting the orientation of eukaryotic 
membrane-spanning proteins. Proc Natl Acad Sci U S A, 86(15), 5786–5790.  
Hartz, D., Binkley, J., Hollingsworth, T., & Gold, L. (1990). Domains of initiator transfer-Rna and 
initiation codon crucial for initiator transfer-Rna selection by Escherichia-coli If3. Genes & 
Development, 4(10), 1790–1800.  
Hatsuzawa, K., Tagaya, M., & Mizushima, S. (1997). The hydrophobic region of signal peptides is 
a determinant for SRP recognition and protein translocation across the ER membrane. Journal 
of Biochemistry, 121, 270–277. 
Heinrich, S. U., Mothes, W., Brunner, J., & Rapoport, T. A. (2000). The Sec61p complex mediates 
the integration of a membrane protein by allowing lipid partitioning of the transmembrane 
domain. Cell, 102(2), 233–44.  
Heinrich, S. U., & Rapoport, T. A. (2003). Cooperation of transmembrane segments during the 
integration of a double-spanning protein into the ER membrane. EMBO Journal, 22(14), 
3654–3663.  
Helmers, J., Schmidt, D., Glavy, J. S., Blobel, G., & Schwartz, T. (2003). The β-subunit of the 
protein-conducting channel of the endoplasmic reticulum functions as the guanine nucleotide 
exchange factor for the β-subunit of the signal recognition particle receptor. Journal of 
Biological Chemistry, 278(26), 23686–23690. 
Hermans, J., Anderson, A. G., & Yun, R. H. (1992). Differential helix propensity of small apolar 
side chains studied by molecular dynamics simulations. Biochemistry, 31(24), 5646–5653.  
Hessa, T., Kim, H., Bihlmaier, K., Lundin, C., Boekel, J., Andersson, H., Nilsson, I., White, S. H., 
& von Heijne, G. (2005). Recognition of transmembrane helices by the endoplasmic 
reticulum translocon. Nature, 433(7024), 377–81.  
Hessa, T., Meindl-Beinker, N. M., Bernsel, A., Kim, H., Sato, Y., Lerch-Bader, M., Nilsson, I., 
White, S. H., & von Heijne, G. (2007). Molecular code for transmembrane-helix recognition 
by the Sec61 translocon. Nature, 450(7172), 1026–1030.  
Higy, M., Junne, T., & Spiess, M. (2004). Topogenesis of membrane proteins at the endoplasmic 
reticulum. Biochemistry, 43(40), 12716–12722.  
Hirashima, A., & Kaji, A. (1973). Role of elongation factor G and a protein factor on the release of 
ribosomes from messenger ribonucleic acid. Journal  Biological Chemistry, 248(21), 7580–
7587.  
Hoffmann, A., Becker, A. H., Zachmann-Brand, B., Deuerling, E., Bukau, B., & Kramer, G. 
(2012). Concerted action of the ribosome and the associated chaperone trigger factor confines 
nascent polypeptide folding. Molecular Cell, 48(1), 63–74.  
Hou, B., Lin, P. J., & Johnson, A. E. (2012). Membrane protein TM segments are retained at the 
translocon during integration until the nascent chain cues FRET-detected release into bulk 
lipid. Molecular Cell, 48(3), 398–408. 
Houben, E. N. G., Zarivach, R., Oudega, B., & Luirink, J. (2005). Early encounters of a nascent 
membrane protein: Specificity and timing of contacts inside and outside the ribosome. 
Journal of Cell Biology, 170(1), 27–35.  
Huber, D., Boyd, D., Xia, Y., Olma, M. H., Gerstein, M., & Beckwith, J. (2005). Use of 
thioredoxin as a reporter to identify a subset of Escherichia coli signal sequences that promote 
signal recognition particle-dependent translocation. Journal of Bacteriology, 187(9), 2983–
2991.  
Hung, D., Falcone, D., Lin, J., Andrews, D. W., & Johnson, A. E. (1996). The cotranslational 
integration of membrane proteins into the phospholipid bilayer is a multistep process. Cell, 
85(3), 369–378.  
Hwa, J., Klein-Seetharaman, J., & Khorana, H. G. (2001). Structure and function in rhodopsin: 
Mass spectrometric identification of the abnormal intradiscal disulfide bond in misfolded 
retinitis pigmentosa mutants. Proceedings of the National Academy of Sciences of the United 
States of America, 98(9), 4872–6.  
Ibba, M., Curnow, A. W., & Söll, D. (1997). Aminoacyl-tRNA synthesis: Divergent routes to a 
common goal. Trends in Biochemical Sciences, 22(2), 39–42. 
Ismail, N. (2006). Active and passive displacement of transmembrane domains both occur during 
opsin biogenesis at the Sec61 translocon. Journal of Cell Science, 119(13), 2826–2836.  
194 
 
Ismail, N., Crawshaw, S. G., Cross, B. C. S., Haagsma, A. C., & High, S. (2008). Specific 
transmembrane segments are selectively delayed at the ER translocon during opsin 
biogenesis. The Biochemical Journal, 411(3), 495–506.  
Ito, K., Uno, M., & Nakamura, Y. (2000). A tripeptide “anticodon” deciphers stop codons in 
messenger RNA. Nature, 403(6770), 680–684.  
Jackson, R. J., Hellen, C. U. T., & Pestova, T. V. (2012). Termination and post-termination events 
in eukaryotic translation. Advances in Protein Chemistry and Structural Biology  1(86). 45-
93  
Marino, J., von Heijne, G., & Beckmann, R. (2016). Small domains fold inside ribosome exit 
tunnel. Manuscript Submitted and under Publication, 590, 655–660.  
Jadhav, B., McKenna, M., Johnson, N., High, S., Sinning, I., & Pool, M. R. (2015). Mammalian 
SRP receptor switches the Sec61 translocase from Sec62 to SRP-dependent translocation. 
Nature Communications, 6, 10133.  
Janda, C. Y., Li, J., Oubridge, C., Hernandez, H., Robinson, C. V, & Nagai, K. (2010). Recognition 
of a signal peptide by the signal recognition particle. Nature, 465(7297), 507–510.  
Jenner, L., Melnikov, S., de Loubresse, N. G., Ben-Shem, A., Iskakova, M., Urzhumtsev, A., 
Meskauskas, A., Dinman, J., Yusupova, G., &  Yusupov, M. (2012). Crystal structure of the 
80S yeast ribosome. Current Opinion in Structural Biology, 22(6), 759–767.  
Kaiser, C. M., Chang, H.-C., Agashe, V. R., Lakshmipathy, S. K., Etchells, S. A, Hayer-Hartl, M., 
Hartl, U., &  Barral, J. M. (2006). Real-time observation of trigger factor function on 
translating ribosomes. Nature, 444(7118), 455–460.  
Kalies, K. U., Rapoport, T. A., & Hartmann, E. (1998). The β subunit of the Sec61 complex 
facilitates cotranslational protein transport and interacts with the signal peptidase during 
translocation. Journal of Cell Biology, 141(4), 887–894. 7 
Karamyshev, A. L., Patrick, A. E., Karamysheva, Z. N., Griesemer, D. S., Hudson, H., Tjon-Kon-
Sang, S., Nilsson, I., Otto, H., Liu, Q., Rospert, S., von Heijne, G., Johnson, A. E., & Thomas, 
P. J. (2014). Inefficient SRP interaction with a nascent chain triggers a MRNA quality control 
pathway. Cell, 156(1-2), 146–157.  
Kauko, A., Hedin, L. E., Thebaud, E., Cristobal, S., Elofsson, A., & von Heijne, G. (2010). 
Repositioning of Transmembrane ??-Helices during Membrane Protein Folding. Journal of 
Molecular Biology, 397(1), 190–201.  
Keenan, R., & Freymann, D. (2001). The signal recognition particle. Annual Review of 
Biochemistry, 70, 755–75.  
Keenan, R. J., Freymann, D. M., Walter, P., & Stroud, R. M. (1998). Crystal structure of the signal 
sequence binding subunit of the signal recognition particle. Cell, 94(2), 181–191.  
Kolupaeva, V. G., Breyne, S. de, Pestova, T. V., & Hellen, C. U. T. (2007). In Vitro Reconstitution 
and biochemical characterization of translation initiation by internal ribosomal entry. Methods 
in Enzymology 430 (7) 409-439  
Kosolapov, A., & Deutsch, C. (2003). Folding of the voltage-gated K+ channel T1 recognition 
domain. Journal of Biological Chemistry, 278(6), 4305–4313.  
Kosolapov, A., & Deutsch, C. (2009). Tertiary interactions within the ribosomal exit tunnel. Nature 
Structural & Molecular Biology, 16(4), 405–411.  
Kosolapov, A., Tu, L., Wang, J., & Deutsch, C. (2004). Structure acquisition of the T1 domain of 
Kv1.3 during biogenesis. Neuron, 44(2), 295–307.  
Kozak, M. (1986). Point mutations define a sequence flanking the AUG initiator codon that 
modulates translation by eukaryotic ribosomes. Cell, 44(2), 283–292.  
Kramer, G., Kudlicki, W., McCarthy, D., Tsalkova, T., Simmons, D., & Hardesty, B. (1999). N-
terminal and C-terminal modifications affect folding, release from the ribosomes and stability 
of in vitro synthesized proteins. International Journal of Biochemistry and Cell Biology, 
31(1), 231–241.  
Kramer, G., Ramachandiran, V., & Hardesty, B. (2001). Cotranslational folding--omnia mea 
mecum porto? The International Journal of Biochemistry & Cell Biology, 33(6), 541–553.  
Kroczynska, B., Evangelista, C. M., Samant, S. S., Elguindi, E. C., & Blond, S. Y. (2004). The 
SANT2 domain of the murine tumorcell DnaJ-like protein 1 human homologue interacts with 
α1-antichymotrypsin and kinetically interferes with its serpin inhibitory activity. Journal of 
Biological Chemistry, 279(12), 11432–11443.  
Laird, V., & High, S. (1997). Discrete cross-linking products identified during membrane protein 
biosynthesis. Journal of Biological Chemistry, 272(3), 1983–1989.  
195 
 
Lakkaraju,  a. K. K., Mary, C., Scherrer, A., Johnson, A. E., & Strub, K. (2008). SRP Keeps 
Polypeptides Translocation-Competent by Slowing Translation to Match Limiting ER-
Targeting Sites. Cell, 133(3), 440–451. 
Lang, S., Benedix, J., Fedeles, S. V., Schorr, S., Schirra, C., Schauble, N., Jalal, C., Greiner, M., 
Haßdenteufel, S.,  Tatzelt, J., Kreutzer, B., Edelmann, L., Krause, E., Rettig, J., Somlo, S.,  
Zimmermann, R., & Dudek, J. (2012). Different effects of Sec61 , Sec62 and Sec63 depletion 
on transport of polypeptides into the endoplasmic reticulum of mammalian cells. Journal of 
Cell Science, 125, 1958–1969. doi:10.1242/jcs.096727 
Laurberg, M., Asahara, H., Korostelev, A., Zhu, J., Trakhanov, S., & Noller, H. F. (2008). 
Structural basis for translation termination on the 70S ribosome. Nature, 454(7206), 852–7.  
Laursen, B., & Sørensen, H. (2005). Initiation of protein synthesis in bacteria. Microbiology and 
Molecular Biology Reviews, 236(3), 747–771.  
Li, L., Park, E., Ling, J., Ingram, J., Ploegh, H., & Rapoport, T. A. (2016). Crystal structure of a 
substrate-engaged SecY protein-translocation channel. Nature, 531(7594), 395–399.  
Liao, S., Lin, J., Do, H., & Johnson, A. E. (1997). Both lumenal and cytosolic gating of the 
aqueous ER translocon pore are regulated from inside the ribosome during membrane protein 
integration. Cell, 90(1), 31–41.  
Lin, P. J., Jongsma, C. G., Pool, M. R., & Johnson, A. E. (2011). Polytopic membrane protein 
folding at L17 in the ribosome tunnel initiates cyclical changes at the translocon. Journal of 
Cell Biology, 195(1), 55–70.  
Lockwood,  A. H., Chakraborty, P. R., & Maitra, U. (1971). A complex between initiation factor 
IF2, guanosine triphosphate, and fMet-tRNA: an intermediate in initiation complex formation. 
Proceedings of the National Academy of Sciences of the United States of America, 68(12), 
3122–6.  
Lu, J., & Deutsch, C. (2005b). Secondary Structure Formation of a Transmembrane Segment in Kv 
Channels Secondary Structure Formation of a Transmembrane Segment in Kv Channels. 
Proteins, 44, 8230–8243.  
Lu, J., & Deutsch, C. (2005a). Folding zones inside the ribosomal exit tunnel. Nature Structural & 
Molecular Biology, 12(12), 1123–1129.  
Lu, J., & Deutsch, C. (2014). Regional Discrimination and Propagation of Local Rearrangements 
along the Ribosomal Exit Tunnel. Journal of Molecular Biology, 426(24), 4061–4073.  
Lu, J., Kobertz, W. R., & Deutsch, C. (2007). Mapping the electrostatic potential within the 
ribosomal exit tunnel. Journal of Molecular Biology, 371(5), 1378–1391.  
Lu, Y., Turnbull, I. R., Bragin,  a, Carveth, K., Verkman,  A S., & Skach, W. R. (2000). 
Reorientation of aquaporin-1 topology during maturation in the endoplasmic reticulum. 
Molecular Biology of the Cell, 11(9), 2973–2985.  
Luirink, J. (2004). SRP-mediated protein targeting: structure and function revisited. Biochimica et 
Biophysica Acta - Molecular Cell Research, 1694 (1-3), 17–35.  
Lycklama A Nijeholt, J. A., De Keyzer, J., Prabudiansyah, I., & Driessen, A. J. M. (2013). 
Characterization of the supporting role of SecE in protein translocation. FEBS Letters, 
587(18),  
MacKenzie, A. E., Caltabiano, G., Kent, T. C., Jenkins, L., McCallum, J. E., Hudson, B. D., 
Nicklin, S. A., Fawcett, L., Markwick, R., Charlton, S. J., & Milligan, G. (2014). The 
antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent 
agonists of human and rat GPR35. Molecular Pharmacology, 85, 91–104.  
Mackenzie, A. E., & Milligan, G. (2015). The emerging pharmacology and function of GPR35 in 
the nervous system. Neuropharmacology. 1-11 
Malkin, L. I., & Rich, A. (1967). Partial resistance of nascent polypeptide chains to proteolytic 
digestion due to ribosomal shielding. Journal of Molecular Biology, 26(2), 329–346. 
doi:10.1016/0022-2836(67)90301-4 
Mccormick, P. J., Miao, Y., Shao, Y., Lin, J., & Johnson, A. E. (2003). Cotranslational protein 
integration into the ER membrane is mediated by the binding of nascent chains to translocon 
proteins. Molecular Cell, 12, 329–341. 
Meacock, S. L. Lecomte F. J. L. Cranshaw, S. G. High, S. (2002). Different Transmembrane 
Domains Associate with Distinct Endoplasmic Reticulum Components during Membrane 
Integration of a Polytopic Protein. Molecular Biology of the Cell, 13(12), 4114–4129.  
 
 
196 
 
Ménétret, J. F., Hegde, R. S., Heinrich, S. U., Chandramouli, P., Ludtke, S. J., Rapoport, T. A., & 
Akey, C. W. (2005). Architecture of the ribosome-channel complex derived from native 
membranes. Journal of Molecular Biology, 348(2), 445–457.  
Milligan, G. (2011). Orthologue selectivity and ligand bias: Translating the pharmacology of 
GPR35. Trends in Pharmacological Sciences, 32(5), 317–325.  
Mingarro, I., Nilsson, I., Whitley, P., & von Heijne, G. (2000). Different conformations of nascent 
polypeptides during translocation across the ER membrane. BMC Cell Biology, 1, 3.  
Mitchell, S. F., & Lorsch, J. R. (2008). Should I stay or should I go? Eukaryotic translation 
initiation factors 1 and 1A control start codon recognition. Journal of Biological Chemistry, 
283(41), 27345–27349.  
Mitra, K., Schaffitzel, C., Shaikh, T., Tama, F., Jenni, S., Brooks, C. L., Ban, N., & Frank, J. 
(2005). Structure of the E. coli protein-conducting channel bound to a translating ribosome. 
Nature, 438(7066), 318–324. 
Mothes, W., Heinrich, S. U., Graf, R., Nilsson, I., von Heijne, G., Brunner, J., & Rapoport, T. A. 
(1997). Molecular Mechanism of Membrane Protein Integration into the Endoplasmic 
Reticulum. Cell, 89(4), 523–533. 
Muller, L., de Escauriaza, M. D., Lajoie, P., Theis, M., Jung, M., Muller, A., Burgard, C.,   
Greiner, M., Snapp, E. L., Dudek, J., &  Zimmermann, R. (2010). Evolutionary gain of function for 
the ER membrane protein Sec62 from yeast to humans. Molecular Biology of the Cell, 21(5), 
691–703.  
Nakatogawa, H., & Ito, K. (2002). The Ribosomal Exit Tunnel Functions as a Discriminating Gate. 
Cell, 108, 629–636. 
Nicchitta, C. V., & Blobel, G. (1993). Lumenal proteins of the mammalian endoplasmic reticulum 
are required to complete protein translocation. Cell, 73(5), 989–998.  
Nilsson, I., Lara, P., Hessa, T., Johnson, A. E., von Heijne, G., & Karamyshev, A. L. (2015). The 
code for directing proteins for translocation across ER membrane: SRP cotranslationally 
recognizes specific features of a signal sequence. Journal of Molecular Biology, 427(6), 
1191–1201.  
Nilsson, O. B., Hedman, R., Marino, J., Wickles, S., Bischoff, L., Johansson, M., … von Heijne, G. 
(2015). Cotranslational Protein Folding inside the Ribosome Exit Tunnel. Cell Reports, 
12(10), 1533-1540 
Nissen, P. (2000). The Structural Basis of Ribosome Activity in Peptide Bond Synthesis. Science, 
289(5481), 920–930.  
Nyathi, Y., Wilkinson, B. M., & Pool, M. R. (2013). Co-translational targeting and translocation of 
proteins to the endoplasmic reticulum. Biochimica et Biophysica Acta - Molecular Cell 
Research, 1833(11), 2392–2402. 
O‟Brien, E. P., Hsu, S. T. D., Christodoulou, J., Vendruscolo, M., & Dobson, C. M. (2010). 
Transient tertiary structure formation within the ribosome exit port. Journal of the American 
Chemical Society, 132(47), 16928–16937. 
O‟Dowd, B. F., Nguyen, T., Marchese, A., Cheng, R., Lynch, K. R., Heng, H. H., Kolakowski, L. 
F., George, S. R. (1998). Discovery of three novel G-protein-coupled receptor genes. 
Genomics, 47(2), 310–3.  
Ogle, J. M., Brodersen, D. E., Clemons, W. M., Tarry, M. J., Carter,  a P., & Ramakrishnan, V. 
(2001). Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science, 
292(5518), 897–902.  
Öjemalm, K., Halling, K. K., Nilsson, I., & Von Heijne, G. (2012). Orientational preferences of 
neighboring helices can drive ER insertion of a marginally hydrophobic transmembrane helix. 
Molecular Cell, 45(4), 529–540.  
Okumura, S. I., Baba, H., Kumada, T., Nanmoku, K., Nakajima, H., Nakane, Y., Hioki, N., & 
Ikenaka, K. (2004). Cloning of a G-protein-coupled receptor that shows an activity to 
transform NIH3T3 cells and is expressed in gastric cancer cells. Cancer Science, 95(2), 131–
135.  
Osborne, A. R., & Rapoport, T. A. (2007). Protein Translocation Is Mediated by Oligomers of the 
SecY Complex with One SecY Copy Forming the Channel. Cell, 129(1), 97–110.  
Oubridge, C., Kuglstatter, A., Jovine, L., & Nagai, K. (2002). Crystal structure of SRP19 in 
complex with the S domain of SRP RNA and its implication for the assembly of the signal 
recognition particle. Molecular Cell, 9(6), 1251–1261.  
 
197 
 
Pace, C. N., & Scholtz, J. M. (1998). A helix propensity scale based on experimental studies of 
peptides and proteins. Biophysical Journal, 75(1), 422–427. 
Passmore, L. A., Schmeing, T. M., Maag, D., Applefield, D. J., Acker, M. G., Algire, M., … 
Ramakrishnan, V. (2007). The Eukaryotic Translation Initiation Factors eIF1 and eIF1A 
Induce an Open Conformation of the 40S Ribosome. Molecular Cell, 26(1), 41–50.  
Patterson, M. A., Bandyopadhyay, A., Devaraneni, P. K., Woodward, J., Rooney, L., Yang, Z., & 
Skach, W. R. (2015). The ribosome-Sec61 translocon complex forms a cytosolically restricted 
environment for early polytopic membrane protein folding. Journal of Biological Chemistry, 
290(48), 28944–28952.  
Peeters, M. C., Wisse, L. E., Dinaj,  a., Vroling, B., Vriend, G., & Ijzerman,  A. P. (2012). The role 
of the second and third extracellular loops of the adenosine A1 receptor in activation and 
allosteric modulation. Biochemical Pharmacology, 84(1), 76–87.  
Pestova, T. V, Borukhov, S. I., & Hellen, C. U. (1998). Eukaryotic ribosomes require initiation 
factors 1 and 1A to locate initiation codons. Nature, 394(6696), 854–859.  
Pestova, T. V, & Hellen, C. U. (2001). Preparation and activity of synthetic unmodified 
mammalian tRNAi(Met) in initiation of translation in vitro. Rna, 7(10), 1496–1505.  
Pestova, T. V, Kolupaeva, V. G., Lomakin, I. B., Pilipenko, E. V, Shatsky, I. N., Agol, V. I., & 
Hellen, C. U. (2001). Molecular mechanisms of translation initiation in eukaryotes. 
Proceedings of the National Academy of Sciences of the United States of America, 98(13), 
7029–36.  
Pestova, T. V, Lomakin, I. B., Lee, J. H., Choi, S. K., Dever, T. E., & Hellen, C. U. (2000). The 
joining of ribosomal subunits in eukaryotes requires eIF5B. Nature, 403(6767), 332–335.  
Peterson, J. H., Woolhead, C. a., & Bernstein, H. D. (2010). The conformation of a nascent 
polypeptide inside the ribosome tunnel affects protein targeting and protein folding. 
Molecular Microbiology, 78(1), 203–217. 
Petrelli, D., La Teana, A., Garofalo, C., Spurio, R., Pon, C. L., & Gualerzi, C. O. (2001). 
Translation initiation factor IF3: Two domains, five functions, one mechanism? EMBO 
Journal, 20(16), 4560–4569.  
Pfeffer, S., Burbaum, L., Unverdorben, P., Pech, M., Chen, Y., Zimmermann, R., Beckmann, R., & 
Förster, F. (2015). Structure of the native Sec61 protein-conducting channel. Nature 
Communications, 6, 8403 1-7.  
Pfeffer, S., Dudek, J., Gogala, M., Schorr, S., Linxweiler, J., Lang, S., Becker, T., Beckmann, R., 
Zimmermann, R., & Förster, F. (2014). Structure of the mammalian oligosaccharyl-
transferase complex in the native ER protein translocon. Nature Communications, 5, 3072.  
Pfeiffer, N. V, Dirndorfer, D., Lang, S., Resenberger, U. K., Restelli, L. M., Hemion, C., 
Miesbauer, M., Frank, S., Neutzer, Zimmermann, R., Winklhofer & Tatzelt, J. (2013). 
Structural features within the nascent chain regulate alternative targeting of secretory proteins 
to mitochondria. The EMBO Journal, 32(7), 1036–51.  
Pisarev, A. V., Skabkin, M. A., Pisareva, V. P., Skabkina, O. V., Rakotondrafara, A. M., Hentze, 
M. W., … Pestova, T. V. (2010). The Role of ABCE1 in Eukaryotic Posttermination 
Ribosomal Recycling. Molecular Cell, 37(2), 196–210. 4 
Plath, K., Mothes, W., Wilkinson, B. M., Stirling, C. J., & Rapoport, T. A. (1998). Signal sequence 
recognition in posttranslational protein transport across the yeast ER membrane. Cell, 94(6), 
795–807.  
Politz, J. C., Yarovoi, S., Kilroy, S. M., Gowda, K., Zwieb, C., & Pederson, T. (2000). Signal 
recognition particle components in the nucleolus. Proceedings of the National Academy of 
Sciences of the United States of America, 97(1), 55–60.  
Pool, M. R. (2005). Signal recognition particles in chloroplasts, bacteria, yeast and mammals. 
Molecular Membrane Biology, 22(1-2), 3–15.  
Pool, M. R. (2009). A trans-membrane segment inside the ribosome exit tunnel triggers RAMP4 
recruitment to the Sec61p translocase. Journal of Cell Biology, 185(5), 889–902.  
Powers, T., & Walter, P. (1995). Reciprocal stimulation of GTP hydrolysis by two directly 
interacting GTPases. Science, 269(C), 1422–1424.  
Rapoport, T. A. (2007). Protein translocation across the eukaryotic endoplasmic reticulum and 
bacterial plasma membranes. Nature, 450(7170), 663–9.  
Robinson, P. J., Findlay, J. E., & Woolhead, C. A. (2012). Compaction of a prokaryotic signal-
anchor transmembrane domain begins within the ribosome tunnel and is stabilized by SRP 
during targeting. Journal of Molecular Biology, 423(4), 600–612.  
198 
 
Rodnina, M. V., Pape, T., Fricke, R., Kuhn, L., & Wintermeyer, W. (1996). Initial binding of the 
elongation factor Tu-GTP-aminoacyl-tRNA complex preceding codon recognition on the 
ribosome. Journal of Biological Chemistry, 271(2), 646–652.  
Rodnina, M. V, Savelsbergh,  a, Katunin, V. I., & Wintermeyer, W. (1997). Hydrolysis of GTP by 
elongation factor G drives tRNA movement on the ribosome. Nature, 385(6611), 37–41.  
Rorbach, J., Richter, R., Wessels, H. J., Wydro, M., Pekalski, M., Farhoud, M., Kuhl, I., Gaisne, 
M., Bonnefoy, N.,  Smeitink, J. A., Lightowlers, R. N., & Chrzanowska-Lightowlers, Z. M. 
A. (2008). The human mitochondrial ribosome recycling factor is essential for cell viability. 
Nucleic Acids Research, 36(18), 5787–5799.  
Rosendal, K. R., Sinning, I., & Wild, K. (2004). Crystallization of the crenarchaeal SRP core. Acta 
Crystallographica Section D: Biological Crystallography, 60(1), 140–143.  
Rothblatt, J. a, Deshaies, R. J., Sanders, S. L., Daum, G., & Schekman, R. (1989). Multiple genes 
are required for proper insertion of secretory proteins into the endoplasmic reticulum in yeast. 
The Journal of Cell Biology, 109(6), 2641–2652. 
Sadlish, H., Pitonzo, D., Johnson, A. E., & Skach, W. R. (2005). Sequential triage of 
transmembrane segments by Sec61alpha during biogenesis of a native multispanning 
membrane protein. Nature Structural & Molecular Biology, 12(10), 870–878.  
Sato, M., Hresko, R., & Mueckler, M. (1998). Testing the charge difference hypothesis for the 
assembly of a eucaryotic multispanning membrane protein. Journal of Biological Chemistry, 
273(39), 25203–25208 
Savelsbergh, A., Katunin, V. I., Mohr, D., Peske, F., Rodnina, M. V., & Wintermeyer, W. (2003). 
An Elongation Factor G-Induced Ribosome Rearrangement Precedes tRNA-mRNA 
Translocation. Molecular Cell, 11(6), 1517–1523. 
 Schaffitzel, C., Oswald, M., Berger, I., Ishikawa, T., Abrahams, J. P., Koerten, H. K., Koning, R. 
I., & Ban, N. (2006). Structure of the E. coli signal recognition particle bound to a translating 
ribosome. Nature, 444(7118), 503–506.  
Schäuble, N., Lang, S., Jung, M., Cappel, S., Schorr, S., Ulucan, Ö., Linxweiler, J., Dudek, J., 
Blum, R., Helms, V., Paton, A. W., Paton, J., Cavalie, A., & Zimmermann, R. (2012). BiP-
mediated closing of the Sec61 channel limits Ca2+ leakage from the ER. The EMBO Journal, 
31(15), 3282–96.  
Schmeing, T. M., Voorhees, R.M.,  Kelley, A. C., Gao, Y., Murphy IV, F. V., Weir, J. R., & 
Ramakrishnan, V.(2010). The Crystal Structure of the Ribosome. Risk Management, 
688(October), 688–695.  
Schmeing, T. M., & Ramakrishnan, V. (2009). What recent ribosome structures have revealed 
about the mechanism of translation. Nature, 461(7268), 1234–1242.  
Schütz, P., Bumann, M., Oberholzer, A. E., Bieniossek, C., Trachsel, H., Altmann, M., & 
Baumann, U. (2008). Crystal structure of the yeast eIF4A-eIF4G complex: an RNA-helicase 
controlled by protein-protein interactions. Proceedings of the National Academy of Sciences 
of the United States of America, 105(28), 9564–9.  
Seidelt, B., Innis, C. A., Wilson, D. N., Gartmann, M., Armache, J.-P., Villa, E., … Beckmann, R. 
(2009). Structural insight into nascent polypeptide chain-mediated translational stalling. 
Science (New York, N.Y.), 326(5958), 1412–1415.  
Shan, S. O., Chandrasekar, S., & Walter, P. (2007). Conformational changes in the GTPase 
modules of the signal reception particle and its receptor drive initiation of protein 
translocation. Journal of Cell Biology, 178(4), 611–620. 
Shan, S., Stroud, R. M., & Walter, P. (2004). Mechanism of association and reciprocal activation of 
two GTPases. PLoS Biology, 2(10), 572-582.  
Shao, S., & Hegde, R. S. (2011). Membrane protein insertion at the endoplasmic reticulum. Annual 
Review of Cell and Developmental Biology, 27, 25–56.  
Shatkin, A. J. (1976). Capping of eucaryotic mRNAs. Cell, 9(4), 645–653.  
Sheets, M. D., & Wickens, M. (1989). Two phases in the addition of a poly ( A ) tail. Genes & 
Development, 1401–1412. 
Shen, K., Arslan, S., Akopian, D., Ha, T., & Shan, S. (2012). Activated GTPase movement on an 
RNA scaffold drives co-translational protein targeting. Nature, 492(7428), 271–5.  
Shibatani, T., David, L. L., McCormack, A. L., Frueh, K., & Skach, W. R. (2005). Proteomic 
analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain 
Sec61, TRAP, and two potential new subunits. Biochemistry, 44(16), 5982–5992.  
Shine, J., & Dalgarno, L. (1974). The 3‟-terminal sequence of Escherichia coli 16S ribosomal 
199 
 
RNA: complementarity to nonsense triplets and ribosome binding sites. Proceedings of the 
National Academy of Sciences of the United States of America, 71(4), 1342–6.  
Sievers, A., Beringer, M., Rodnina, M. V, & Wolfenden, R. (2004). The ribosome as an entropy 
trap.., Proceedings of the National Academy of Sciences of the United States of America 
101(21), 7897–901.  
Sommer, N., Junne, T., Kalies, K. U., Spiess, M., & Hartmann, E. (2013). TRAP assists membrane 
protein topogenesis at the mammalian ER membrane. Biochimica et Biophysica Acta - 
Molecular Cell Research, 1833(12), 3104–3111.  
Sonenberg, N., & Hinnebusch, A. G. (2009). Regulation of Translation Initiation in Eukaryotes: 
Mechanisms and Biological Targets. Cell, 136(4), 731–745.  
Spahn, C. M. T., Beckmann, R., Eswar, N., Penczek, P. A., Sali, A., Blobel, G., & Frank, J. (2001). 
Structure of the 80S ribosome from Saccharomyces cerevisiae - tRNA-ribosome and subunit-
subunit interactions. Cell, 107(3), 373–386.  
Thomas, Y., Bui, N., & Strub, K. (1997). A truncation in the 14 kDa protein of the signal 
recognition particle leads to tertiary structure changes in the RNA and abolishes the 
elongation arrest activity of the particle. Nucleic Acids Research, 25(10), 1920–1929.  
Tsukazaki, T., Mori, H., Fukai, S., Ishitani, R., Mori, T., Dohmae, N., Perederina, A., Sugita, Y., 
Vassylyev, D. G., Ito, K., & Nureki, O. (2008). Conformational transition of Sec machinery 
inferred from bacterial SecYE structures. Nature, 455(7215), 988–91.  
Tu, L., Khanna, P., & Deutsch, C. (2014). Transmembrane segments form tertiary hairpins in the 
folding vestibule of the ribosome. Journal of Molecular Biology, 426(1), 185–198.  
Tu, L. W., & Deutsch, C. (2010). A Folding Zone in the Ribosomal Exit Tunnel for Kv1.3 Helix 
Formation. Journal of Molecular Biology, 396(5), 1346–1360.  
Tu, L., Wang, J., Helm, A., Skach, W. R., & Deutsch, C. (2000). Transmembrane biogenesis of 
Kv1.3. Biochemistry, 39(4), 824–836.  
Tyedmers, J., Lerner, M., Wiedmann, M., Volkmer, J., & Zimmermann, R. (2003). Polypeptide-
binding proteins mediate completion of co-translational protein translocation into the 
mammalian endoplasmic reticulum. EMBO Reports, 4(5), 505–10.  
Ullers, R. S., Houben, E. N. G., Raine, A., Ten Hagen-Jongman, C. M., Ehrenberg, M., Brunner, J., 
Oudega, B., & Luirink, J. (2003). Interplay of signal recognition particle and trigger factor at 
L23 near the nascent chain exit site on the Escherichia coli ribosome. Journal of Cell Biology, 
161(4), 679–684.  
Ulmschneider, M. B., Ulmschneider, J. P., Schiller, N., Wallace, B. a., von Heijne, G., & White, S. 
H. (2014). Spontaneous transmembrane helix insertion thermodynamically mimics 
translocon-guided insertion. Nature Communications, 5, 4863. 
Van Der Laan, M., Bechduft, P., Kol, S., Nouwen, N., & Driessen, A. J. M. (2004). F1F0 ATP 
synthase subunit c is a substrate of the novel YidC pathway for membrane protein biogenesis. 
Journal of Cell Biology, 165(2), 213–222. 
Voigt, S., Jungnickel, B., Hartmann, E., & Rapoport, T. A. (1996). Signal sequence-dependent 
function of the TRAM protein during early phases of protein transport across the endoplasmic 
reticulum membrane. Journal of Cell Biology, 134(1), 25–35.  
von Heijne, G. (1985). Signal sequences. Journal of Molecular Biology, 184(1), 99–105.  
von Heijne, G. (1990). The Signal peptide. J Membr Biol, 115, 195–201.  
von Heijne, G. (1992). Membrane protein structure prediction. Journal of Molecular Biology, 
225(2), 487–494. 
Voorhees, R. M., & Hegde, R. S. (2015). Structures of the scanning and engaged states of the 
mammalian SRP-ribosome complex. eLife, 4, 1–21.  
Voss, N. R., Gerstein, M., Steitz, T. a., & Moore, P. B. (2006). The geometry of the ribosomal 
polypeptide exit tunnel. Journal of Molecular Biology, 360(4), 893–906.  
Wang, J., & Purisima, E. O. (1996). Analysis of thermodynamic determinants in helix propensities 
of nonpolar amino acids through a novel free energy calculation. Journal of the American 
Chemical Society, 118(5), 995–1001.  
Wang, S., Sakai, H., & Wiedmann, M. (1995). NAC covers ribosome-associated nascent chains 
thereby forming a protective environment for regions of nascent chains just emerging from 
the peptidyl transferase center. Journal of Cell Biology, 130(3), 519–528.  
Watson, H. R., Wunderley, L., Andreou, T., Warwicker, J., & High, S. (2013). Reorientation of the 
first signal-anchor sequence during potassium channel biogenesis at the Sec61 complex. 
Biochemical Journal, 456(2), 297–309.  
200 
 
Weichenrieder, O., Stehlin, C., Kapp, U., Birse, D. E., Timmins, P. A., Strub, K., & Cusack, S. 
(2001). Hierarchical assembly of the Alu domain of the mammalian signal recognition 
particle. RNA, 7(5), 731–40.  
Weixlbaumer, A., Jin, H., Neubauer, C., Voorhees, R. M., Petry, S., Kelley, A. C., & 
Ramakrishnan, V. (2008). Insights into Translational Termination from the Structure of RF2 
Bound to the Ribosome. Science, 322(5903), 953–956.  
White, S. H., & Von Heijne, G. (2005). Transmembrane helices before, during, and after insertion. 
Current Opinion in Structural Biology, 15(4), 378–386.  
Whitley, P., Nilsson, I., & Von Heijne, G. (1996). A nascent secretory protein may traverse the 
ribosome/endoplasmic reticulum translocase complex as an extended chain. Journal of 
Biological Chemistry, 271(11), 6241–6244.  
Wild, K., Halic, M., Sinning, I., & Beckmann, R. (2004). SRP meets the ribosome. Nature 
Structural & Molecular Biology, 11(11), 1049–1053.  
Wilkinson, B. M., Brownsword, J. K., Mousley, C. J., & Stirling, C. J. (2010). Sss1p is required to 
complete protein translocon activation. Journal of Biological Chemistry, 285(42), 32671–
32677. d 
Wimberly, B. T., Brodersen, D. E., Clemons Jr, W. M., Morgan-Warren, R. J., Carter, A. P., 
Vonrhein, C., Hartsch, T., &  Ramakrishnan, V. (2000). Structure of the 30S ribosomal 
subunit. Nature, 407, 327–339.  
Woolhead, C. A., Johnson, A. E., & Bernstein, H. D. (2006). Translation arrest requires two-way 
communication between a nascent polypeptide and the ribosome. Molecular Cell, 22(5), 587–
598.  
Woolhead, C. A., McCormick, P. J., & Johnson, A. E. (2004). Nascent membrane and secretory 
proteins differ in FRET-detected folding far inside the ribosome and in their exposure to 
ribosomal proteins. Cell, 116(5), 725–736. 
Yam, A. Y., Xia, Y., Lin, H.-T. J., Burlingame, A., Gerstein, M., & Frydman, J. (2008). Defining 
the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins 
with complex topologies. Nature Structural & Molecular Biology, 15(12), 1255–62.  
Yonath, A., Leonard, K. R., & Wittmann, H. G. (1987). A tunnel in the large ribosomal subunit 
revealed by three-dimensionnal image reconstruction. Science, 236(15), 813–816. 
Yosef, I., Bochkareva, E. S., & Bibi, E. (2010). Escherichia coli SRP, Its Protein Subunit Ffh, and 
the Ffh M Domain Are Able To Selectively Limit Membrane Protein Expression When 
Overexpressed. mBio, 1(2), e00020–10–e00020–16. 
Yusupova, G. Z., Yusupov, M. M., Cate, J. H. D., & Noller, H. F. (2001). The path of messenger 
RNA through the ribosome. Cell, 106(2), 233–241.  
Zavialov, A. V., Buckingham, R. H., & Ehrenberg, M. (2001). A posttermination ribosomal 
complex is the guanine nucleotide exchange factor for peptide release factor RF3. Cell, 
107(1), 115–124.  
Zavialov, A. V., Hauryliuk, V. V., & Ehrenberg, M. (2005). Guanine-nucleotide exchange on 
ribosome-bound elongation factor G initiates the translocation of tRNAs. Journal of Biology, 
4(2), 9.  
Zhang, D., & Shan, S. O. (2012). Translation elongation regulates substrate selection by the signal 
recognition particle. Journal of Biological Chemistry, 287(10), 7652–7660.  
Zhang, X., Kung, S., & Shan, S. ou. (2008). Demonstration of a Multistep Mechanism for 
Assembly of the SRP??SRP Receptor Complex: Implications for the Catalytic Role of SRP 
RNA. Journal of Molecular Biology, 381(3), 581–593. 
Zheng, N., & Gierasch, L. M. (1996). Signal sequences: The same yet different. Cell, 86(6), 849–
852.  
Ziv, G., Haran, G., & Thirumalai, D. (2005). Ribosome exit tunnel can entropically stabilize alpha-
helices. Proceedings of the National Academy of Sciences of the United States of America, 
102(52), 18956–18961.  
Zopf, D., Bernstein, H. D., Johnson, A. E., & Walter, P. (1990). The methionine-rich domain of the 
54 kd protein subunit of the signal recognition particle contains an RNA binding site and can 
be crosslinked to a signal sequence. The EMBO Journal, 9(13), 4511–7.  
Zucca, P., & Sanjust, E. (2014). Inorganic materials as supports for covalent enzyme 
immobilization: Methods and mechanisms. Molecules, 19(9), 14139–14194.  
 
 
201 
 
 
 
 
